efo_id	trait	uri
EFO_0001060	celiac disease	http://www.ebi.ac.uk/efo/EFO_0001060
EFO_0001065	endometriosis	http://www.ebi.ac.uk/efo/EFO_0001065
EFO_0001068	malaria	http://www.ebi.ac.uk/efo/EFO_0001068
EFO_0001071	lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071
EFO_0005133	MHPG measurement	http://www.ebi.ac.uk/efo/EFO_0005133
EFO_0005130	thyroxine measurement	http://www.ebi.ac.uk/efo/EFO_0005130
EFO_0005119	antioxidant measurement	http://www.ebi.ac.uk/efo/EFO_0005119
EFO_0005108	arm span	http://www.ebi.ac.uk/efo/EFO_0005108
EFO_0005117	CCL5 measurement	http://www.ebi.ac.uk/efo/EFO_0005117
EFO_0005109	energy expenditure	http://www.ebi.ac.uk/efo/EFO_0005109
EFO_0005110	fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005110
EFO_0005111	folic acid measurement	http://www.ebi.ac.uk/efo/EFO_0005111
EFO_0005112	gestational age	http://www.ebi.ac.uk/efo/EFO_0005112
EFO_0005114	head circumference	http://www.ebi.ac.uk/efo/EFO_0005114
EFO_0005118	IGFBP-1 measurement	http://www.ebi.ac.uk/efo/EFO_0005118
EFO_0005115	metabolic rate measurement	http://www.ebi.ac.uk/efo/EFO_0005115
EFO_0005116	urinary metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0005116
EFO_0005134	amino acid measurement	http://www.ebi.ac.uk/efo/EFO_0005134
EFO_0005106	body composition measurement	http://www.ebi.ac.uk/efo/EFO_0005106
EFO_0003939	energy intake	http://www.ebi.ac.uk/efo/EFO_0003939
EFO_0003940	physical activity	http://www.ebi.ac.uk/efo/EFO_0003940
GO_0097334	response to perphenazine	http://purl.obolibrary.org/obo/GO_0097334
EFO_0005043	cardiac troponin T measurement	http://www.ebi.ac.uk/efo/EFO_0005043
EFO_0001059	cataract	http://www.ebi.ac.uk/efo/EFO_0001059
HP_0001268	Mental deterioration	http://purl.obolibrary.org/obo/HP_0001268
EFO_0000538	hypertrophic cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0000538
EFO_0004995	lean body mass	http://www.ebi.ac.uk/efo/EFO_0004995
EFO_0004732	lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004732
EFO_0004992	otitis media	http://www.ebi.ac.uk/efo/EFO_0004992
EFO_0000278	pancreatitis	http://www.ebi.ac.uk/efo/EFO_0000278
EFO_0004985	platelet reactivity measurement	http://www.ebi.ac.uk/efo/EFO_0004985
GO_0031427	response to methotrexate	http://purl.obolibrary.org/obo/GO_0031427
GO_1901905	response to tamsulosin	http://purl.obolibrary.org/obo/GO_1901905
GO_1990054	response to temozolomide	http://purl.obolibrary.org/obo/GO_1990054
EFO_0004993	serum IgM measurement	http://www.ebi.ac.uk/efo/EFO_0004993
EFO_0005045	visceral Leishmaniasis	http://www.ebi.ac.uk/efo/EFO_0005045
GO_0014072	response to opiate	http://purl.obolibrary.org/obo/GO_0014072
EFO_0005047	erythrocyte measurement	http://www.ebi.ac.uk/efo/EFO_0005047
GO_0097335	response to quetiapine	http://purl.obolibrary.org/obo/GO_0097335
GO_0097336	response to risperidone	http://purl.obolibrary.org/obo/GO_0097336
GO_0097337	response to ziprasidone	http://purl.obolibrary.org/obo/GO_0097337
EFO_0004320	suicidal ideation	http://www.ebi.ac.uk/efo/EFO_0004320
EFO_0004629	von Willebrand factor measurement	http://www.ebi.ac.uk/efo/EFO_0004629
HP_0025095	Sneeze	http://purl.obolibrary.org/obo/HP_0025095
EFO_0004291	braces	http://www.ebi.ac.uk/efo/EFO_0004291
EFO_0004294	left atrial function	http://www.ebi.ac.uk/efo/EFO_0004294
EFO_0004295	left ventricular function	http://www.ebi.ac.uk/efo/EFO_0004295
EFO_0004296	thyroid function	http://www.ebi.ac.uk/efo/EFO_0004296
EFO_0004298	cardiovascular measurement	http://www.ebi.ac.uk/efo/EFO_0004298
EFO_0004300	longevity	http://www.ebi.ac.uk/efo/EFO_0004300
EFO_0004301	blood viscosity	http://www.ebi.ac.uk/efo/EFO_0004301
EFO_0004302	anthropometric measurement	http://www.ebi.ac.uk/efo/EFO_0004302
EFO_0004304	blood sedimentation	http://www.ebi.ac.uk/efo/EFO_0004304
EFO_0004305	erythrocyte count	http://www.ebi.ac.uk/efo/EFO_0004305
EFO_0004306	erythrocyte indices	http://www.ebi.ac.uk/efo/EFO_0004306
EFO_0005843	cortisol measurement	http://www.ebi.ac.uk/efo/EFO_0005843
EFO_0005844	response to dietary antigen	http://www.ebi.ac.uk/efo/EFO_0005844
EFO_0005845	hemoglobin A2 measurement	http://www.ebi.ac.uk/efo/EFO_0005845
EFO_0005846	cryoglobulinemia	http://www.ebi.ac.uk/efo/EFO_0005846
EFO_0005849	serum lipase activity measurement	http://www.ebi.ac.uk/efo/EFO_0005849
EFO_0005850	emphysema pattern measurement	http://www.ebi.ac.uk/efo/EFO_0005850
EFO_0005851	height-adjusted body mass index	http://www.ebi.ac.uk/efo/EFO_0005851
EFO_0005852	Heschl's gyrus morphology measurement	http://www.ebi.ac.uk/efo/EFO_0005852
Orphanet_182098	pneumoconiosis	http://www.orpha.net/ORDO/Orphanet_182098
EFO_0005853	response to silica exposure	http://www.ebi.ac.uk/efo/EFO_0005853
EFO_0005854	allergic rhinitis	http://www.ebi.ac.uk/efo/EFO_0005854
EFO_0005890	osteoarthritis biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0005890
GO_0007605	sensory perception of sound	http://purl.obolibrary.org/obo/GO_0007605
GO_0007601	visual perception	http://purl.obolibrary.org/obo/GO_0007601
EFO_0005895	ossification of the posterior longitudinal ligament of the spine	http://www.ebi.ac.uk/efo/EFO_0005895
EFO_0005917	generalised epilepsy	http://www.ebi.ac.uk/efo/EFO_0005917
EFO_0005918	osteoprotegerin measurement	http://www.ebi.ac.uk/efo/EFO_0005918
EFO_0005919	recombination measurement	http://www.ebi.ac.uk/efo/EFO_0005919
EFO_0005921	FEV change measurement	http://www.ebi.ac.uk/efo/EFO_0005921
EFO_0005922	esophageal squamous cell carcinoma	http://www.ebi.ac.uk/efo/EFO_0005922
EFO_0005924	binge eating	http://www.ebi.ac.uk/efo/EFO_0005924
EFO_0005935	overweight body mass index status	http://www.ebi.ac.uk/efo/EFO_0005935
EFO_0005936	underweight body mass index status	http://www.ebi.ac.uk/efo/EFO_0005936
EFO_0005937	longitudinal BMI measurement	http://www.ebi.ac.uk/efo/EFO_0005937
EFO_0005938	congenital left-sided heart lesions	http://www.ebi.ac.uk/efo/EFO_0005938
EFO_0005939	parental genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0005939
EFO_0005940	psychotic symptoms	http://www.ebi.ac.uk/efo/EFO_0005940
EFO_0005941	mammographic density measurement	http://www.ebi.ac.uk/efo/EFO_0005941
EFO_0005942	chemotherapy-induced hypertension	http://www.ebi.ac.uk/efo/EFO_0005942
EFO_0005943	response to bevacizumab	http://www.ebi.ac.uk/efo/EFO_0005943
EFO_0005944	cumulative dose response to bevacizumab	http://www.ebi.ac.uk/efo/EFO_0005944
EFO_0005229	reading	http://www.ebi.ac.uk/efo/EFO_0005229
Orphanet_3437	Vogt-Koyanagi-Harada disease	http://www.orpha.net/ORDO/Orphanet_3437
EFO_0005949	antinuclear antibody measurement	http://www.ebi.ac.uk/efo/EFO_0005949
EFO_0006266	sum of skinfolds	http://www.ebi.ac.uk/efo/EFO_0006266
EFO_0001372	neonate	http://www.ebi.ac.uk/efo/EFO_0001372
EFO_0006309	plasma plasminogen measurement	http://www.ebi.ac.uk/efo/EFO_0006309
EFO_0004802	family size	http://www.ebi.ac.uk/efo/EFO_0004802
EFO_0004209	hypospadias	http://www.ebi.ac.uk/efo/EFO_0004209
HP_0000545	Myopia	http://purl.obolibrary.org/obo/HP_0000545
HP_0011141	age-related cataract	http://purl.obolibrary.org/obo/HP_0011141
EFO_0006312	mitochondrial DNA measurement	http://www.ebi.ac.uk/efo/EFO_0006312
EFO_0006314	response to high-dose melphalan	http://www.ebi.ac.uk/efo/EFO_0006314
EFO_0006315	thiopurine immunosuppressant-induced pancreatitis	http://www.ebi.ac.uk/efo/EFO_0006315
EFO_0006316	infant expressive language ability	http://www.ebi.ac.uk/efo/EFO_0006316
EFO_0006317	response to thiopurine	http://www.ebi.ac.uk/efo/EFO_0006317
EFO_0006319	HIV viral set point measurement	http://www.ebi.ac.uk/efo/EFO_0006319
Orphanet_391311	susceptibility to viral and mycobacterial infections	http://www.orpha.net/ORDO/Orphanet_391311
EFO_0006320	antidepressant-induced side effect	http://www.ebi.ac.uk/efo/EFO_0006320
EFO_0006321	antidepressant-induced dizziness	http://www.ebi.ac.uk/efo/EFO_0006321
EFO_0006322	antidepressant-induced sexual dysfunction	http://www.ebi.ac.uk/efo/EFO_0006322
EFO_0006323	antidepressant-induced visual impairment	http://www.ebi.ac.uk/efo/EFO_0006323
EFO_0006324	antidepressant-induced hearing impairment	http://www.ebi.ac.uk/efo/EFO_0006324
EFO_0006326	response to bupropion	http://www.ebi.ac.uk/efo/EFO_0006326
EFO_0006330	response to buspirone	http://www.ebi.ac.uk/efo/EFO_0006330
EFO_0006329	response to citalopram	http://www.ebi.ac.uk/efo/EFO_0006329
EFO_0006327	response to sertraline	http://www.ebi.ac.uk/efo/EFO_0006327
EFO_0006328	response to venlafaxine	http://www.ebi.ac.uk/efo/EFO_0006328
EFO_0006331	selenium measurement	http://www.ebi.ac.uk/efo/EFO_0006331
EFO_0006332	serum iron measurement	http://www.ebi.ac.uk/efo/EFO_0006332
EFO_0006333	transferrin saturation measurement	http://www.ebi.ac.uk/efo/EFO_0006333
EFO_0006334	total iron binding capacity	http://www.ebi.ac.uk/efo/EFO_0006334
EFO_0006335	systolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006335
EFO_0006336	diastolic blood pressure	http://www.ebi.ac.uk/efo/EFO_0006336
EFO_0006337	response to allopurinol	http://www.ebi.ac.uk/efo/EFO_0006337
EFO_0006339	smooth surface dental caries	http://www.ebi.ac.uk/efo/EFO_0006339
EFO_0006340	mean arterial pressure	http://www.ebi.ac.uk/efo/EFO_0006340
EFO_0006341	transferrin measurement	http://www.ebi.ac.uk/efo/EFO_0006341
EFO_0004872	inflammatory biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0004872
EFO_0006505	chronic bronchitis	http://www.ebi.ac.uk/efo/EFO_0006505
EFO_0000217	gastritis	http://www.ebi.ac.uk/efo/EFO_0000217
EFO_0006344	medication adherence behavior	http://www.ebi.ac.uk/efo/EFO_0006344
EFO_0006345	response to phenytoin	http://www.ebi.ac.uk/efo/EFO_0006345
EFO_0006346	severe cutaneous adverse reaction	http://www.ebi.ac.uk/efo/EFO_0006346
EFO_0006347	pulmonary artery enlargement	http://www.ebi.ac.uk/efo/EFO_0006347
EFO_0006352	laryngeal squamous cell carcinoma	http://www.ebi.ac.uk/efo/EFO_0006352
EFO_0006501	carotid plaque build	http://www.ebi.ac.uk/efo/EFO_0006501
EFO_0006502	mammographic density percentage	http://www.ebi.ac.uk/efo/EFO_0006502
EFO_0006503	dense area measurement	http://www.ebi.ac.uk/efo/EFO_0006503
EFO_0006504	non-dense area measurement	http://www.ebi.ac.uk/efo/EFO_0006504
EFO_0006506	hepatic lipid content measurement	http://www.ebi.ac.uk/efo/EFO_0006506
EFO_0006512	angiographic measurement	http://www.ebi.ac.uk/efo/EFO_0006512
EFO_0006511	Kashin-Beck disease	http://www.ebi.ac.uk/efo/EFO_0006511
EFO_0006510	Herpes Zoster	http://www.ebi.ac.uk/efo/EFO_0006510
EFO_0006508	cotinine glucuronidation measurement	http://www.ebi.ac.uk/efo/EFO_0006508
EFO_0006507	nicotine glucuronidation measurement	http://www.ebi.ac.uk/efo/EFO_0006507
EFO_0006513	hereditary hemochromatosis type 1	http://www.ebi.ac.uk/efo/EFO_0006513
EFO_0006514	Alzheimer's disease biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0006514
EFO_0006515	angiotensin-converting enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0006515
EFO_0006516	superior frontal gyrus grey matter volume measurement	http://www.ebi.ac.uk/efo/EFO_0006516
EFO_0006517	interferon alpha measurement	http://www.ebi.ac.uk/efo/EFO_0006517
EFO_0006518	response to losartan	http://www.ebi.ac.uk/efo/EFO_0006518
EFO_0006519	MMR-related febrile seizures	http://www.ebi.ac.uk/efo/EFO_0006519
HP_0002373	Febrile seizure (within the age range of 3 months to 6 years)	http://purl.obolibrary.org/obo/HP_0002373
HP_0002900	hypokalemia	http://purl.obolibrary.org/obo/HP_0002900
EFO_0006520	carbon monoxide exhalation measurement	http://www.ebi.ac.uk/efo/EFO_0006520
EFO_0006521	calcium intake measurement	http://www.ebi.ac.uk/efo/EFO_0006521
EFO_0006524	L-arginine measurement	http://www.ebi.ac.uk/efo/EFO_0006524
EFO_0006522	asymmetrical dimethylarginine measurement	http://www.ebi.ac.uk/efo/EFO_0006522
EFO_0006523	symmetrical dimethylarginine measurement	http://www.ebi.ac.uk/efo/EFO_0006523
EFO_0006525	cigarettes per day measurement	http://www.ebi.ac.uk/efo/EFO_0006525
EFO_0006526	pack-years measurement	http://www.ebi.ac.uk/efo/EFO_0006526
EFO_0006527	smoking status measurement	http://www.ebi.ac.uk/efo/EFO_0006527
HP_0012235	drug-induced agranulocytosis	http://purl.obolibrary.org/obo/HP_0012235
EFO_0006781	coffee consumption measurement	http://www.ebi.ac.uk/efo/EFO_0006781
EFO_0006782	cups of coffee per day measurement	http://www.ebi.ac.uk/efo/EFO_0006782
EFO_0006783	psychosocial stress measurement	http://www.ebi.ac.uk/efo/EFO_0006783
EFO_0006784	body height at birth	http://www.ebi.ac.uk/efo/EFO_0006784
EFO_0006785	infant body height	http://www.ebi.ac.uk/efo/EFO_0006785
EFO_0006788	anxiety disorder	http://www.ebi.ac.uk/efo/EFO_0006788
EFO_0006789	typhoid fever	http://www.ebi.ac.uk/efo/EFO_0006789
EFO_0006791	vascular brain injury	http://www.ebi.ac.uk/efo/EFO_0006791
EFO_0006792	Lewy body dementia	http://www.ebi.ac.uk/efo/EFO_0006792
EFO_0006794	cerebrospinal fluid biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0006794
EFO_0006793	left inferior lateral ventricle volume measurement	http://www.ebi.ac.uk/efo/EFO_0006793
EFO_0006795	serum VEGFR2 concentration measurement	http://www.ebi.ac.uk/efo/EFO_0006795
EFO_0006797	neurofibrillary tangles measurement	http://www.ebi.ac.uk/efo/EFO_0006797
EFO_0006798	neuritic plaque measurement	http://www.ebi.ac.uk/efo/EFO_0006798
EFO_0006800	vascular brain injury measurement	http://www.ebi.ac.uk/efo/EFO_0006800
EFO_0006801	Alzheimer's disease neuropathologic change	http://www.ebi.ac.uk/efo/EFO_0006801
HP_0100256	senile plaques	http://purl.obolibrary.org/obo/HP_0100256
EFO_0006802	response to red blood cell transfusion	http://www.ebi.ac.uk/efo/EFO_0006802
EFO_0006804	alloimmunization	http://www.ebi.ac.uk/efo/EFO_0006804
EFO_0006805	word list delayed recall measurement	http://www.ebi.ac.uk/efo/EFO_0006805
EFO_0006806	paragraph delayed recall measurement	http://www.ebi.ac.uk/efo/EFO_0006806
EFO_0006809	docosapentaenoic acid measurement	http://www.ebi.ac.uk/efo/EFO_0006809
EFO_0006810	oleic acid measurement	http://www.ebi.ac.uk/efo/EFO_0006810
EFO_0006808	arachidonic acid measurement	http://www.ebi.ac.uk/efo/EFO_0006808
EFO_0006807	linoleic acid measurement	http://www.ebi.ac.uk/efo/EFO_0006807
EFO_0004307	glucose tolerance test	http://www.ebi.ac.uk/efo/EFO_0004307
EFO_0004308	leukocyte count	http://www.ebi.ac.uk/efo/EFO_0004308
EFO_0004309	platelet count	http://www.ebi.ac.uk/efo/EFO_0004309
EFO_0004310	partial thromboplastin time	http://www.ebi.ac.uk/efo/EFO_0004310
EFO_0004311	heart function measurement	http://www.ebi.ac.uk/efo/EFO_0004311
EFO_0004312	vital capacity	http://www.ebi.ac.uk/efo/EFO_0004312
EFO_0004314	forced expiratory volume	http://www.ebi.ac.uk/efo/EFO_0004314
EFO_0004315	drinking behavior	http://www.ebi.ac.uk/efo/EFO_0004315
EFO_0004318	smoking behavior	http://www.ebi.ac.uk/efo/EFO_0004318
EFO_0004319	smoking cessation	http://www.ebi.ac.uk/efo/EFO_0004319
EFO_0004913	lentiform nucleus measurement	http://www.ebi.ac.uk/efo/EFO_0004913
EFO_0004321	attempted suicide	http://www.ebi.ac.uk/efo/EFO_0004321
EFO_0004323	mental process	http://www.ebi.ac.uk/efo/EFO_0004323
EFO_0004325	blood pressure	http://www.ebi.ac.uk/efo/EFO_0004325
EFO_0004326	heart rate	http://www.ebi.ac.uk/efo/EFO_0004326
EFO_0004327	electrocardiography	http://www.ebi.ac.uk/efo/EFO_0004327
EFO_0004328	exercise test	http://www.ebi.ac.uk/efo/EFO_0004328
EFO_0004329	alcohol drinking	http://www.ebi.ac.uk/efo/EFO_0004329
EFO_0004330	coffee consumption	http://www.ebi.ac.uk/efo/EFO_0004330
GO_0044691	tooth eruption	http://purl.obolibrary.org/obo/GO_0044691
EFO_0004333	episodic memory	http://www.ebi.ac.uk/efo/EFO_0004333
EFO_0004335	short-term memory	http://www.ebi.ac.uk/efo/EFO_0004335
EFO_0004336	speech perception	http://www.ebi.ac.uk/efo/EFO_0004336
EFO_0004337	intelligence	http://www.ebi.ac.uk/efo/EFO_0004337
EFO_0004338	body weight	http://www.ebi.ac.uk/efo/EFO_0004338
EFO_0005204	bulimia nervosa	http://www.ebi.ac.uk/efo/EFO_0005204
EFO_0001061	cervical carcinoma	http://www.ebi.ac.uk/efo/EFO_0001061
EFO_0005205	response to dabigatran etexilate	http://www.ebi.ac.uk/efo/EFO_0005205
EFO_0005211	aspirin hydrolysis measurement	http://www.ebi.ac.uk/efo/EFO_0005211
EFO_0005210	brain connectivity measurement	http://www.ebi.ac.uk/efo/EFO_0005210
GO_0097328	response to carboplatin	http://purl.obolibrary.org/obo/GO_0097328
EFO_0005208	glomerular filtration rate	http://www.ebi.ac.uk/efo/EFO_0005208
EFO_0005206	oligoclonal band measurement	http://www.ebi.ac.uk/efo/EFO_0005206
EFO_0004339	body height	http://www.ebi.ac.uk/efo/EFO_0004339
EFO_0004340	body mass index	http://www.ebi.ac.uk/efo/EFO_0004340
EFO_0004341	body fat distribution	http://www.ebi.ac.uk/efo/EFO_0004341
EFO_0004342	waist circumference	http://www.ebi.ac.uk/efo/EFO_0004342
EFO_0004343	waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0004343
EFO_0004344	birth weight	http://www.ebi.ac.uk/efo/EFO_0004344
EFO_0004345	corneal topography	http://www.ebi.ac.uk/efo/EFO_0004345
EFO_0004346	neuroimaging measurement	http://www.ebi.ac.uk/efo/EFO_0004346
EFO_0004348	hematocrit	http://www.ebi.ac.uk/efo/EFO_0004348
EFO_0004350	reasoning	http://www.ebi.ac.uk/efo/EFO_0004350
EFO_0004351	resting heart rate	http://www.ebi.ac.uk/efo/EFO_0004351
EFO_0004352	mortality	http://www.ebi.ac.uk/efo/EFO_0004352
EFO_0004354	circadian rhythm	http://www.ebi.ac.uk/efo/EFO_0004354
GO_0050909	sensory perception of taste	http://purl.obolibrary.org/obo/GO_0050909
EFO_0004357	electroencephalogram measurement	http://www.ebi.ac.uk/efo/EFO_0004357
EFO_0004358	event-related brain oscillation	http://www.ebi.ac.uk/efo/EFO_0004358
EFO_0004362	psychomotor performance	http://www.ebi.ac.uk/efo/EFO_0004362
EFO_0004363	information processing speed	http://www.ebi.ac.uk/efo/EFO_0004363
EFO_0004365	personality trait	http://www.ebi.ac.uk/efo/EFO_0004365
EFO_0004458	c-reactive protein measurement	http://www.ebi.ac.uk/efo/EFO_0004458
EFO_0004459	ferritin measurement	http://www.ebi.ac.uk/efo/EFO_0004459
EFO_0004460	soluble transferrin receptor measurement	http://www.ebi.ac.uk/efo/EFO_0004460
EFO_0004461	iron biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0004461
EFO_0004462	PR interval	http://www.ebi.ac.uk/efo/EFO_0004462
EFO_0004463	angiotensin converting enzyme activity measurement	http://www.ebi.ac.uk/efo/EFO_0004463
EFO_0004464	brain measurement	http://www.ebi.ac.uk/efo/EFO_0004464
EFO_0004465	fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004465
EFO_0004466	fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004466
EFO_0004467	insulin measurement	http://www.ebi.ac.uk/efo/EFO_0004467
EFO_0004468	glucose measurement	http://www.ebi.ac.uk/efo/EFO_0004468
EFO_0004502	adiponectin measurement	http://www.ebi.ac.uk/efo/EFO_0004502
EFO_0004503	hematological measurement	http://www.ebi.ac.uk/efo/EFO_0004503
EFO_0004504	serum hepcidin measurement	http://www.ebi.ac.uk/efo/EFO_0004504
EFO_0004505	telomere length	http://www.ebi.ac.uk/efo/EFO_0004505
EFO_0004506	monocyte early outgrowth colony forming unit	http://www.ebi.ac.uk/efo/EFO_0004506
EFO_0004507	D dimer measurement	http://www.ebi.ac.uk/efo/EFO_0004507
EFO_0004508	spine bone size	http://www.ebi.ac.uk/efo/EFO_0004508
EFO_0004509	hemoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004509
EFO_0004510	hpv seropositivity	http://www.ebi.ac.uk/efo/EFO_0004510
EFO_0004511	femoral neck bone geometry	http://www.ebi.ac.uk/efo/EFO_0004511
EFO_0004512	bone measurement	http://www.ebi.ac.uk/efo/EFO_0004512
EFO_0004516	bone fracture related measurement	http://www.ebi.ac.uk/efo/EFO_0004516
EFO_0004517	arterial stiffness measurement	http://www.ebi.ac.uk/efo/EFO_0004517
EFO_0004518	creatinine measurement	http://www.ebi.ac.uk/efo/EFO_0004518
EFO_0004519	soluble p-selectin measurement	http://www.ebi.ac.uk/efo/EFO_0004519
EFO_0004520	icam-1 measurement	http://www.ebi.ac.uk/efo/EFO_0004520
GO_0050913	sensory perception of bitter taste	http://purl.obolibrary.org/obo/GO_0050913
EFO_0004526	mean corpuscular volume	http://www.ebi.ac.uk/efo/EFO_0004526
EFO_0004527	mean corpuscular hemoglobin	http://www.ebi.ac.uk/efo/EFO_0004527
EFO_0004529	lipid measurement	http://www.ebi.ac.uk/efo/EFO_0004529
EFO_0004530	triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0004530
EFO_0004531	urate measurement	http://www.ebi.ac.uk/efo/EFO_0004531
EFO_0004532	serum gamma-glutamyl transferase measurement	http://www.ebi.ac.uk/efo/EFO_0004532
EFO_0004533	alkaline phosphatase measurement	http://www.ebi.ac.uk/efo/EFO_0004533
EFO_0004534	creatine kinase measurement	http://www.ebi.ac.uk/efo/EFO_0004534
EFO_0004535	serum albumin measurement	http://www.ebi.ac.uk/efo/EFO_0004535
EFO_0004537	neonatal systemic lupus erythematosus	http://www.ebi.ac.uk/efo/EFO_0004537
EFO_0004540	chronic fatigue syndrome	http://www.ebi.ac.uk/efo/EFO_0004540
EFO_0004541	HbA1c measurement	http://www.ebi.ac.uk/efo/EFO_0004541
EFO_0004569	brain serotonin transporter measurement	http://www.ebi.ac.uk/efo/EFO_0004569
EFO_0004570	bilirubin measurement	http://www.ebi.ac.uk/efo/EFO_0004570
EFO_0004571	butyrylcholinesterase measurement	http://www.ebi.ac.uk/efo/EFO_0004571
EFO_0004572	C4BP measurement	http://www.ebi.ac.uk/efo/EFO_0004572
EFO_0004573	chemerin measurement	http://www.ebi.ac.uk/efo/EFO_0004573
EFO_0004574	total cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004574
EFO_0004575	e-selectin measurement	http://www.ebi.ac.uk/efo/EFO_0004575
EFO_0004576	fetal hemoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004576
EFO_0004577	infant head circumference	http://www.ebi.ac.uk/efo/EFO_0004577
EFO_0004578	homocysteine measurement	http://www.ebi.ac.uk/efo/EFO_0004578
EFO_0004579	serum IgE measurement	http://www.ebi.ac.uk/efo/EFO_0004579
EFO_0004581	interleukin 18 measurement	http://www.ebi.ac.uk/efo/EFO_0004581
EFO_0004582	liver enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0004582
EFO_0004735	serum alanine aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004735
EFO_0004584	mean platelet volume	http://www.ebi.ac.uk/efo/EFO_0004584
EFO_0004585	naphthyl-keratin adduct measurement	http://www.ebi.ac.uk/efo/EFO_0004585
EFO_0004587	lymphocyte count	http://www.ebi.ac.uk/efo/EFO_0004587
EFO_0004589	brachial circumference	http://www.ebi.ac.uk/efo/EFO_0004589
EFO_0004591	childhood onset asthma	http://www.ebi.ac.uk/efo/EFO_0004591
EFO_0004593	gestational diabetes	http://www.ebi.ac.uk/efo/EFO_0004593
EFO_0004232	eosinophilic esophagitis	http://www.ebi.ac.uk/efo/EFO_0004232
EFO_0004595	hiv mother to child transmission	http://www.ebi.ac.uk/efo/EFO_0004595
EFO_0004596	diabetes mellitus type 2 associated cataract	http://www.ebi.ac.uk/efo/EFO_0004596
EFO_0004599	acute graft vs. host disease	http://www.ebi.ac.uk/efo/EFO_0004599
EFO_0004606	gallbladder neoplasm	http://www.ebi.ac.uk/efo/EFO_0004606
EFO_0004607	duodenal ulcer	http://www.ebi.ac.uk/efo/EFO_0004607
EFO_0004610	acute lung injury	http://www.ebi.ac.uk/efo/EFO_0004610
EFO_0004611	low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004611
EFO_0004612	high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0004612
EFO_0004614	apolipoprotein a 1 measurement	http://www.ebi.ac.uk/efo/EFO_0004614
EFO_0004616	osteoarthritis, knee	http://www.ebi.ac.uk/efo/EFO_0004616
EFO_0004617	cystatin c measurement	http://www.ebi.ac.uk/efo/EFO_0004617
EFO_0004618	vitamin K measurement	http://www.ebi.ac.uk/efo/EFO_0004618
EFO_0004619	factor VII measurement	http://www.ebi.ac.uk/efo/EFO_0004619
EFO_0004620	vitamin B12 measurement	http://www.ebi.ac.uk/efo/EFO_0004620
EFO_0004621	vitamin B6 measurement	http://www.ebi.ac.uk/efo/EFO_0004621
EFO_0004622	sphingolipid measurement	http://www.ebi.ac.uk/efo/EFO_0004622
EFO_0004623	fibrinogen measurement	http://www.ebi.ac.uk/efo/EFO_0004623
EFO_0004624	prostate specific antigen measurement	http://www.ebi.ac.uk/efo/EFO_0004624
EFO_0004625	progranulin measurement	http://www.ebi.ac.uk/efo/EFO_0004625
EFO_0004626	igfbp-3 measurement	http://www.ebi.ac.uk/efo/EFO_0004626
EFO_0004631	vitamin D measurement	http://www.ebi.ac.uk/efo/EFO_0004631
EFO_0004632	nevus count	http://www.ebi.ac.uk/efo/EFO_0004632
EFO_0004633	protein c measurement	http://www.ebi.ac.uk/efo/EFO_0004633
EFO_0004634	coagulation factor measurement	http://www.ebi.ac.uk/efo/EFO_0004634
EFO_0004635	leptin receptor measurement	http://www.ebi.ac.uk/efo/EFO_0004635
EFO_0004639	phospholipid measurement	http://www.ebi.ac.uk/efo/EFO_0004639
EFO_0004640	haptoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0004640
EFO_0004641	white matter integrity	http://www.ebi.ac.uk/efo/EFO_0004641
EFO_0004642	cortisol secretion measurement	http://www.ebi.ac.uk/efo/EFO_0004642
EFO_0004644	TPE interval measurement	http://www.ebi.ac.uk/efo/EFO_0004644
EFO_0004645	response to vaccine	http://www.ebi.ac.uk/efo/EFO_0004645
EFO_0004647	response to platinum based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0004647
GO_0036288	response to ximelagatran	http://purl.obolibrary.org/obo/GO_0036288
EFO_0004653	response to tnf antagonist	http://www.ebi.ac.uk/efo/EFO_0004653
EFO_0004667	biological variation design	http://www.ebi.ac.uk/efo/EFO_0004667
EFO_0004670	beta-amyloid 1-42 measurement	http://www.ebi.ac.uk/efo/EFO_0004670
EFO_0004682	QT interval	http://www.ebi.ac.uk/efo/EFO_0004682
EFO_0004684	tumor necrosis factor-alpha measurement	http://www.ebi.ac.uk/efo/EFO_0004684
EFO_0004685	hip geometry	http://www.ebi.ac.uk/efo/EFO_0004685
EFO_0004908	testosterone measurement	http://www.ebi.ac.uk/efo/EFO_0004908
EFO_0004909	dihydrotestosterone measurement	http://www.ebi.ac.uk/efo/EFO_0004909
EFO_0004911	familial hypercholesterolemia	http://www.ebi.ac.uk/efo/EFO_0004911
EFO_0004912	serum IgA measurement	http://www.ebi.ac.uk/efo/EFO_0004912
EFO_0004914	facial neural processing	http://www.ebi.ac.uk/efo/EFO_0004914
EFO_0004915	vaspin measurement	http://www.ebi.ac.uk/efo/EFO_0004915
EFO_0000280	Barrett's esophagus	http://www.ebi.ac.uk/efo/EFO_0000280
EFO_0001358	post-traumatic stress disorder	http://www.ebi.ac.uk/efo/EFO_0001358
EFO_0000707	squamous cell carcinoma	http://www.ebi.ac.uk/efo/EFO_0000707
EFO_0003047	hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0003047
EFO_0004149	neuropathy	http://www.ebi.ac.uk/efo/EFO_0004149
EFO_0004741	blood urea nitrogen measurement	http://www.ebi.ac.uk/efo/EFO_0004741
GO_1901555	response to paclitaxel	http://purl.obolibrary.org/obo/GO_1901555
EFO_0004825	temperament and character inventory	http://www.ebi.ac.uk/efo/EFO_0004825
GO_0033273	response to vitamin	http://purl.obolibrary.org/obo/GO_0033273
EFO_0004696	sex hormone-binding globulin measurement	http://www.ebi.ac.uk/efo/EFO_0004696
EFO_0004701	methamphetamine dependence	http://www.ebi.ac.uk/efo/EFO_0004701
EFO_0004704	age at menopause	http://www.ebi.ac.uk/efo/EFO_0004704
EFO_0004705	hypothyroidism	http://www.ebi.ac.uk/efo/EFO_0004705
EFO_0004707	infantile hypertrophic pyloric stenosis	http://www.ebi.ac.uk/efo/EFO_0004707
EFO_0004708	nodular sclerosis Hodgkin lymphoma	http://www.ebi.ac.uk/efo/EFO_0004708
EFO_0004713	FEV/FEC ratio	http://www.ebi.ac.uk/efo/EFO_0004713
EFO_0004714	sexual dysfunction	http://www.ebi.ac.uk/efo/EFO_0004714
EFO_0004715	mri defined brain infarct	http://www.ebi.ac.uk/efo/EFO_0004715
EFO_0004718	vascular dementia	http://www.ebi.ac.uk/efo/EFO_0004718
EFO_0004720	prion disease	http://www.ebi.ac.uk/efo/EFO_0004720
EFO_0004723	coronary artery calcification	http://www.ebi.ac.uk/efo/EFO_0004723
EFO_0004724	carotid-femoral pulse wave velocity	http://www.ebi.ac.uk/efo/EFO_0004724
EFO_0004725	metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0004725
EFO_0004730	hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004730
EFO_0004731	eye measurement	http://www.ebi.ac.uk/efo/EFO_0004731
EFO_0004733	anti-cyclic citrullinated peptide antibody measurement	http://www.ebi.ac.uk/efo/EFO_0004733
EFO_0004737	carotenoid measurement	http://www.ebi.ac.uk/efo/EFO_0004737
EFO_0004738	tocopherol measurement	http://www.ebi.ac.uk/efo/EFO_0004738
EFO_0004739	circulating cell free dna measurement	http://www.ebi.ac.uk/efo/EFO_0004739
EFO_0004743	facial morphology	http://www.ebi.ac.uk/efo/EFO_0004743
EFO_0004998	carbohydrate measurement	http://www.ebi.ac.uk/efo/EFO_0004998
EFO_0005002	lysine measurement	http://www.ebi.ac.uk/efo/EFO_0005002
EFO_0004999	N-glycan measurement	http://www.ebi.ac.uk/efo/EFO_0004999
EFO_0005000	leptin measurement	http://www.ebi.ac.uk/efo/EFO_0005000
EFO_0004744	matrix metalloproteinase measurement	http://www.ebi.ac.uk/efo/EFO_0004744
EFO_0004745	nt-probnp measurement	http://www.ebi.ac.uk/efo/EFO_0004745
EFO_0004746	lipoprotein-associated phospholipase a(2) measurement	http://www.ebi.ac.uk/efo/EFO_0004746
EFO_0004747	protein measurement	http://www.ebi.ac.uk/efo/EFO_0004747
EFO_0004749	CCL2 measurement	http://www.ebi.ac.uk/efo/EFO_0004749
EFO_0004760	t-tau measurement	http://www.ebi.ac.uk/efo/EFO_0004760
EFO_0004761	uric acid measurement	http://www.ebi.ac.uk/efo/EFO_0004761
EFO_0004762	vascular endothelial growth factor measurement	http://www.ebi.ac.uk/efo/EFO_0004762
EFO_0004763	p-tau measurement	http://www.ebi.ac.uk/efo/EFO_0004763
EFO_0004764	adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0004764
EFO_0004770	ovarian reserve	http://www.ebi.ac.uk/efo/EFO_0004770
EFO_0004771	visual cortical surface area measurement	http://www.ebi.ac.uk/efo/EFO_0004771
EFO_0004772	early onset hypertension	http://www.ebi.ac.uk/efo/EFO_0004772
EFO_0004775	toxic epidermal necrolysis	http://www.ebi.ac.uk/efo/EFO_0004775
EFO_0004776	alcohol and nicotine codependence	http://www.ebi.ac.uk/efo/EFO_0004776
EFO_0004777	alcohol withdrawal	http://www.ebi.ac.uk/efo/EFO_0004777
EFO_0004778	self rated health	http://www.ebi.ac.uk/efo/EFO_0004778
EFO_0004779	chaos measure	http://www.ebi.ac.uk/efo/EFO_0004779
EFO_0004782	behavior or behavioral disorder measurement	http://www.ebi.ac.uk/efo/EFO_0004782
EFO_0004784	self reported educational attainment	http://www.ebi.ac.uk/efo/EFO_0004784
EFO_0004785	south texas assessment of neurocognition	http://www.ebi.ac.uk/efo/EFO_0004785
EFO_0004789	atrial natriuretic factor measurement	http://www.ebi.ac.uk/efo/EFO_0004789
EFO_0004790	CD40 ligand measurement	http://www.ebi.ac.uk/efo/EFO_0004790
EFO_0004791	tissue plasminogen activator measurement	http://www.ebi.ac.uk/efo/EFO_0004791
EFO_0004792	plasminogen activator inhibitor 1 measurement	http://www.ebi.ac.uk/efo/EFO_0004792
GO_1901557	response to fenofibrate	http://purl.obolibrary.org/obo/GO_1901557
EFO_0004795	skin sensitivity to sun	http://www.ebi.ac.uk/efo/EFO_0004795
EFO_0004798	copy number variation	http://www.ebi.ac.uk/efo/EFO_0004798
EFO_0001360	type ii diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001360
EFO_0001365	age-related macular degeneration	http://www.ebi.ac.uk/efo/EFO_0001365
EFO_0001378	multiple myeloma	http://www.ebi.ac.uk/efo/EFO_0001378
EFO_0001422	cirrhosis of liver	http://www.ebi.ac.uk/efo/EFO_0001422
EFO_0001645	coronary artery disease	http://www.ebi.ac.uk/efo/EFO_0001645
EFO_0001663	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663
EFO_0002503	cardiac hypertrophy	http://www.ebi.ac.uk/efo/EFO_0002503
EFO_0002506	osteoarthritis	http://www.ebi.ac.uk/efo/EFO_0002506
EFO_0002508	parkinson's disease	http://www.ebi.ac.uk/efo/EFO_0002508
EFO_0002608	aids dementia	http://www.ebi.ac.uk/efo/EFO_0002608
EFO_0002609	juvenile idiopathic arthritis	http://www.ebi.ac.uk/efo/EFO_0002609
EFO_0002614	insulin resistance	http://www.ebi.ac.uk/efo/EFO_0002614
EFO_0002618	pancreatic carcinoma	http://www.ebi.ac.uk/efo/EFO_0002618
EFO_0002628	peripartum cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0002628
EFO_0002686	atopy	http://www.ebi.ac.uk/efo/EFO_0002686
EFO_0002690	systemic lupus erythematosus	http://www.ebi.ac.uk/efo/EFO_0002690
EFO_0002892	thyroid carcinoma	http://www.ebi.ac.uk/efo/EFO_0002892
EFO_0002916	esophageal carcinoma	http://www.ebi.ac.uk/efo/EFO_0002916
EFO_0003060	non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0003060
EFO_0003086	kidney disease	http://www.ebi.ac.uk/efo/EFO_0003086
EFO_0003095	non-alcoholic fatty liver disease	http://www.ebi.ac.uk/efo/EFO_0003095
EFO_0003096	pick disease	http://www.ebi.ac.uk/efo/EFO_0003096
EFO_0003100	peripheral neuropathy	http://www.ebi.ac.uk/efo/EFO_0003100
EFO_0003108	essential tremor	http://www.ebi.ac.uk/efo/EFO_0003108
EFO_0003144	heart failure	http://www.ebi.ac.uk/efo/EFO_0003144
EFO_0003912	ankle brachial index	http://www.ebi.ac.uk/efo/EFO_0003912
EFO_0003757	asperger syndrome	http://www.ebi.ac.uk/efo/EFO_0003757
EFO_0003758	autism	http://www.ebi.ac.uk/efo/EFO_0003758
EFO_0003761	unipolar depression	http://www.ebi.ac.uk/efo/EFO_0003761
EFO_0003762	vitamin D deficiency	http://www.ebi.ac.uk/efo/EFO_0003762
EFO_0003767	inflammatory bowel disease	http://www.ebi.ac.uk/efo/EFO_0003767
EFO_0003768	nicotine dependence	http://www.ebi.ac.uk/efo/EFO_0003768
EFO_0003770	diabetic retinopathy	http://www.ebi.ac.uk/efo/EFO_0003770
EFO_0004765	visceral adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0004765
EFO_0003778	psoriatic arthritis	http://www.ebi.ac.uk/efo/EFO_0003778
EFO_0003780	Behcet's syndrome	http://www.ebi.ac.uk/efo/EFO_0003780
EFO_0003781	carotid artery disease	http://www.ebi.ac.uk/efo/EFO_0003781
EFO_0003784	skin pigmentation	http://www.ebi.ac.uk/efo/EFO_0003784
EFO_0003819	dental caries	http://www.ebi.ac.uk/efo/EFO_0003819
EFO_0003821	migraine disorder	http://www.ebi.ac.uk/efo/EFO_0003821
EFO_0003829	alcohol dependence	http://www.ebi.ac.uk/efo/EFO_0003829
GO_0006954	inflammatory response	http://purl.obolibrary.org/obo/GO_0006954
EFO_0003843	pain	http://www.ebi.ac.uk/efo/EFO_0003843
EFO_0003847	mental retardation	http://www.ebi.ac.uk/efo/EFO_0003847
EFO_0003867	rhabdomyolysis	http://www.ebi.ac.uk/efo/EFO_0003867
EFO_0003868	mouth neoplasm	http://www.ebi.ac.uk/efo/EFO_0003868
EFO_0005081	surfactant protein D measurement	http://www.ebi.ac.uk/efo/EFO_0005081
EFO_0003870	brain aneurysm	http://www.ebi.ac.uk/efo/EFO_0003870
EFO_0003882	osteoporosis	http://www.ebi.ac.uk/efo/EFO_0003882
EFO_0003884	chronic kidney disease	http://www.ebi.ac.uk/efo/EFO_0003884
EFO_0003885	multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003885
EFO_0003888	attention deficit hyperactivity disorder	http://www.ebi.ac.uk/efo/EFO_0003888
EFO_0003889	functional laterality	http://www.ebi.ac.uk/efo/EFO_0003889
EFO_0003890	drug dependence	http://www.ebi.ac.uk/efo/EFO_0003890
EFO_0003892	pulmonary function measurement	http://www.ebi.ac.uk/efo/EFO_0003892
EFO_0003897	stomach neoplasm	http://www.ebi.ac.uk/efo/EFO_0003897
EFO_0003898	ankylosing spondylitis	http://www.ebi.ac.uk/efo/EFO_0003898
HP_0000539	Abnormality of refraction	http://purl.obolibrary.org/obo/HP_0000539
EFO_0003914	atherosclerosis	http://www.ebi.ac.uk/efo/EFO_0003914
EFO_0003923	bone density	http://www.ebi.ac.uk/efo/EFO_0003923
EFO_0003924	hair color	http://www.ebi.ac.uk/efo/EFO_0003924
EFO_0003926	neuropsychological test	http://www.ebi.ac.uk/efo/EFO_0003926
Orphanet_98974	Fuchs endothelial corneal dystrophy	http://www.orpha.net/ORDO/Orphanet_98974
EFO_0003947	personality	http://www.ebi.ac.uk/efo/EFO_0003947
EFO_0003949	eye color	http://www.ebi.ac.uk/efo/EFO_0003949
EFO_0003956	seasonal allergic rhinitis	http://www.ebi.ac.uk/efo/EFO_0003956
EFO_0003958	sunburn	http://www.ebi.ac.uk/efo/EFO_0003958
EFO_0003959	cleft lip	http://www.ebi.ac.uk/efo/EFO_0003959
EFO_0003963	freckles	http://www.ebi.ac.uk/efo/EFO_0003963
EFO_0004190	open-angle glaucoma	http://www.ebi.ac.uk/efo/EFO_0004190
EFO_0004191	androgenetic alopecia	http://www.ebi.ac.uk/efo/EFO_0004191
EFO_0004192	alopecia areata	http://www.ebi.ac.uk/efo/EFO_0004192
EFO_0004193	basal cell carcinoma	http://www.ebi.ac.uk/efo/EFO_0004193
EFO_0004194	IgA glomerulonephritis	http://www.ebi.ac.uk/efo/EFO_0004194
EFO_0004197	hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004197
EFO_0004207	pathological myopia	http://www.ebi.ac.uk/efo/EFO_0004207
EFO_0004208	vitiligo	http://www.ebi.ac.uk/efo/EFO_0004208
EFO_0004210	gallstones	http://www.ebi.ac.uk/efo/EFO_0004210
EFO_0004211	hypertriglyceridemia	http://www.ebi.ac.uk/efo/EFO_0004211
EFO_0004212	keloid	http://www.ebi.ac.uk/efo/EFO_0004212
EFO_0004213	otosclerosis	http://www.ebi.ac.uk/efo/EFO_0004213
EFO_0004214	abdominal aortic aneurysm	http://www.ebi.ac.uk/efo/EFO_0004214
EFO_0004215	anorexia nervosa	http://www.ebi.ac.uk/efo/EFO_0004215
EFO_0004216	conduct disorder	http://www.ebi.ac.uk/efo/EFO_0004216
EFO_0004220	chronic hepatitis C virus infection	http://www.ebi.ac.uk/efo/EFO_0004220
HP_0009907	Attached earlobe	http://purl.obolibrary.org/obo/HP_0009907
HP_0000483	astigmatism	http://purl.obolibrary.org/obo/HP_0000483
EFO_0004224	coronary restenosis	http://www.ebi.ac.uk/efo/EFO_0004224
EFO_0004225	coronary vasospasm	http://www.ebi.ac.uk/efo/EFO_0004225
EFO_0004226	creutzfeldt jacob disease	http://www.ebi.ac.uk/efo/EFO_0004226
EFO_0004227	dengue hemorrhagic fever	http://www.ebi.ac.uk/efo/EFO_0004227
EFO_0004228	drug-induced liver injury	http://www.ebi.ac.uk/efo/EFO_0004228
EFO_0004229	dupuytren contracture	http://www.ebi.ac.uk/efo/EFO_0004229
EFO_0004230	endometrial neoplasm	http://www.ebi.ac.uk/efo/EFO_0004230
EFO_0004234	erectile dysfunction	http://www.ebi.ac.uk/efo/EFO_0004234
EFO_0004235	exfoliation syndrome	http://www.ebi.ac.uk/efo/EFO_0004235
EFO_0004236	focal segmental glomerulosclerosis	http://www.ebi.ac.uk/efo/EFO_0004236
EFO_0004238	hearing loss	http://www.ebi.ac.uk/efo/EFO_0004238
EFO_0004240	heroin dependence	http://www.ebi.ac.uk/efo/EFO_0004240
EFO_0004242	obsessive-compulsive disorder	http://www.ebi.ac.uk/efo/EFO_0004242
EFO_0004243	carcinoid tumor	http://www.ebi.ac.uk/efo/EFO_0004243
EFO_0005260	response to antimicrotubule agent	http://www.ebi.ac.uk/efo/EFO_0005260
GO_1902520	response to doxorubicin	http://purl.obolibrary.org/obo/GO_1902520
GO_1902522	response to epirubicin	http://purl.obolibrary.org/obo/GO_1902522
GO_1902521	response to etoposide	http://purl.obolibrary.org/obo/GO_1902521
EFO_0000398	dermatomyositis	http://www.ebi.ac.uk/efo/EFO_0000398
EFO_0000478	Esophageal adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0000478
EFO_0002610	cocaine dependence	http://www.ebi.ac.uk/efo/EFO_0002610
EFO_0004768	follicle stimulating hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004768
EFO_0005252	orthostatic hypotension	http://www.ebi.ac.uk/efo/EFO_0005252
EFO_0004820	sex ratio	http://www.ebi.ac.uk/efo/EFO_0004820
EFO_0004823	perception of facial expression	http://www.ebi.ac.uk/efo/EFO_0004823
EFO_0004826	anti-neutrophil antibody associated vasculitis	http://www.ebi.ac.uk/efo/EFO_0004826
EFO_0004827	economic and social preference	http://www.ebi.ac.uk/efo/EFO_0004827
EFO_0004829	response to irinotecan	http://www.ebi.ac.uk/efo/EFO_0004829
EFO_0004831	RR interval	http://www.ebi.ac.uk/efo/EFO_0004831
EFO_0004832	optic disc size measurement	http://www.ebi.ac.uk/efo/EFO_0004832
EFO_0004833	neutrophil count	http://www.ebi.ac.uk/efo/EFO_0004833
EFO_0005536	nitric oxide exhalation measurement	http://www.ebi.ac.uk/efo/EFO_0005536
EFO_0005537	triple-negative breast cancer	http://www.ebi.ac.uk/efo/EFO_0005537
EFO_0005538	thrombin generation potential measurement	http://www.ebi.ac.uk/efo/EFO_0005538
EFO_0004799	cholelithiasis	http://www.ebi.ac.uk/efo/EFO_0004799
EFO_0004800	frontal theta oscillation measurement	http://www.ebi.ac.uk/efo/EFO_0004800
GO_1901556	response to candesartan	http://purl.obolibrary.org/obo/GO_1901556
EFO_0004803	male fertility	http://www.ebi.ac.uk/efo/EFO_0004803
EFO_0004805	formal thought disorder	http://www.ebi.ac.uk/efo/EFO_0004805
EFO_0004806	asbestos exposure measurement	http://www.ebi.ac.uk/efo/EFO_0004806
EFO_0004807	short sleep	http://www.ebi.ac.uk/efo/EFO_0004807
EFO_0004808	L lactate dehydrogenase measurement	http://www.ebi.ac.uk/efo/EFO_0004808
EFO_0004809	fructose-bisphosphate aldolase measurement	http://www.ebi.ac.uk/efo/EFO_0004809
EFO_0004810	interleukin-6 measurement	http://www.ebi.ac.uk/efo/EFO_0004810
EFO_0004811	interleukin-8 measurement	http://www.ebi.ac.uk/efo/EFO_0004811
EFO_0004244	interstitial lung disease	http://www.ebi.ac.uk/efo/EFO_0004244
EFO_0004246	mucocutaneous lymph node syndrome	http://www.ebi.ac.uk/efo/EFO_0004246
EFO_0004247	mood disorder	http://www.ebi.ac.uk/efo/EFO_0004247
EFO_0005295	migraine with aura	http://www.ebi.ac.uk/efo/EFO_0005295
EFO_0004239	chronic hepatitis B virus infection	http://www.ebi.ac.uk/efo/EFO_0004239
EFO_0005297	Granulomatosis with Polyangiitis	http://www.ebi.ac.uk/efo/EFO_0005297
EFO_0003785	allergy	http://www.ebi.ac.uk/efo/EFO_0003785
EFO_0005299	non-word reading	http://www.ebi.ac.uk/efo/EFO_0005299
EFO_0005298	allergic sensitization measurement	http://www.ebi.ac.uk/efo/EFO_0005298
EFO_0005318	axial length measurement	http://www.ebi.ac.uk/efo/EFO_0005318
EFO_0005320	contact dermatitis due to nickel	http://www.ebi.ac.uk/efo/EFO_0005320
EFO_0005321	molar-incisor hypomineralization	http://www.ebi.ac.uk/efo/EFO_0005321
EFO_0005322	callous-unemotional behaviour	http://www.ebi.ac.uk/efo/EFO_0005322
EFO_0005324	Post-operative sensory disturbance	http://www.ebi.ac.uk/efo/EFO_0005324
EFO_0000588	mesothelioma	http://www.ebi.ac.uk/efo/EFO_0000588
EFO_0005325	response to angiotensin-converting enzyme inhibitor	http://www.ebi.ac.uk/efo/EFO_0005325
EFO_0000094	B-cell acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000094
EFO_0000553	invasive lobular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000553
EFO_0003894	acne	http://www.ebi.ac.uk/efo/EFO_0003894
EFO_0003902	spinal fracture	http://www.ebi.ac.uk/efo/EFO_0003902
EFO_0004313	maximal midexpiratory flow rate	http://www.ebi.ac.uk/efo/EFO_0004313
EFO_0005307	torsades de pointes	http://www.ebi.ac.uk/efo/EFO_0005307
EFO_0005401	response to high sodium diet	http://www.ebi.ac.uk/efo/EFO_0005401
EFO_0005402	response to low sodium diet	http://www.ebi.ac.uk/efo/EFO_0005402
EFO_0005403	response to dietary potassium supplementation	http://www.ebi.ac.uk/efo/EFO_0005403
EFO_0005404	response to cold pressor test	http://www.ebi.ac.uk/efo/EFO_0005404
EFO_0005405	response to antihypertensive drug	http://www.ebi.ac.uk/efo/EFO_0005405
EFO_0005407	psychosis	http://www.ebi.ac.uk/efo/EFO_0005407
EFO_0005408	pyroglutamine measurement	http://www.ebi.ac.uk/efo/EFO_0005408
EFO_0005409	fat body mass	http://www.ebi.ac.uk/efo/EFO_0005409
EFO_0005410	tooth agenesis	http://www.ebi.ac.uk/efo/EFO_0005410
EFO_0005411	schizoaffective disorder	http://www.ebi.ac.uk/efo/EFO_0005411
EFO_0005413	joint damage measurement	http://www.ebi.ac.uk/efo/EFO_0005413
EFO_0005414	airway hyperresponsiveness	http://www.ebi.ac.uk/efo/EFO_0005414
EFO_0005415	serum alpha-1-antitrypsin measurement	http://www.ebi.ac.uk/efo/EFO_0005415
EFO_0005416	serum ST2 measurement	http://www.ebi.ac.uk/efo/EFO_0005416
EFO_0005417	response to mTOR inhibitor	http://www.ebi.ac.uk/efo/EFO_0005417
EFO_0005419	contrast sensitivity measurement	http://www.ebi.ac.uk/efo/EFO_0005419
EFO_0005420	grey matter volume measurement	http://www.ebi.ac.uk/efo/EFO_0005420
EFO_0005421	serum homoarginine measurement	http://www.ebi.ac.uk/efo/EFO_0005421
EFO_0005422	skin aging	http://www.ebi.ac.uk/efo/EFO_0005422
EFO_0005423	adolescent idiopathic scoliosis	http://www.ebi.ac.uk/efo/EFO_0005423
EFO_0005424	dyslexia	http://www.ebi.ac.uk/efo/EFO_0005424
EFO_0005425	language impairment	http://www.ebi.ac.uk/efo/EFO_0005425
EFO_0005427	social communication impairment	http://www.ebi.ac.uk/efo/EFO_0005427
EFO_0005429	borderline personality disorder symptom	http://www.ebi.ac.uk/efo/EFO_0005429
EFO_0005430	nicotine use	http://www.ebi.ac.uk/efo/EFO_0005430
EFO_0005431	illegal drug consumption	http://www.ebi.ac.uk/efo/EFO_0005431
EFO_0005432	non-substance related disinhibited behaviour	http://www.ebi.ac.uk/efo/EFO_0005432
Orphanet_99701	Mesial temporal lobe epilepsy with hippocampal sclerosis	http://www.orpha.net/ORDO/Orphanet_99701
EFO_0004812	interleukin-1 beta measurement	http://www.ebi.ac.uk/efo/EFO_0004812
EFO_0004813	alpha globulin measurement	http://www.ebi.ac.uk/efo/EFO_0004813
EFO_0001073	obesity	http://www.ebi.ac.uk/efo/EFO_0001073
EFO_0001075	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075
EFO_0001357	sporadic amyotrophic lateral sclerosis	http://www.ebi.ac.uk/efo/EFO_0001357
EFO_0001359	type i diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0001359
EFO_0004256	neuromyelitis optica	http://www.ebi.ac.uk/efo/EFO_0004256
EFO_0004257	neurotic disorder	http://www.ebi.ac.uk/efo/EFO_0004257
EFO_0004259	osteonecrosis	http://www.ebi.ac.uk/efo/EFO_0004259
EFO_0004261	osteitis deformans	http://www.ebi.ac.uk/efo/EFO_0004261
EFO_0004262	panic disorder	http://www.ebi.ac.uk/efo/EFO_0004262
EFO_0004263	partial epilepsy	http://www.ebi.ac.uk/efo/EFO_0004263
EFO_0004265	peripheral arterial disease	http://www.ebi.ac.uk/efo/EFO_0004265
EFO_0004266	primary ovarian insufficiency	http://www.ebi.ac.uk/efo/EFO_0004266
EFO_0004267	biliary liver cirrhosis	http://www.ebi.ac.uk/efo/EFO_0004267
EFO_0004268	sclerosing cholangitis	http://www.ebi.ac.uk/efo/EFO_0004268
EFO_0004269	cardiac arrhythmia	http://www.ebi.ac.uk/efo/EFO_0004269
EFO_0004270	restless legs syndrome	http://www.ebi.ac.uk/efo/EFO_0004270
EFO_0004272	anemia (phenotype)	http://www.ebi.ac.uk/efo/EFO_0004272
EFO_0004273	scoliosis	http://www.ebi.ac.uk/efo/EFO_0004273
EFO_0004274	gout	http://www.ebi.ac.uk/efo/EFO_0004274
EFO_0004276	Stevens-Johnson syndrome	http://www.ebi.ac.uk/efo/EFO_0004276
EFO_0004278	sudden cardiac arrest	http://www.ebi.ac.uk/efo/EFO_0004278
EFO_0004279	suntan	http://www.ebi.ac.uk/efo/EFO_0004279
GO_0043278	response to morphine	http://purl.obolibrary.org/obo/GO_0043278
EFO_0005760	serum carcinoembryonic antigen measurement	http://www.ebi.ac.uk/efo/EFO_0005760
EFO_0005761	lupus nephritis	http://www.ebi.ac.uk/efo/EFO_0005761
EFO_0005762	neuropathic pain	http://www.ebi.ac.uk/efo/EFO_0005762
EFO_0005763	pulse pressure measurement	http://www.ebi.ac.uk/efo/EFO_0005763
GO_1905119	response to haloperidol	http://purl.obolibrary.org/obo/GO_1905119
EFO_0005766	skin fluorescence measurement	http://www.ebi.ac.uk/efo/EFO_0005766
EFO_0005767	rheumatoid factor measurement	http://www.ebi.ac.uk/efo/EFO_0005767
EFO_0005768	response to rate control therapy	http://www.ebi.ac.uk/efo/EFO_0005768
EFO_0004280	movement disorder	http://www.ebi.ac.uk/efo/EFO_0004280
EFO_0005088	testicular carcinoma	http://www.ebi.ac.uk/efo/EFO_0005088
EFO_0004282	thoracic aortic aneurysm	http://www.ebi.ac.uk/efo/EFO_0004282
EFO_0004284	upper aerodigestive tract neoplasm	http://www.ebi.ac.uk/efo/EFO_0004284
EFO_0004285	albuminuria	http://www.ebi.ac.uk/efo/EFO_0004285
EFO_0004286	venous thromboembolism	http://www.ebi.ac.uk/efo/EFO_0004286
EFO_0004287	ventricular fibrillation	http://www.ebi.ac.uk/efo/EFO_0004287
EFO_0004983	complement C3 measurement	http://www.ebi.ac.uk/efo/EFO_0004983
EFO_0004984	complement C4 measurement	http://www.ebi.ac.uk/efo/EFO_0004984
EFO_0004994	lumbar disc degeneration	http://www.ebi.ac.uk/efo/EFO_0004994
EFO_0004536	total blood protein measurement	http://www.ebi.ac.uk/efo/EFO_0004536
EFO_0004996	type 1 diabetes nephropathy	http://www.ebi.ac.uk/efo/EFO_0004996
EFO_0005035	hippocampal volume	http://www.ebi.ac.uk/efo/EFO_0005035
EFO_0005036	platelet measurement	http://www.ebi.ac.uk/efo/EFO_0005036
EFO_0005037	aortic root size	http://www.ebi.ac.uk/efo/EFO_0005037
EFO_0005038	hair morphology	http://www.ebi.ac.uk/efo/EFO_0005038
EFO_0005039	hippocampal atrophy	http://www.ebi.ac.uk/efo/EFO_0005039
EFO_0000714	survival time	http://www.ebi.ac.uk/efo/EFO_0000714
EFO_0004471	insulin sensitivity measurement	http://www.ebi.ac.uk/efo/EFO_0004471
EFO_0005188	CCL11 measurement	http://www.ebi.ac.uk/efo/EFO_0005188
EFO_0005139	serum ceruloplasmin measurement	http://www.ebi.ac.uk/efo/EFO_0005139
EFO_0005187	C-peptide measurement	http://www.ebi.ac.uk/efo/EFO_0005187
EFO_0005189	respiratory quotient	http://www.ebi.ac.uk/efo/EFO_0005189
EFO_0005190	urinary nitrogen measurement	http://www.ebi.ac.uk/efo/EFO_0005190
EFO_0005191	waist height ratio	http://www.ebi.ac.uk/efo/EFO_0005191
EFO_0005056	age at death	http://www.ebi.ac.uk/efo/EFO_0005056
EFO_0004750	interleukin 10 measurement	http://www.ebi.ac.uk/efo/EFO_0004750
EFO_0004753	interleukin 12 measurement	http://www.ebi.ac.uk/efo/EFO_0004753
EFO_0004754	interleukin 1 receptor antagonist measurement	http://www.ebi.ac.uk/efo/EFO_0004754
EFO_0004751	CCL4 measurement	http://www.ebi.ac.uk/efo/EFO_0004751
EFO_0004752	parathyroid hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004752
EFO_0005057	myoglobin measurement	http://www.ebi.ac.uk/efo/EFO_0005057
EFO_0005058	tyrosine measurement	http://www.ebi.ac.uk/efo/EFO_0005058
EFO_0005059	acylcarnitine measurement	http://www.ebi.ac.uk/efo/EFO_0005059
EFO_0005080	CC16 measurement	http://www.ebi.ac.uk/efo/EFO_0005080
EFO_0005092	entorhinal cortical volume	http://www.ebi.ac.uk/efo/EFO_0005092
EFO_0005093	hip circumference	http://www.ebi.ac.uk/efo/EFO_0005093
EFO_0005091	monocyte count	http://www.ebi.ac.uk/efo/EFO_0005091
EFO_0005094	P wave duration	http://www.ebi.ac.uk/efo/EFO_0005094
EFO_0005095	PR segment	http://www.ebi.ac.uk/efo/EFO_0005095
EFO_0005089	whole-brain volume	http://www.ebi.ac.uk/efo/EFO_0005089
EFO_0004997	type 2 diabetes nephropathy	http://www.ebi.ac.uk/efo/EFO_0004997
EFO_0004630	factor VIII measurement	http://www.ebi.ac.uk/efo/EFO_0004630
EFO_0004469	HOMA-B	http://www.ebi.ac.uk/efo/EFO_0004469
EFO_0004501	HOMA-IR	http://www.ebi.ac.uk/efo/EFO_0004501
EFO_0004627	IgF-1 measurement	http://www.ebi.ac.uk/efo/EFO_0004627
EFO_0004637	protein S measurement	http://www.ebi.ac.uk/efo/EFO_0004637
GO_0097338	response to clozapine	http://purl.obolibrary.org/obo/GO_0097338
GO_0097333	response to olanzapine	http://purl.obolibrary.org/obo/GO_0097333
EFO_0005132	5-HIAA measurement	http://www.ebi.ac.uk/efo/EFO_0005132
EFO_0005128	albumin:globulin ratio measurement	http://www.ebi.ac.uk/efo/EFO_0005128
EFO_0005126	arylesterase enzyme measurement	http://www.ebi.ac.uk/efo/EFO_0005126
EFO_0005127	cancer biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0005127
EFO_0005129	hepatitis C induced liver cirrhosis	http://www.ebi.ac.uk/efo/EFO_0005129
EFO_0005131	HVA measurement	http://www.ebi.ac.uk/efo/EFO_0005131
GO_0097329	response to antimetabolite	http://purl.obolibrary.org/obo/GO_0097329
GO_0006306	DNA methylation	http://purl.obolibrary.org/obo/GO_0006306
EFO_0005266	serum selenium measurement	http://www.ebi.ac.uk/efo/EFO_0005266
EFO_0005267	serum copper measurement	http://www.ebi.ac.uk/efo/EFO_0005267
EFO_0005268	serum zinc measurement	http://www.ebi.ac.uk/efo/EFO_0005268
EFO_0005269	congenital heart malformation	http://www.ebi.ac.uk/efo/EFO_0005269
EFO_0005272	sleep quality	http://www.ebi.ac.uk/efo/EFO_0005272
EFO_0005273	sleep depth	http://www.ebi.ac.uk/efo/EFO_0005273
EFO_0005274	sleep time	http://www.ebi.ac.uk/efo/EFO_0005274
EFO_0005275	dihydroxy docosatrienoic acid measurement	http://www.ebi.ac.uk/efo/EFO_0005275
EFO_0005276	Hydroxy-leucine measurement	http://www.ebi.ac.uk/efo/EFO_0005276
EFO_0005279	temporomandibular joint disorder	http://www.ebi.ac.uk/efo/EFO_0005279
EFO_0005280	sleep latency	http://www.ebi.ac.uk/efo/EFO_0005280
EFO_0005300	word reading	http://www.ebi.ac.uk/efo/EFO_0005300
EFO_0005230	anxiety	http://www.ebi.ac.uk/efo/EFO_0005230
GO_0072718	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718
EFO_0005240	rhegmatogenous retinal detachment	http://www.ebi.ac.uk/efo/EFO_0005240
EFO_0005241	employment status	http://www.ebi.ac.uk/efo/EFO_0005241
EFO_0005242	methamphetamine-induced psychosis	http://www.ebi.ac.uk/efo/EFO_0005242
EFO_0005243	myeloperoxidase measurement	http://www.ebi.ac.uk/efo/EFO_0005243
EFO_0005244	gastric bypass	http://www.ebi.ac.uk/efo/EFO_0005244
EFO_0005246	hypersomnia	http://www.ebi.ac.uk/efo/EFO_0005246
EFO_0005247	anti-Helicobacter pylori serum IgG measurement	http://www.ebi.ac.uk/efo/EFO_0005247
GO_0072758	response to topoisomerase inhibitor	http://purl.obolibrary.org/obo/GO_0072758
GO_1901563	response to camptothecin	http://purl.obolibrary.org/obo/GO_1901563
EFO_0005250	occupation-related stress disorder	http://www.ebi.ac.uk/efo/EFO_0005250
GO_1902518	response to cyclophosphamide	http://purl.obolibrary.org/obo/GO_1902518
GO_1902519	response to docetaxel	http://purl.obolibrary.org/obo/GO_1902519
EFO_0005257	response to anthracycline-based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0005257
EFO_0005526	response to alcohol	http://www.ebi.ac.uk/efo/EFO_0005526
EFO_0005527	ejection fraction measurement	http://www.ebi.ac.uk/efo/EFO_0005527
EFO_0005528	parasitemia measurement	http://www.ebi.ac.uk/efo/EFO_0005528
EFO_0005529	Chagas cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0005529
EFO_0005531	urticaria	http://www.ebi.ac.uk/efo/EFO_0005531
EFO_0005532	angioedema	http://www.ebi.ac.uk/efo/EFO_0005532
EFO_0005533	response to non-steroidal anti-inflammatory	http://www.ebi.ac.uk/efo/EFO_0005533
EFO_0005534	delayed encephalopathy after acute carbon monoxide poisoning	http://www.ebi.ac.uk/efo/EFO_0005534
Orphanet_398934	malignant epithelial tumor of ovary	http://www.orpha.net/ORDO/Orphanet_398934
Orphanet_2495	meningioma	http://www.orpha.net/ORDO/Orphanet_2495
Orphanet_35093	isolated scaphocephaly	http://www.orpha.net/ORDO/Orphanet_35093
Orphanet_70589	bronchopulmonary dysplasia	http://www.orpha.net/ORDO/Orphanet_70589
Orphanet_79102	thyrotoxic periodic paralysis	http://www.orpha.net/ORDO/Orphanet_79102
Orphanet_232	sickle cell anemia	http://www.orpha.net/ORDO/Orphanet_232
Orphanet_98963	granular corneal dystrophy type II	http://www.orpha.net/ORDO/Orphanet_98963
Orphanet_139039	orofacial clefting syndrome	http://www.orpha.net/ORDO/Orphanet_139039
Orphanet_166282	familial sick sinus syndrome	http://www.orpha.net/ORDO/Orphanet_166282
Orphanet_524	Li-Fraumeni syndrome	http://www.orpha.net/ORDO/Orphanet_524
Orphanet_2573	Moyamoya disease	http://www.orpha.net/ORDO/Orphanet_2573
GO_0061476	response to anticoagulant	http://purl.obolibrary.org/obo/GO_0061476
GO_0061477	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477
EFO_0004838	calcium measurement	http://www.ebi.ac.uk/efo/EFO_0004838
EFO_0004839	CD4:CD8 lymphocyte ratio	http://www.ebi.ac.uk/efo/EFO_0004839
EFO_0004840	cortical thickness	http://www.ebi.ac.uk/efo/EFO_0004840
EFO_0004841	digit length ratio	http://www.ebi.ac.uk/efo/EFO_0004841
EFO_0004842	eosinophil count	http://www.ebi.ac.uk/efo/EFO_0004842
EFO_0004843	vitamin B measurement	http://www.ebi.ac.uk/efo/EFO_0004843
EFO_0004844	hip bone size	http://www.ebi.ac.uk/efo/EFO_0004844
EFO_0004845	magnesium measurement	http://www.ebi.ac.uk/efo/EFO_0004845
EFO_0004846	serotonin measurement	http://www.ebi.ac.uk/efo/EFO_0004846
EFO_0004847	age at onset	http://www.ebi.ac.uk/efo/EFO_0004847
GO_0061479	response to reverse transcriptase inhibitor	http://purl.obolibrary.org/obo/GO_0061479
GO_1901554	response to acetaminophen	http://purl.obolibrary.org/obo/GO_1901554
GO_0061478	response to platelet aggregation inhibitor	http://purl.obolibrary.org/obo/GO_0061478
GO_1901558	response to metformin	http://purl.obolibrary.org/obo/GO_1901558
EFO_0004857	vitamin A measurement	http://www.ebi.ac.uk/efo/EFO_0004857
GO_1901559	response to ribavirin	http://purl.obolibrary.org/obo/GO_1901559
EFO_0004859	abdominal aortic artery calcification	http://www.ebi.ac.uk/efo/EFO_0004859
EFO_0004860	common carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0004860
EFO_0004861	phosphorus measurement	http://www.ebi.ac.uk/efo/EFO_0004861
EFO_0000574	lymphoma	http://www.ebi.ac.uk/efo/EFO_0000574
EFO_0003839	retinopathy	http://www.ebi.ac.uk/efo/EFO_0003839
EFO_0005192	red blood cell distribution width	http://www.ebi.ac.uk/efo/EFO_0005192
EFO_0001361	pulmonary arterial hypertension	http://www.ebi.ac.uk/efo/EFO_0001361
EFO_0003756	autism spectrum disorder	http://www.ebi.ac.uk/efo/EFO_0003756
EFO_0005193	serum IgG glycosylation measurement	http://www.ebi.ac.uk/efo/EFO_0005193
EFO_0005194	amyloid-beta measurement	http://www.ebi.ac.uk/efo/EFO_0005194
EFO_0004556	antibody measurement	http://www.ebi.ac.uk/efo/EFO_0004556
EFO_0000769	Epstein-Barr virus infection	http://www.ebi.ac.uk/efo/EFO_0000769
EFO_0001062	cytomegalovirus infection	http://www.ebi.ac.uk/efo/EFO_0001062
EFO_0005195	response to cholinesterase inhibitor	http://www.ebi.ac.uk/efo/EFO_0005195
EFO_0005196	vasoactive peptide measurement	http://www.ebi.ac.uk/efo/EFO_0005196
EFO_0005197	beta-2 microglobulin measurement	http://www.ebi.ac.uk/efo/EFO_0005197
EFO_0005199	renal transplant outcome measurement	http://www.ebi.ac.uk/efo/EFO_0005199
EFO_0005201	height growth measurement	http://www.ebi.ac.uk/efo/EFO_0005201
EFO_0001382	puberty	http://www.ebi.ac.uk/efo/EFO_0001382
EFO_0005202	response to hydrochlorothiazide	http://www.ebi.ac.uk/efo/EFO_0005202
EFO_0004862	phytosterol measurement	http://www.ebi.ac.uk/efo/EFO_0004862
EFO_0004863	recombination rate	http://www.ebi.ac.uk/efo/EFO_0004863
EFO_0004864	renal sinus adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0004864
EFO_0004865	thyroid volume	http://www.ebi.ac.uk/efo/EFO_0004865
EFO_0004866	autoantibody measurement	http://www.ebi.ac.uk/efo/EFO_0004866
EFO_0004867	vitamin E measurement	http://www.ebi.ac.uk/efo/EFO_0004867
EFO_0004868	volumetric brain MRI	http://www.ebi.ac.uk/efo/EFO_0004868
EFO_0004869	YKL40 measurement	http://www.ebi.ac.uk/efo/EFO_0004869
EFO_0004870	sleep measurement	http://www.ebi.ac.uk/efo/EFO_0004870
EFO_0004874	memory performance	http://www.ebi.ac.uk/efo/EFO_0004874
EFO_0004875	mathematical ability	http://www.ebi.ac.uk/efo/EFO_0004875
EFO_0000222	acute myeloid leukemia	http://www.ebi.ac.uk/efo/EFO_0000222
EFO_0000565	leukemia	http://www.ebi.ac.uk/efo/EFO_0000565
EFO_0006913	prefrontal cortex cytoarchtiectural measurement	http://www.ebi.ac.uk/efo/EFO_0006913
EFO_0007328	influenza	http://www.ebi.ac.uk/efo/EFO_0007328
EFO_0004233	leukopenia	http://www.ebi.ac.uk/efo/EFO_0004233
EFO_0004565	serum IgG measurement	http://www.ebi.ac.uk/efo/EFO_0004565
EFO_0004567	antipsychotic drug related weight gain	http://www.ebi.ac.uk/efo/EFO_0004567
EFO_0004568	serum non-albumin protein measurement	http://www.ebi.ac.uk/efo/EFO_0004568
HP_0012042	Aspirin-induced asthma	http://purl.obolibrary.org/obo/HP_0012042
EFO_0004608	cystic fibrosis associated meconium ileus	http://www.ebi.ac.uk/efo/EFO_0004608
EFO_0004609	treatment refractory schizophrenia	http://www.ebi.ac.uk/efo/EFO_0004609
EFO_0004694	factor XI measurement	http://www.ebi.ac.uk/efo/EFO_0004694
EFO_0004695	intraocular pressure measurement	http://www.ebi.ac.uk/efo/EFO_0004695
EFO_0004698	insomnia	http://www.ebi.ac.uk/efo/EFO_0004698
GO_0097366	response to bronchodilator	http://purl.obolibrary.org/obo/GO_0097366
EFO_0004729	vitamin measurement	http://www.ebi.ac.uk/efo/EFO_0004729
EFO_0004736	aspartate aminotransferase measurement	http://www.ebi.ac.uk/efo/EFO_0004736
EFO_0004873	cytokine measurement	http://www.ebi.ac.uk/efo/EFO_0004873
EFO_0004880	urinary arsenic measurement	http://www.ebi.ac.uk/efo/EFO_0004880
EFO_0004881	asparaginase hypersensitivity	http://www.ebi.ac.uk/efo/EFO_0004881
EFO_0004248	male infertility	http://www.ebi.ac.uk/efo/EFO_0004248
EFO_0004249	meningococcal infection	http://www.ebi.ac.uk/efo/EFO_0004249
EFO_0004251	myeloproliferative disorder	http://www.ebi.ac.uk/efo/EFO_0004251
EFO_0004252	nasopharyngeal neoplasm	http://www.ebi.ac.uk/efo/EFO_0004252
EFO_0004253	nephrolithiasis	http://www.ebi.ac.uk/efo/EFO_0004253
EFO_0004254	membranous glomerulonephritis	http://www.ebi.ac.uk/efo/EFO_0004254
EFO_0004255	nephrotic syndrome	http://www.ebi.ac.uk/efo/EFO_0004255
Orphanet_126	blepharophimosis-ptosis-epicanthus inversus syndrome	http://www.orpha.net/ORDO/Orphanet_126
Orphanet_440	familial hypospadias	http://www.orpha.net/ORDO/Orphanet_440
Orphanet_1572	common variable immunodeficiency	http://www.orpha.net/ORDO/Orphanet_1572
Orphanet_2133	hemoglobin E disease	http://www.orpha.net/ORDO/Orphanet_2133
Orphanet_586	cystic fibrosis	http://www.orpha.net/ORDO/Orphanet_586
Orphanet_821	Sotos syndrome	http://www.orpha.net/ORDO/Orphanet_821
Orphanet_355	Gaucher disease	http://www.orpha.net/ORDO/Orphanet_355
Orphanet_388	Hirschsprung disease	http://www.orpha.net/ORDO/Orphanet_388
GO_0031960	response to corticosteroid	http://purl.obolibrary.org/obo/GO_0031960
EFO_0003015	aggressive behavior	http://www.ebi.ac.uk/efo/EFO_0003015
HP_0000175	cleft palate	http://purl.obolibrary.org/obo/HP_0000175
EFO_0003925	cognition	http://www.ebi.ac.uk/efo/EFO_0003925
EFO_0004514	bone quantitative ultrasound measurement	http://www.ebi.ac.uk/efo/EFO_0004514
EFO_0005654	velocity of sound measurement	http://www.ebi.ac.uk/efo/EFO_0005654
EFO_0005657	response to protease inhibitor	http://www.ebi.ac.uk/efo/EFO_0005657
EFO_0005782	age-related hearing impairment	http://www.ebi.ac.uk/efo/EFO_0005782
Orphanet_282	frontotemporal dementia	http://www.orpha.net/ORDO/Orphanet_282
EFO_0005658	response to selective serotonin reuptake inhibitor	http://www.ebi.ac.uk/efo/EFO_0005658
EFO_0005659	plasma beta-amyloid 1-40 measurement	http://www.ebi.ac.uk/efo/EFO_0005659
EFO_0005660	plasma beta-amyloid 1-42 measurement	http://www.ebi.ac.uk/efo/EFO_0005660
EFO_0005661	Child Behaviour Checklist assessment	http://www.ebi.ac.uk/efo/EFO_0005661
EFO_0005664	blood metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0005664
EFO_0000555	irritable bowel syndrome	http://www.ebi.ac.uk/efo/EFO_0000555
Orphanet_136	cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy	http://www.orpha.net/ORDO/Orphanet_136
EFO_0005665	white matter hyperintensity measurement	http://www.ebi.ac.uk/efo/EFO_0005665
EFO_0005666	thyroid peroxidase antibody measurement	http://www.ebi.ac.uk/efo/EFO_0005666
EFO_0005667	urinary albumin excretion rate	http://www.ebi.ac.uk/efo/EFO_0005667
EFO_0005669	intracerebral hemorrhage	http://www.ebi.ac.uk/efo/EFO_0005669
EFO_0005670	smoking initiation	http://www.ebi.ac.uk/efo/EFO_0005670
EFO_0005671	smoking behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0005671
Orphanet_199315	familial clubfoot with or without associated lower limb anomalies	http://www.orpha.net/ORDO/Orphanet_199315
EFO_0005672	acute coronary syndrome	http://www.ebi.ac.uk/efo/EFO_0005672
EFO_0005674	white matter microstructure measurement	http://www.ebi.ac.uk/efo/EFO_0005674
EFO_0005675	vitamin D-binding protein measurement	http://www.ebi.ac.uk/efo/EFO_0005675
EFO_0005676	Autoimmune Hepatitis	http://www.ebi.ac.uk/efo/EFO_0005676
EFO_0005677	puberty onset measurement	http://www.ebi.ac.uk/efo/EFO_0005677
EFO_0005678	hippocampal sclerosis of aging	http://www.ebi.ac.uk/efo/EFO_0005678
Orphanet_2445	Conotruncal heart malformations	http://www.orpha.net/ORDO/Orphanet_2445
EFO_0005681	Staphylococcus aureus infection	http://www.ebi.ac.uk/efo/EFO_0005681
EFO_0005682	oxygen saturation measurement	http://www.ebi.ac.uk/efo/EFO_0005682
EFO_0005686	receptive language perception	http://www.ebi.ac.uk/efo/EFO_0005686
EFO_0005687	fibromyalgia	http://www.ebi.ac.uk/efo/EFO_0005687
EFO_0005689	non-high density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0005689
EFO_0005690	musical aptitude	http://www.ebi.ac.uk/efo/EFO_0005690
Orphanet_797	sarcoidosis	http://www.orpha.net/ORDO/Orphanet_797
Orphanet_683	progressive supranuclear palsy	http://www.orpha.net/ORDO/Orphanet_683
Orphanet_654	nephroblastoma	http://www.orpha.net/ORDO/Orphanet_654
Orphanet_3389	tuberculosis	http://www.orpha.net/ORDO/Orphanet_3389
Orphanet_30391	biliary atresia	http://www.orpha.net/ORDO/Orphanet_30391
EFO_0005262	mitral annular calcification	http://www.ebi.ac.uk/efo/EFO_0005262
EFO_0004814	interleukin-6 receptor measurement	http://www.ebi.ac.uk/efo/EFO_0004814
EFO_0004815	alpha macroglobulin measurement	http://www.ebi.ac.uk/efo/EFO_0004815
EFO_0004628	insulin like growth factor measurement	http://www.ebi.ac.uk/efo/EFO_0004628
EFO_0004818	transforming growth factor beta measurement	http://www.ebi.ac.uk/efo/EFO_0004818
EFO_0004819	resistin measurement	http://www.ebi.ac.uk/efo/EFO_0004819
EFO_0004884	breast size	http://www.ebi.ac.uk/efo/EFO_0004884
EFO_0004885	early cardiac repolarization measurement	http://www.ebi.ac.uk/efo/EFO_0004885
EFO_0004887	maximal oxygen uptake measurement	http://www.ebi.ac.uk/efo/EFO_0004887
EFO_0004888	post operative nausea and vomiting	http://www.ebi.ac.uk/efo/EFO_0004888
EFO_0004889	postoperative ventricular dysfunction	http://www.ebi.ac.uk/efo/EFO_0004889
EFO_0004890	anti-social behavior	http://www.ebi.ac.uk/efo/EFO_0004890
EFO_0004892	sasang constitutional medicine	http://www.ebi.ac.uk/efo/EFO_0004892
EFO_0004893	testicular dysgenesis syndrome	http://www.ebi.ac.uk/efo/EFO_0004893
HP_0001636	tetralogy of fallot	http://purl.obolibrary.org/obo/HP_0001636
EFO_0004895	Tourette syndrome	http://www.ebi.ac.uk/efo/EFO_0004895
EFO_0004886	intracranial volume measurement	http://www.ebi.ac.uk/efo/EFO_0004886
EFO_0004710	pelvic organ prolapse	http://www.ebi.ac.uk/efo/EFO_0004710
EFO_0004697	estradiol measurement	http://www.ebi.ac.uk/efo/EFO_0004697
EFO_0004699	gambling behaviour	http://www.ebi.ac.uk/efo/EFO_0004699
EFO_0004555	glycoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0004555
GO_0007568	aging	http://purl.obolibrary.org/obo/GO_0007568
GO_0007608	sensory perception of smell	http://purl.obolibrary.org/obo/GO_0007608
GO_0007610	behavior	http://purl.obolibrary.org/obo/GO_0007610
GO_0009314	response to radiation	http://purl.obolibrary.org/obo/GO_0009314
GO_0009615	response to virus	http://purl.obolibrary.org/obo/GO_0009615
GO_0010226	response to lithium ion	http://purl.obolibrary.org/obo/GO_0010226
GO_0035456	response to interferon beta	http://purl.obolibrary.org/obo/GO_0035456
GO_0036270	response to diuretic	http://purl.obolibrary.org/obo/GO_0036270
GO_0036271	response to methylphenidate	http://purl.obolibrary.org/obo/GO_0036271
GO_0036273	response to statin	http://purl.obolibrary.org/obo/GO_0036273
GO_0036274	response to lapatinib	http://purl.obolibrary.org/obo/GO_0036274
GO_0036275	response to 5' fluorouracil	http://purl.obolibrary.org/obo/GO_0036275
GO_0036276	response to antidepressant	http://purl.obolibrary.org/obo/GO_0036276
GO_0036277	response to anticonvulsant	http://purl.obolibrary.org/obo/GO_0036277
GO_0036287	response to iloperidone	http://purl.obolibrary.org/obo/GO_0036287
GO_0042476	odontogenesis	http://purl.obolibrary.org/obo/GO_0042476
GO_0042493	response to drug	http://purl.obolibrary.org/obo/GO_0042493
GO_0046677	response to antibiotic	http://purl.obolibrary.org/obo/GO_0046677
GO_0051384	response to glucocorticoid	http://purl.obolibrary.org/obo/GO_0051384
GO_0070527	platelet aggregation	http://purl.obolibrary.org/obo/GO_0070527
GO_0097327	response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097327
GO_0097332	response to antipsychotic drug	http://purl.obolibrary.org/obo/GO_0097332
EFO_0004528	mean corpuscular hemoglobin concentration	http://www.ebi.ac.uk/efo/EFO_0004528
EFO_0005053	internal carotid intimal medial thickness	http://www.ebi.ac.uk/efo/EFO_0005053
EFO_0000095	chronic lymphocytic leukemia	http://www.ebi.ac.uk/efo/EFO_0000095
EFO_0000096	neoplasm of mature b-cells	http://www.ebi.ac.uk/efo/EFO_0000096
EFO_0000174	ewing sarcoma	http://www.ebi.ac.uk/efo/EFO_0000174
EFO_0000178	gastric carcinoma	http://www.ebi.ac.uk/efo/EFO_0000178
EFO_0000180	HIV-1 infection	http://www.ebi.ac.uk/efo/EFO_0000180
EFO_0000182	hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0000182
EFO_0000183	hodgkins lymphoma	http://www.ebi.ac.uk/efo/EFO_0000183
EFO_0000195	metabolic syndrome	http://www.ebi.ac.uk/efo/EFO_0000195
EFO_0000200	plasma cell neoplasm	http://www.ebi.ac.uk/efo/EFO_0000200
EFO_0000220	acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_0000220
EFO_0000249	Alzheimer's disease	http://www.ebi.ac.uk/efo/EFO_0000249
EFO_0004515	muscle measurement	http://www.ebi.ac.uk/efo/EFO_0004515
EFO_0000253	amyotrophic lateral sclerosis	http://www.ebi.ac.uk/efo/EFO_0000253
EFO_0000270	asthma	http://www.ebi.ac.uk/efo/EFO_0000270
EFO_0000274	atopic eczema	http://www.ebi.ac.uk/efo/EFO_0000274
EFO_0000275	atrial fibrillation	http://www.ebi.ac.uk/efo/EFO_0000275
EFO_0000279	azoospermia	http://www.ebi.ac.uk/efo/EFO_0000279
EFO_0000289	bipolar disorder	http://www.ebi.ac.uk/efo/EFO_0000289
EFO_0000292	bladder carcinoma	http://www.ebi.ac.uk/efo/EFO_0000292
EFO_0000305	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305
EFO_0000319	cardiovascular disease	http://www.ebi.ac.uk/efo/EFO_0000319
EFO_0000326	central nervous system cancer	http://www.ebi.ac.uk/efo/EFO_0000326
EFO_0000339	chronic myelogenous leukemia	http://www.ebi.ac.uk/efo/EFO_0000339
EFO_0000341	chronic obstructive pulmonary disease	http://www.ebi.ac.uk/efo/EFO_0000341
EFO_0005842	colorectal cancer	http://www.ebi.ac.uk/efo/EFO_0005842
Orphanet_156071	keratoconus	http://www.orpha.net/ORDO/Orphanet_156071
EFO_0000384	crohn's disease	http://www.ebi.ac.uk/efo/EFO_0000384
EFO_0000400	diabetes mellitus	http://www.ebi.ac.uk/efo/EFO_0000400
EFO_0000401	diabetic nephropathy	http://www.ebi.ac.uk/efo/EFO_0000401
EFO_0000403	diffuse large b-cell lymphoma	http://www.ebi.ac.uk/efo/EFO_0000403
EFO_0000405	digestive system disease	http://www.ebi.ac.uk/efo/EFO_0000405
EFO_0000407	dilated cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0000407
EFO_0000409	disease free survival	http://www.ebi.ac.uk/efo/EFO_0000409
EFO_0000464	emphysema	http://www.ebi.ac.uk/efo/EFO_0000464
EFO_0000474	epilepsy	http://www.ebi.ac.uk/efo/EFO_0000474
EFO_0000482	event free survival time	http://www.ebi.ac.uk/efo/EFO_0000482
EFO_0000483	exercise	http://www.ebi.ac.uk/efo/EFO_0000483
EFO_0000516	glaucoma	http://www.ebi.ac.uk/efo/EFO_0000516
EFO_0000519	glioblastoma multiforme	http://www.ebi.ac.uk/efo/EFO_0000519
EFO_0000537	hypertension	http://www.ebi.ac.uk/efo/EFO_0000537
EFO_0000540	immune system disease	http://www.ebi.ac.uk/efo/EFO_0000540
EFO_0000571	lung adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0000571
EFO_0000612	myocardial infarction	http://www.ebi.ac.uk/efo/EFO_0000612
EFO_0000614	narcolepsy with cataplexy	http://www.ebi.ac.uk/efo/EFO_0000614
EFO_0000621	neuroblastoma	http://www.ebi.ac.uk/efo/EFO_0000621
EFO_0000625	nevus	http://www.ebi.ac.uk/efo/EFO_0000625
EFO_0000649	periodontitis	http://www.ebi.ac.uk/efo/EFO_0000649
EFO_0000660	polycystic ovary syndrome	http://www.ebi.ac.uk/efo/EFO_0000660
EFO_0000668	preeclampsia	http://www.ebi.ac.uk/efo/EFO_0000668
EFO_0000676	psoriasis	http://www.ebi.ac.uk/efo/EFO_0000676
EFO_0000677	mental or behavioural disorder	http://www.ebi.ac.uk/efo/EFO_0000677
EFO_0000681	renal cell carcinoma	http://www.ebi.ac.uk/efo/EFO_0000681
EFO_0000685	rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0000685
EFO_0000692	schizophrenia	http://www.ebi.ac.uk/efo/EFO_0000692
EFO_0000702	small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0000702
EFO_0000712	stroke	http://www.ebi.ac.uk/efo/EFO_0000712
EFO_0000713	subarachnoid hemorrhage	http://www.ebi.ac.uk/efo/EFO_0000713
EFO_0005090	basophil count	http://www.ebi.ac.uk/efo/EFO_0005090
EFO_0000717	systemic scleroderma	http://www.ebi.ac.uk/efo/EFO_0000717
EFO_0000729	ulcerative colitis	http://www.ebi.ac.uk/efo/EFO_0000729
EFO_0000731	uterine fibroid	http://www.ebi.ac.uk/efo/EFO_0000731
EFO_0000756	melanoma	http://www.ebi.ac.uk/efo/EFO_0000756
EFO_0000765	aids	http://www.ebi.ac.uk/efo/EFO_0000765
EFO_0000768	idiopathic pulmonary fibrosis	http://www.ebi.ac.uk/efo/EFO_0000768
EFO_0005054	QRS complex	http://www.ebi.ac.uk/efo/EFO_0005054
EFO_0004979	comprehensive strength index	http://www.ebi.ac.uk/efo/EFO_0004979
EFO_0003896	left ventricular hypertrophy	http://www.ebi.ac.uk/efo/EFO_0003896
EFO_0001054	leprosy	http://www.ebi.ac.uk/efo/EFO_0001054
EFO_0006812	autoimmune thyroid disease	http://www.ebi.ac.uk/efo/EFO_0006812
EFO_0004237	Graves disease	http://www.ebi.ac.uk/efo/EFO_0004237
EFO_0003779	Hashimoto's thyroiditis	http://www.ebi.ac.uk/efo/EFO_0003779
EFO_0006882	suicide behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0006882
EFO_0006883	alpha peak frequency measurement	http://www.ebi.ac.uk/efo/EFO_0006883
EFO_0004767	visceral:subcutaneous adipose tissue ratio	http://www.ebi.ac.uk/efo/EFO_0004767
EFO_0004766	subcutaneous adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0004766
EFO_0007034	seropositivity measurement	http://www.ebi.ac.uk/efo/EFO_0007034
EFO_0007035	Chlamydia pneumoniae seropositivity	http://www.ebi.ac.uk/efo/EFO_0007035
EFO_0007036	herpes virus seropositivity	http://www.ebi.ac.uk/efo/EFO_0007036
EFO_0007037	cytomegalovirus seropositivity	http://www.ebi.ac.uk/efo/EFO_0007037
EFO_0007038	Influenza A seropositivity	http://www.ebi.ac.uk/efo/EFO_0007038
EFO_0007039	human herpesvirus 8 seropositivity	http://www.ebi.ac.uk/efo/EFO_0007039
EFO_0007040	blood lead measurement	http://www.ebi.ac.uk/efo/EFO_0007040
EFO_0007041	obese body mass index status	http://www.ebi.ac.uk/efo/EFO_0007041
EFO_0007042	polychlorinated biphenyls measurement	http://www.ebi.ac.uk/efo/EFO_0007042
EFO_0007043	response to transplant	http://www.ebi.ac.uk/efo/EFO_0007043
EFO_0007044	response to allogeneic hematopoietic stem cell transplant	http://www.ebi.ac.uk/efo/EFO_0007044
EFO_0000638	overall survival	http://www.ebi.ac.uk/efo/EFO_0000638
GO_0034097	response to cytokine	http://purl.obolibrary.org/obo/GO_0034097
EFO_0007117	carotid artery intima media thickness	http://www.ebi.ac.uk/efo/EFO_0007117
EFO_0007118	sitting height ratio	http://www.ebi.ac.uk/efo/EFO_0007118
EFO_0007119	Sasang constitutional medicine type	http://www.ebi.ac.uk/efo/EFO_0007119
EFO_0007120	Tae-Yang	http://www.ebi.ac.uk/efo/EFO_0007120
EFO_0007123	So-Eum	http://www.ebi.ac.uk/efo/EFO_0007123
EFO_0007122	Tae-Eum	http://www.ebi.ac.uk/efo/EFO_0007122
EFO_0007121	So-Yang	http://www.ebi.ac.uk/efo/EFO_0007121
EFO_0007574	blood toxic metal measurement	http://www.ebi.ac.uk/efo/EFO_0007574
EFO_0007575	blood aluminium measurement	http://www.ebi.ac.uk/efo/EFO_0007575
EFO_0007576	blood cadmium measurement	http://www.ebi.ac.uk/efo/EFO_0007576
EFO_0007577	blood cobalt measurement	http://www.ebi.ac.uk/efo/EFO_0007577
EFO_0007578	blood copper measurement	http://www.ebi.ac.uk/efo/EFO_0007578
EFO_0007579	blood chromium measurement	http://www.ebi.ac.uk/efo/EFO_0007579
EFO_0007580	blood mercury measurement	http://www.ebi.ac.uk/efo/EFO_0007580
EFO_0007581	blood manganese measurement	http://www.ebi.ac.uk/efo/EFO_0007581
EFO_0007582	blood molybdenum measurement	http://www.ebi.ac.uk/efo/EFO_0007582
EFO_0007583	blood nickel measurement	http://www.ebi.ac.uk/efo/EFO_0007583
EFO_0007584	blood zinc measurement	http://www.ebi.ac.uk/efo/EFO_0007584
EFO_0007585	Cannabis use	http://www.ebi.ac.uk/efo/EFO_0007585
EFO_0007586	Cannabis use initiation	http://www.ebi.ac.uk/efo/EFO_0007586
EFO_0006930	brain volume measurement	http://www.ebi.ac.uk/efo/EFO_0006930
EFO_0007602	total ventricular volume measurement	http://www.ebi.ac.uk/efo/EFO_0007602
EFO_0006827	reninangiotensinaldosterone system measurement	http://www.ebi.ac.uk/efo/EFO_0006827
EFO_0006835	pyoderma gangrenosum	http://www.ebi.ac.uk/efo/EFO_0006835
EFO_0006834	septic shock	http://www.ebi.ac.uk/efo/EFO_0006834
EFO_0006829	GFR change measurement	http://www.ebi.ac.uk/efo/EFO_0006829
HP_0012115	hepatitis	http://purl.obolibrary.org/obo/HP_0012115
EFO_0006830	insulin metabolic clearance rate measurement	http://www.ebi.ac.uk/efo/EFO_0006830
EFO_0006833	glucose effectiveness measurement	http://www.ebi.ac.uk/efo/EFO_0006833
EFO_0006831	acute insulin response measurement	http://www.ebi.ac.uk/efo/EFO_0006831
EFO_0006832	disposition index measurement	http://www.ebi.ac.uk/efo/EFO_0006832
EFO_0003106	pneumonia	http://www.ebi.ac.uk/efo/EFO_0003106
HP_0100806	sepsis	http://purl.obolibrary.org/obo/HP_0100806
EFO_0004991	myasthenia gravis	http://www.ebi.ac.uk/efo/EFO_0004991
EFO_0000203	monoclonal gammopathy	http://www.ebi.ac.uk/efo/EFO_0000203
EFO_0007591	bone mineral accretion measurement	http://www.ebi.ac.uk/efo/EFO_0007591
EFO_0007592	response to bleomycin	http://www.ebi.ac.uk/efo/EFO_0007592
EFO_0007593	chromatid break measurement	http://www.ebi.ac.uk/efo/EFO_0007593
EFO_0006929	IgG index	http://www.ebi.ac.uk/efo/EFO_0006929
EFO_0006928	motion sickness	http://www.ebi.ac.uk/efo/EFO_0006928
EFO_0004683	wet macular degeneration	http://www.ebi.ac.uk/efo/EFO_0004683
EFO_0004830	caudate nucleus volume	http://www.ebi.ac.uk/efo/EFO_0004830
EFO_0006931	nucleus accumbens volume	http://www.ebi.ac.uk/efo/EFO_0006931
EFO_0006932	putamen volume	http://www.ebi.ac.uk/efo/EFO_0006932
EFO_0006933	pallidum volume	http://www.ebi.ac.uk/efo/EFO_0006933
EFO_0006934	amygdala volume	http://www.ebi.ac.uk/efo/EFO_0006934
EFO_0006935	thalamus volume	http://www.ebi.ac.uk/efo/EFO_0006935
HP_0000708	behavioral abnormality	http://purl.obolibrary.org/obo/HP_0000708
EFO_1000636	inflammatory skin disease	http://www.ebi.ac.uk/efo/EFO_1000636
EFO_1000651	recalcitrant atopic dermatitis	http://www.ebi.ac.uk/efo/EFO_1000651
EFO_0004288	colonic neoplasm	http://www.ebi.ac.uk/efo/EFO_0004288
EFO_0007047	Toxoplasma gondii seropositivity	http://www.ebi.ac.uk/efo/EFO_0007047
EFO_0007050	HSV1 seropositivity	http://www.ebi.ac.uk/efo/EFO_0007050
EFO_0007048	human herpesvirus 6 seropositivity	http://www.ebi.ac.uk/efo/EFO_0007048
EFO_0007049	gliadin seropositivity	http://www.ebi.ac.uk/efo/EFO_0007049
EFO_0007046	executive function	http://www.ebi.ac.uk/efo/EFO_0007046
EFO_0007051	vein graft stenosis	http://www.ebi.ac.uk/efo/EFO_0007051
EFO_0007053	myelosuppression	http://www.ebi.ac.uk/efo/EFO_0007053
EFO_0007052	antisocial behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0007052
EFO_1000656	sporadic Creutzfeld Jacob disease	http://www.ebi.ac.uk/efo/EFO_1000656
EFO_0003776	coronary artery bypass	http://www.ebi.ac.uk/efo/EFO_0003776
EFO_0003834	cutaneous lupus erythematosus	http://www.ebi.ac.uk/efo/EFO_0003834
EFO_0007054	microsatellite instability measurement	http://www.ebi.ac.uk/efo/EFO_0007054
EFO_1000657	rectum cancer	http://www.ebi.ac.uk/efo/EFO_1000657
EFO_1000780	autoimmune pancreatitis type 1	http://www.ebi.ac.uk/efo/EFO_1000780
EFO_0007125	lachrymal gland lesion	http://www.ebi.ac.uk/efo/EFO_0007125
EFO_0006816	response to heparin	http://www.ebi.ac.uk/efo/EFO_0006816
HP_0001873	thrombocytopenia	http://purl.obolibrary.org/obo/HP_0001873
EFO_0005627	perianal Crohn's disease	http://www.ebi.ac.uk/efo/EFO_0005627
EFO_0005624	ileocolitis	http://www.ebi.ac.uk/efo/EFO_0005624
HP_0012219	erythema nodosum	http://purl.obolibrary.org/obo/HP_0012219
EFO_0006818	stricture	http://www.ebi.ac.uk/efo/EFO_0006818
EFO_0006819	mild disease course	http://www.ebi.ac.uk/efo/EFO_0006819
EFO_0006820	complicated disease course	http://www.ebi.ac.uk/efo/EFO_0006820
EFO_0006821	trans fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0006821
EFO_0006822	trans-16:1n-7 fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0006822
EFO_0006824	cis/trans-18:2 fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0006824
EFO_0006826	trans/trans-18:2 fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0006826
EFO_0006876	seasonality measurement	http://www.ebi.ac.uk/efo/EFO_0006876
EFO_0006864	breastfeeding duration	http://www.ebi.ac.uk/efo/EFO_0006864
EFO_1000059	cervical artery dissection	http://www.ebi.ac.uk/efo/EFO_1000059
EFO_0006866	electrodermal activity measurement	http://www.ebi.ac.uk/efo/EFO_0006866
EFO_0006867	skin conductance level	http://www.ebi.ac.uk/efo/EFO_0006867
EFO_0006868	skin conductance response amplitude	http://www.ebi.ac.uk/efo/EFO_0006868
EFO_0006869	skin conductance response frequency	http://www.ebi.ac.uk/efo/EFO_0006869
EFO_0006875	acoustic startle blink response measurement	http://www.ebi.ac.uk/efo/EFO_0006875
EFO_0006874	antisaccade response measurement	http://www.ebi.ac.uk/efo/EFO_0006874
EFO_0006870	alpha wave measurement	http://www.ebi.ac.uk/efo/EFO_0006870
EFO_0006871	beta wave measurement	http://www.ebi.ac.uk/efo/EFO_0006871
EFO_0006872	delta wave measurement	http://www.ebi.ac.uk/efo/EFO_0006872
EFO_0006873	theta wave measurement	http://www.ebi.ac.uk/efo/EFO_0006873
EFO_0006896	glucose homeostasis measurement	http://www.ebi.ac.uk/efo/EFO_0006896
EFO_0006897	airway responsiveness measurement	http://www.ebi.ac.uk/efo/EFO_0006897
EFO_0006898	airway wall thickness measurement	http://www.ebi.ac.uk/efo/EFO_0006898
EFO_0006899	PCSK9 protein measurement	http://www.ebi.ac.uk/efo/EFO_0006899
GO_1903491	response to simvastatin	http://purl.obolibrary.org/obo/GO_1903491
EFO_0006900	endothelial growth factor measurement	http://www.ebi.ac.uk/efo/EFO_0006900
EFO_0006901	angiopoietin-2 measurement	http://www.ebi.ac.uk/efo/EFO_0006901
EFO_0006902	angiopoietin-2 receptor measurement	http://www.ebi.ac.uk/efo/EFO_0006902
EFO_0006903	hepatocyte growth factor measurement	http://www.ebi.ac.uk/efo/EFO_0006903
EFO_0006904	response to efavirenz	http://www.ebi.ac.uk/efo/EFO_0006904
EFO_0006905	response to abacavir	http://www.ebi.ac.uk/efo/EFO_0006905
EFO_0006906	virologic response measurement	http://www.ebi.ac.uk/efo/EFO_0006906
EFO_0006920	BNP measurement	http://www.ebi.ac.uk/efo/EFO_0006920
EFO_0006919	cardiovascular event measurement	http://www.ebi.ac.uk/efo/EFO_0006919
EFO_0006924	household air pollution measurement	http://www.ebi.ac.uk/efo/EFO_0006924
EFO_0006921	birth measurement	http://www.ebi.ac.uk/efo/EFO_0006921
EFO_0006922	delivery measurement	http://www.ebi.ac.uk/efo/EFO_0006922
EFO_0006923	fertility measurement	http://www.ebi.ac.uk/efo/EFO_0006923
EFO_0006925	lipoprotein A measurement	http://www.ebi.ac.uk/efo/EFO_0006925
EFO_1000630	marginal zone B-cell lymphoma	http://www.ebi.ac.uk/efo/EFO_1000630
EFO_0006916	response to dalcetrapib	http://www.ebi.ac.uk/efo/EFO_0006916
EFO_0006918	female fertility	http://www.ebi.ac.uk/efo/EFO_0006918
EFO_0006917	spontaneous preterm birth	http://www.ebi.ac.uk/efo/EFO_0006917
Orphanet_93930	bladder exstrophy	http://www.orpha.net/ORDO/Orphanet_93930
EFO_0003826	salivary gland neoplasm	http://www.ebi.ac.uk/efo/EFO_0003826
EFO_0006936	optic disc measurement	http://www.ebi.ac.uk/efo/EFO_0006936
EFO_0006937	optic disc area measurement	http://www.ebi.ac.uk/efo/EFO_0006937
EFO_0006938	optic rim area measurement	http://www.ebi.ac.uk/efo/EFO_0006938
EFO_0006939	cup-to-disc ratio measurement	http://www.ebi.ac.uk/efo/EFO_0006939
EFO_0006940	optic cup area measurement	http://www.ebi.ac.uk/efo/EFO_0006940
EFO_0006941	grip strength measurement	http://www.ebi.ac.uk/efo/EFO_0006941
EFO_0006942	facial pigmentation measurement	http://www.ebi.ac.uk/efo/EFO_0006942
EFO_0006943	blood pressure change measurement	http://www.ebi.ac.uk/efo/EFO_0006943
EFO_0006944	systolic blood pressure change measurement	http://www.ebi.ac.uk/efo/EFO_0006944
EFO_0006945	diastolic blood pressure change measurement	http://www.ebi.ac.uk/efo/EFO_0006945
EFO_0006946	behavioural disinhibition measurement	http://www.ebi.ac.uk/efo/EFO_0006946
EFO_0006947	red wine liking measurement	http://www.ebi.ac.uk/efo/EFO_0006947
EFO_0006948	white wine liking measurement	http://www.ebi.ac.uk/efo/EFO_0006948
EFO_0006950	response to vincristine	http://www.ebi.ac.uk/efo/EFO_0006950
EFO_0006951	ototoxicity	http://www.ebi.ac.uk/efo/EFO_0006951
EFO_0006952	cytotoxicity measurement	http://www.ebi.ac.uk/efo/EFO_0006952
EFO_1000648	developmental dysplasia of the hip	http://www.ebi.ac.uk/efo/EFO_1000648
EFO_1000566	Testicular Germ Cell Tumor	http://www.ebi.ac.uk/efo/EFO_1000566
EFO_0006953	family history of lung cancer	http://www.ebi.ac.uk/efo/EFO_0006953
EFO_0006954	response to triamcinolone acetonide	http://www.ebi.ac.uk/efo/EFO_0006954
EFO_0006955	ADAMTS13 activity measurement	http://www.ebi.ac.uk/efo/EFO_0006955
EFO_0006956	intraocular pressure change measurement	http://www.ebi.ac.uk/efo/EFO_0006956
EFO_0006957	X12063 measurement	http://www.ebi.ac.uk/efo/EFO_0006957
EFO_0006958	mannose measurement	http://www.ebi.ac.uk/efo/EFO_0006958
EFO_0006959	gene methylation measurement	http://www.ebi.ac.uk/efo/EFO_0006959
EFO_1000649	estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_1000649
HP_0100578	lipoatrophy	http://purl.obolibrary.org/obo/HP_0100578
EFO_1000654	childhood cancer	http://www.ebi.ac.uk/efo/EFO_1000654
EFO_0006995	response to diisocyanate	http://www.ebi.ac.uk/efo/EFO_0006995
EFO_0006996	response to homoharringtonine	http://www.ebi.ac.uk/efo/EFO_0006996
EFO_0006992	response to biological dust exposure	http://www.ebi.ac.uk/efo/EFO_0006992
EFO_0006993	response to mineral dust exposure	http://www.ebi.ac.uk/efo/EFO_0006993
EFO_0006994	response to gases and fumes exposure	http://www.ebi.ac.uk/efo/EFO_0006994
EFO_0006997	response to cold medicine	http://www.ebi.ac.uk/efo/EFO_0006997
EFO_0006998	response to stavudine	http://www.ebi.ac.uk/efo/EFO_0006998
EFO_0006999	cancer aggressiveness measurement	http://www.ebi.ac.uk/efo/EFO_0006999
EFO_0007000	Gleason score measurement	http://www.ebi.ac.uk/efo/EFO_0007000
EFO_0007001	dehydroepiandrosterone sulphate measurement	http://www.ebi.ac.uk/efo/EFO_0007001
EFO_0007002	luteinizing hormone measurement	http://www.ebi.ac.uk/efo/EFO_0007002
EFO_0007003	prolactin measurement	http://www.ebi.ac.uk/efo/EFO_0007003
EFO_0007004	progesterone measurement	http://www.ebi.ac.uk/efo/EFO_0007004
EFO_0007005	free androgen index	http://www.ebi.ac.uk/efo/EFO_0007005
EFO_0007006	depressive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007006
EFO_0007007	ticagrelor measurement	http://www.ebi.ac.uk/efo/EFO_0007007
EFO_0007020	AR-C124910XXmeasurement	http://www.ebi.ac.uk/efo/EFO_0007020
EFO_0007008	allergy measurement	http://www.ebi.ac.uk/efo/EFO_0007008
EFO_0007009	skin pigmentation measurement	http://www.ebi.ac.uk/efo/EFO_0007009
EFO_0007010	drug use measurement	http://www.ebi.ac.uk/efo/EFO_0007010
EFO_0007011	SSRI use measurement	http://www.ebi.ac.uk/efo/EFO_0007011
EFO_0007012	NSAID use measurement	http://www.ebi.ac.uk/efo/EFO_0007012
EFO_0007013	aspirin use measurement	http://www.ebi.ac.uk/efo/EFO_0007013
EFO_0007014	3-hydroxypropylmercapturic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007014
EFO_0007015	3-hydroxy-1-methylpropylmercapturic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007015
EFO_0007016	food allergy measurement	http://www.ebi.ac.uk/efo/EFO_0007016
EFO_0007017	peanut allergy measurement	http://www.ebi.ac.uk/efo/EFO_0007017
EFO_0007018	egg allergy measurement	http://www.ebi.ac.uk/efo/EFO_0007018
EFO_0007019	milk allergy measurement	http://www.ebi.ac.uk/efo/EFO_0007019
EFO_0007021	Lewy body measurement	http://www.ebi.ac.uk/efo/EFO_0007021
EFO_1000478	pituitary gland adenoma	http://www.ebi.ac.uk/efo/EFO_1000478
EFO_0007612	response to Montelukast	http://www.ebi.ac.uk/efo/EFO_0007612
EFO_0007613	response to endocrine therapy	http://www.ebi.ac.uk/efo/EFO_0007613
EFO_0007614	asthma exacerbation measurement	http://www.ebi.ac.uk/efo/EFO_0007614
EFO_0007615	thrombus formation measurement	http://www.ebi.ac.uk/efo/EFO_0007615
EFO_0007616	hearing measurement	http://www.ebi.ac.uk/efo/EFO_0007616
EFO_0007617	pure tone hearing measurement	http://www.ebi.ac.uk/efo/EFO_0007617
EFO_0007618	hearing threshold measurement	http://www.ebi.ac.uk/efo/EFO_0007618
EFO_0007619	suicide ideation measurement	http://www.ebi.ac.uk/efo/EFO_0007619
EFO_0007620	volumetric bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007620
EFO_0007621	bone mineral content measurement	http://www.ebi.ac.uk/efo/EFO_0007621
EFO_0007622	sRAGE measurement	http://www.ebi.ac.uk/efo/EFO_0007622
EFO_0007623	suicide behaviour	http://www.ebi.ac.uk/efo/EFO_0007623
EFO_0007624	suicide	http://www.ebi.ac.uk/efo/EFO_0007624
EFO_0007645	longitudinal alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007645
EFO_0001064	Down syndrome	http://www.ebi.ac.uk/efo/EFO_0001064
HP_0006695	Atrioventricular canal defect	http://purl.obolibrary.org/obo/HP_0006695
EFO_0007646	amyloid plaque accumulation rate	http://www.ebi.ac.uk/efo/EFO_0007646
EFO_0007634	major depressive episode	http://www.ebi.ac.uk/efo/EFO_0007634
HP_0002015	dysphagia	http://purl.obolibrary.org/obo/HP_0002015
EFO_1001252	gastric cardia carcinoma	http://www.ebi.ac.uk/efo/EFO_1001252
EFO_0007635	concentration dose ratio	http://www.ebi.ac.uk/efo/EFO_0007635
EFO_0000389	cutaneous melanoma	http://www.ebi.ac.uk/efo/EFO_0000389
EFO_0007636	attention function measurement	http://www.ebi.ac.uk/efo/EFO_0007636
EFO_0007637	traditional Chinese medicine type	http://www.ebi.ac.uk/efo/EFO_0007637
EFO_0007638	Yu-Zhi constitution type	http://www.ebi.ac.uk/efo/EFO_0007638
HP_0012735	Cough	http://purl.obolibrary.org/obo/HP_0012735
EFO_0007639	minimal erythema dose	http://www.ebi.ac.uk/efo/EFO_0007639
EFO_0007647	response to vancomycin	http://www.ebi.ac.uk/efo/EFO_0007647
EFO_0007648	vancomycin trough measurement	http://www.ebi.ac.uk/efo/EFO_0007648
EFO_0007649	renal elimination rate measurement	http://www.ebi.ac.uk/efo/EFO_0007649
HP_0001634	Mitral valve prolapse	http://purl.obolibrary.org/obo/HP_0001634
EFO_0007650	soluble interleukin-2 receptor subunit alpha measurement	http://www.ebi.ac.uk/efo/EFO_0007650
EFO_0007651	urinary S-phenylmercapturic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007651
EFO_0007652	health trait	http://www.ebi.ac.uk/efo/EFO_0007652
EFO_0007653	clinical ideal cardiovascular health	http://www.ebi.ac.uk/efo/EFO_0007653
EFO_0007654	clinical and behavioural ideal cardiovascular health	http://www.ebi.ac.uk/efo/EFO_0007654
EFO_0007655	clusterin measurement	http://www.ebi.ac.uk/efo/EFO_0007655
EFO_0007656	plasma clusterin measurement	http://www.ebi.ac.uk/efo/EFO_0007656
EFO_0007657	cerebrospinal fluid clusterin measurement	http://www.ebi.ac.uk/efo/EFO_0007657
EFO_0007658	carrier status	http://www.ebi.ac.uk/efo/EFO_0007658
EFO_0007659	APOE carrier status	http://www.ebi.ac.uk/efo/EFO_0007659
EFO_0004562	cryptorchidism	http://www.ebi.ac.uk/efo/EFO_0004562
EFO_0000503	gastric adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0000503
EFO_0000557	juvenile dermatomyositis	http://www.ebi.ac.uk/efo/EFO_0000557
EFO_0000783	myositis	http://www.ebi.ac.uk/efo/EFO_0000783
EFO_0003063	polymyositis	http://www.ebi.ac.uk/efo/EFO_0003063
EFO_0000311	cancer	http://www.ebi.ac.uk/efo/EFO_0000311
EFO_0005140	autoimmune disease	http://www.ebi.ac.uk/efo/EFO_0005140
EFO_0007697	left superior temporal gyrus grey matter volume measurement	http://www.ebi.ac.uk/efo/EFO_0007697
EFO_0007698	GBA carrier status	http://www.ebi.ac.uk/efo/EFO_0007698
EFO_0007699	eye movement measurement	http://www.ebi.ac.uk/efo/EFO_0007699
EFO_0007700	exploratory eye movement measurement	http://www.ebi.ac.uk/efo/EFO_0007700
EFO_0007701	spine bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007701
EFO_0007702	hip bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007702
EFO_0007703	hystidil-tRNA synthetase autoantibody measurement	http://www.ebi.ac.uk/efo/EFO_0007703
EFO_0007704	depressive episode measurement	http://www.ebi.ac.uk/efo/EFO_0007704
EFO_0007705	manic episode measurement	http://www.ebi.ac.uk/efo/EFO_0007705
EFO_0007706	manic or hypomanic episode	http://www.ebi.ac.uk/efo/EFO_0007706
EFO_1001482	cardiotoxicity	http://www.ebi.ac.uk/efo/EFO_1001482
EFO_0007707	cerebral amyloid deposition measurement	http://www.ebi.ac.uk/efo/EFO_0007707
EFO_0007708	t-tau:beta-amyloid 1-42 ratio measurement	http://www.ebi.ac.uk/efo/EFO_0007708
EFO_0007709	p-tau:beta-amyloid 1-42 ratio measurement	http://www.ebi.ac.uk/efo/EFO_0007709
HP_0100543	cognitive impairment	http://purl.obolibrary.org/obo/HP_0100543
EFO_0007710	cognitive decline measurement	http://www.ebi.ac.uk/efo/EFO_0007710
EFO_1001483	non-obstructive coronary artery disease	http://www.ebi.ac.uk/efo/EFO_1001483
EFO_0007716	carotid artery measurement	http://www.ebi.ac.uk/efo/EFO_0007716
EFO_0007717	carotid artery geometry measurement	http://www.ebi.ac.uk/efo/EFO_0007717
EFO_0007718	carotid artery stiffness measurement	http://www.ebi.ac.uk/efo/EFO_0007718
EFO_0007719	carotid artery external diameter measurement	http://www.ebi.ac.uk/efo/EFO_0007719
EFO_0007720	carotid artery internal diameter measurement	http://www.ebi.ac.uk/efo/EFO_0007720
EFO_0007721	carotid artery central pulse pressure measurement	http://www.ebi.ac.uk/efo/EFO_0007721
EFO_0007722	carotid artery wall cross sectional area measurement	http://www.ebi.ac.uk/efo/EFO_0007722
EFO_0007723	carotid artery mean blood pressure measurement	http://www.ebi.ac.uk/efo/EFO_0007723
EFO_0007724	carotid artery circumferential wall stress measurement	http://www.ebi.ac.uk/efo/EFO_0007724
HP_0010886	Osteochondritis Dissecans	http://purl.obolibrary.org/obo/HP_0010886
EFO_0004317	extraversion	http://www.ebi.ac.uk/efo/EFO_0004317
HP_0000093	proteinuria	http://purl.obolibrary.org/obo/HP_0000093
EFO_0007737	BMI-adjusted adiponectin measurement	http://www.ebi.ac.uk/efo/EFO_0007737
EFO_0007738	cingulate cortex measurement	http://www.ebi.ac.uk/efo/EFO_0007738
EFO_0007739	left superior temporal gyrus thickness measurement	http://www.ebi.ac.uk/efo/EFO_0007739
EFO_0007740	S wave amplitude	http://www.ebi.ac.uk/efo/EFO_0007740
EFO_0007741	R wave amplitude	http://www.ebi.ac.uk/efo/EFO_0007741
EFO_0007742	QRS amplitude	http://www.ebi.ac.uk/efo/EFO_0007742
EFO_1001486	primary biliary cirrhosis	http://www.ebi.ac.uk/efo/EFO_1001486
EFO_1001487	secondary biliary cirrhosis	http://www.ebi.ac.uk/efo/EFO_1001487
EFO_1001488	influenza A (H1N1)	http://www.ebi.ac.uk/efo/EFO_1001488
EFO_0007743	influenza A severity measurement	http://www.ebi.ac.uk/efo/EFO_0007743
EFO_1000802	alcoholic liver cirrhosis	http://www.ebi.ac.uk/efo/EFO_1000802
EFO_1001492	atrophic macular degeneration	http://www.ebi.ac.uk/efo/EFO_1001492
HP_0000023	inguinal hernia	http://purl.obolibrary.org/obo/HP_0000023
EFO_0007766	response to beta blocker	http://www.ebi.ac.uk/efo/EFO_0007766
EFO_0007767	response to calcium channel blocker	http://www.ebi.ac.uk/efo/EFO_0007767
EFO_0007768	response to exercise	http://www.ebi.ac.uk/efo/EFO_0007768
EFO_0007769	thoracic-to-hip circumference ratio measurement	http://www.ebi.ac.uk/efo/EFO_0007769
EFO_0007770	post-operative fentanyl consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007770
EFO_0007771	pathologic complete response measurement	http://www.ebi.ac.uk/efo/EFO_0007771
EFO_0007772	calcaneal bone quantitative ultrasound measurement	http://www.ebi.ac.uk/efo/EFO_0007772
HP_0001977	abnormal thrombosis	http://purl.obolibrary.org/obo/HP_0001977
EFO_0003907	deep vein thrombosis	http://www.ebi.ac.uk/efo/EFO_0003907
EFO_1001504	small vessel stroke	http://www.ebi.ac.uk/efo/EFO_1001504
Orphanet_46724	Cerebral arteriovenous malformation	http://www.orpha.net/ORDO/Orphanet_46724
EFO_0007780	periodontal measurement	http://www.ebi.ac.uk/efo/EFO_0007780
EFO_1001506	primary angle closure glaucoma	http://www.ebi.ac.uk/efo/EFO_1001506
EFO_1001507	Asparaginase-induced acute pancreatitis	http://www.ebi.ac.uk/efo/EFO_1001507
EFO_0007783	mosaic loss of chromosome Y measurement	http://www.ebi.ac.uk/efo/EFO_0007783
EFO_0007784	functional decline measurement	http://www.ebi.ac.uk/efo/EFO_0007784
EFO_0007785	femoral neck bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007785
EFO_0007788	BMI-adjusted waist-hip ratio	http://www.ebi.ac.uk/efo/EFO_0007788
EFO_0007789	BMI-adjusted waist circumference	http://www.ebi.ac.uk/efo/EFO_0007789
EFO_0007790	Epstein Barr virus nuclear antigen 1 IgG measurement	http://www.ebi.ac.uk/efo/EFO_0007790
EFO_0007791	rheumatoid factor seropositivity measurement	http://www.ebi.ac.uk/efo/EFO_0007791
EFO_0007792	antipsychotic drug use measurement	http://www.ebi.ac.uk/efo/EFO_0007792
EFO_1001022	low tension glaucoma	http://www.ebi.ac.uk/efo/EFO_1001022
EFO_0007810	Plasmodium falciparum antigen IgG1 measurement	http://www.ebi.ac.uk/efo/EFO_0007810
EFO_0007811	Plasmodium falciparum antigen IgG3 measurement	http://www.ebi.ac.uk/efo/EFO_0007811
EFO_0007812	Plasmodium falciparum antigen IgG measurement	http://www.ebi.ac.uk/efo/EFO_0007812
EFO_0007813	cotinine measurement	http://www.ebi.ac.uk/efo/EFO_0007813
EFO_0007814	refractive error measurement	http://www.ebi.ac.uk/efo/EFO_0007814
EFO_0007191	cannabis dependence	http://www.ebi.ac.uk/efo/EFO_0007191
HP_0001945	fever	http://purl.obolibrary.org/obo/HP_0001945
EFO_0007815	response to dabrafenib	http://www.ebi.ac.uk/efo/EFO_0007815
EFO_0007816	response to trametinib	http://www.ebi.ac.uk/efo/EFO_0007816
EFO_0007817	sleep apnea measurement	http://www.ebi.ac.uk/efo/EFO_0007817
EFO_0007818	athletic endurance measurement	http://www.ebi.ac.uk/efo/EFO_0007818
EFO_0007819	advanced glycation end-product measurement	http://www.ebi.ac.uk/efo/EFO_0007819
EFO_0007835	alcohol dependence measurement	http://www.ebi.ac.uk/efo/EFO_0007835
EFO_0007836	coenzyme Q10 measurement	http://www.ebi.ac.uk/efo/EFO_0007836
EFO_0007838	response to anti-thyroid drug	http://www.ebi.ac.uk/efo/EFO_0007838
EFO_1001514	endometrial endometrioid carcinoma	http://www.ebi.ac.uk/efo/EFO_1001514
EFO_1001515	ovarian endometrioid carcinoma	http://www.ebi.ac.uk/efo/EFO_1001515
EFO_1001516	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516
EFO_0006859	head and neck malignant neoplasia	http://www.ebi.ac.uk/efo/EFO_0006859
Orphanet_52	Alagille syndrome	http://www.orpha.net/ORDO/Orphanet_52
HP_0001395	Hepatic fibrosis	http://purl.obolibrary.org/obo/HP_0001395
EFO_0007851	seroconversion	http://www.ebi.ac.uk/efo/EFO_0007851
EFO_0007853	response to mercaptopurine	http://www.ebi.ac.uk/efo/EFO_0007853
EFO_0007854	knee peak torque measurement	http://www.ebi.ac.uk/efo/EFO_0007854
EFO_0007856	facial height measurement	http://www.ebi.ac.uk/efo/EFO_0007856
EFO_0007857	facial depth measurement	http://www.ebi.ac.uk/efo/EFO_0007857
EFO_0007858	eye morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007858
EFO_0003948	gastroesophageal reflux disease	http://www.ebi.ac.uk/efo/EFO_0003948
EFO_0005514	HER2 status	http://www.ebi.ac.uk/efo/EFO_0005514
EFO_1001466	Graves ophthalmopathy	http://www.ebi.ac.uk/efo/EFO_1001466
EFO_0004955	Breslow thickness	http://www.ebi.ac.uk/efo/EFO_0004955
EFO_0003033	bacteriemia	http://www.ebi.ac.uk/efo/EFO_0003033
EFO_1001925	pneumococcal bacteremia	http://www.ebi.ac.uk/efo/EFO_1001925
EFO_1001926	pathological gambling	http://www.ebi.ac.uk/efo/EFO_1001926
EFO_1001927	cutaneous squamous cell carcinoma	http://www.ebi.ac.uk/efo/EFO_1001927
EFO_0007859	response to interferon	http://www.ebi.ac.uk/efo/EFO_0007859
EFO_0007860	ADHD symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007860
EFO_0007862	reproductive behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0007862
EFO_0007863	illness severity status	http://www.ebi.ac.uk/efo/EFO_0007863
EFO_0007864	sulfate measurement	http://www.ebi.ac.uk/efo/EFO_0007864
EFO_0007865	loneliness measurement	http://www.ebi.ac.uk/efo/EFO_0007865
EFO_0007866	response to rifampicin	http://www.ebi.ac.uk/efo/EFO_0007866
EFO_0007867	response to gefitinib	http://www.ebi.ac.uk/efo/EFO_0007867
EFO_0007868	response to erlotinib	http://www.ebi.ac.uk/efo/EFO_0007868
EFO_0005213	central corneal thickness	http://www.ebi.ac.uk/efo/EFO_0005213
EFO_1001209	temporal arteritis	http://www.ebi.ac.uk/efo/EFO_1001209
EFO_0000373	congestive heart failure	http://www.ebi.ac.uk/efo/EFO_0000373
EFO_1000726	lichen planus	http://www.ebi.ac.uk/efo/EFO_1000726
HP_0000202	oral cleft	http://purl.obolibrary.org/obo/HP_0000202
EFO_1001998	complex regional pain syndrome	http://www.ebi.ac.uk/efo/EFO_1001998
EFO_0007888	age at voice drop	http://www.ebi.ac.uk/efo/EFO_0007888
EFO_0007887	autosomal dominant compelling helio-ophthalmic outburst syndrome	http://www.ebi.ac.uk/efo/EFO_0007887
EFO_0007889	dysmenorrheic pain measurement	http://www.ebi.ac.uk/efo/EFO_0007889
EFO_0007890	pericardial adipose tissue measurement	http://www.ebi.ac.uk/efo/EFO_0007890
EFO_0007891	skin barrier function measurement	http://www.ebi.ac.uk/efo/EFO_0007891
EFO_0007892	donor genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0007892
EFO_0007893	alpha-carotene measurement	http://www.ebi.ac.uk/efo/EFO_0007893
EFO_0007894	beta-carotene measurement	http://www.ebi.ac.uk/efo/EFO_0007894
EFO_0007895	lutein measurement	http://www.ebi.ac.uk/efo/EFO_0007895
EFO_0007896	zeaxanthin measurement	http://www.ebi.ac.uk/efo/EFO_0007896
EFO_0007897	cryptoxanthin measurement	http://www.ebi.ac.uk/efo/EFO_0007897
EFO_0007898	alpha-tocopherol measurement	http://www.ebi.ac.uk/efo/EFO_0007898
EFO_0007899	gamma-tocopherol measurement	http://www.ebi.ac.uk/efo/EFO_0007899
EFO_0007900	retinol measurement	http://www.ebi.ac.uk/efo/EFO_0007900
EFO_0007901	hepcidin:ferritin ratio	http://www.ebi.ac.uk/efo/EFO_0007901
EFO_0007902	hepcidin:transferrin saturation ratio	http://www.ebi.ac.uk/efo/EFO_0007902
EFO_0007903	magnesium:calcium ratio	http://www.ebi.ac.uk/efo/EFO_0007903
EFO_0007626	emphysema imaging measurement	http://www.ebi.ac.uk/efo/EFO_0007626
EFO_0007627	airway imaging measurement	http://www.ebi.ac.uk/efo/EFO_0007627
EFO_0007628	gas trapping measurement	http://www.ebi.ac.uk/efo/EFO_0007628
EFO_1001250	rotator cuff tear	http://www.ebi.ac.uk/efo/EFO_1001250
EFO_0007629	hemoglobin A1 measurement	http://www.ebi.ac.uk/efo/EFO_0007629
EFO_0007630	glycerophospholipid measurement	http://www.ebi.ac.uk/efo/EFO_0007630
EFO_0007631	hexose measurement	http://www.ebi.ac.uk/efo/EFO_0007631
EFO_0006462	ovarian mucinous adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0006462
HP_0001919	Acute kidney injury	http://purl.obolibrary.org/obo/HP_0001919
EFO_0007633	response to thioamide	http://www.ebi.ac.uk/efo/EFO_0007633
EFO_0007632	postprandial hyperlipidemia	http://www.ebi.ac.uk/efo/EFO_0007632
EFO_0007660	neuroticism measurement	http://www.ebi.ac.uk/efo/EFO_0007660
EFO_0007662	response to triptolide	http://www.ebi.ac.uk/efo/EFO_0007662
EFO_0007663	childhood aggressive behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0007663
EFO_1001253	maculopapular eruption	http://www.ebi.ac.uk/efo/EFO_1001253
EFO_0007661	response to lamotrigine	http://www.ebi.ac.uk/efo/EFO_0007661
EFO_0007664	outer ear morphology trait	http://www.ebi.ac.uk/efo/EFO_0007664
EFO_0007665	ear protrusion	http://www.ebi.ac.uk/efo/EFO_0007665
EFO_0007666	lobe size	http://www.ebi.ac.uk/efo/EFO_0007666
EFO_0007667	lobe attachment	http://www.ebi.ac.uk/efo/EFO_0007667
EFO_0007668	tragus size	http://www.ebi.ac.uk/efo/EFO_0007668
EFO_0007669	antitragus size	http://www.ebi.ac.uk/efo/EFO_0007669
EFO_0007670	helix rolling	http://www.ebi.ac.uk/efo/EFO_0007670
EFO_0007671	folding of antihelix	http://www.ebi.ac.uk/efo/EFO_0007671
EFO_0007672	crus helix expression	http://www.ebi.ac.uk/efo/EFO_0007672
EFO_0007673	superior crus of antihelix expression	http://www.ebi.ac.uk/efo/EFO_0007673
EFO_0007674	Darwin's tubercule	http://www.ebi.ac.uk/efo/EFO_0007674
EFO_0007675	metastasis measurement	http://www.ebi.ac.uk/efo/EFO_0007675
EFO_0004953	date of diagnosis	http://www.ebi.ac.uk/efo/EFO_0004953
EFO_0007676	response to zileuton	http://www.ebi.ac.uk/efo/EFO_0007676
HP_0002140	Ischemic stroke	http://purl.obolibrary.org/obo/HP_0002140
Orphanet_278	corticobasal degeneration	http://www.orpha.net/ORDO/Orphanet_278
EFO_1001254	noise-induced hearing loss	http://www.ebi.ac.uk/efo/EFO_1001254
EFO_0007677	LDL peak particle diameter measurement	http://www.ebi.ac.uk/efo/EFO_0007677
EFO_0007678	total fat intake measurement	http://www.ebi.ac.uk/efo/EFO_0007678
EFO_0004920	progression free survival	http://www.ebi.ac.uk/efo/EFO_0004920
HP_0010865	oppositional defiant disorder	http://purl.obolibrary.org/obo/HP_0010865
EFO_1001480	metastatic colorectal cancer	http://www.ebi.ac.uk/efo/EFO_1001480
EFO_0007679	oppositional defiant disorder measurement	http://www.ebi.ac.uk/efo/EFO_0007679
EFO_0007680	gait measurement	http://www.ebi.ac.uk/efo/EFO_0007680
EFO_0007681	triglyceride change measurement	http://www.ebi.ac.uk/efo/EFO_0007681
EFO_0007682	response to cetuximab	http://www.ebi.ac.uk/efo/EFO_0007682
EFO_0007684	response to high fat food intake	http://www.ebi.ac.uk/efo/EFO_0007684
EFO_0007685	trichloroethylene-induced hypersensitivity	http://www.ebi.ac.uk/efo/EFO_0007685
EFO_1000782	altitude sickness	http://www.ebi.ac.uk/efo/EFO_1000782
EFO_1000881	coronary aneurysm	http://www.ebi.ac.uk/efo/EFO_1000881
EFO_1001489	skin and soft tissue Staphylococcus aureus infection	http://www.ebi.ac.uk/efo/EFO_1001489
EFO_1001490	late-onset myasthenia gravis	http://www.ebi.ac.uk/efo/EFO_1001490
EFO_0007744	lung disease severity measurement	http://www.ebi.ac.uk/efo/EFO_0007744
EFO_0007745	lactate measurement	http://www.ebi.ac.uk/efo/EFO_0007745
EFO_0007746	white matter lesion progression measurement	http://www.ebi.ac.uk/efo/EFO_0007746
EFO_0007747	postburn hypertrophic scarring severity measurement	http://www.ebi.ac.uk/efo/EFO_0007747
EFO_1001293	collagenous colitis	http://www.ebi.ac.uk/efo/EFO_1001293
EFO_0007753	seasonal gut microbiome measurement	http://www.ebi.ac.uk/efo/EFO_0007753
EFO_0007754	response to immunochemotherapy	http://www.ebi.ac.uk/efo/EFO_0007754
EFO_0007755	atopic march	http://www.ebi.ac.uk/efo/EFO_0007755
EFO_0007756	Staphylococcus aureus carrier status	http://www.ebi.ac.uk/efo/EFO_0007756
EFO_0007757	persistent Staphylococcus aureus carrier status	http://www.ebi.ac.uk/efo/EFO_0007757
EFO_0007759	alpha-linolenic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007759
EFO_0007761	docosahexaenoic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007761
EFO_0007762	gamma-linolenic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007762
EFO_0007763	dihomo-gamma-linolenic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007763
EFO_0007764	delta-5 desaturase measurement	http://www.ebi.ac.uk/efo/EFO_0007764
EFO_0007765	delta-6 desaturase measurement	http://www.ebi.ac.uk/efo/EFO_0007765
EFO_0007774	thrombomodulin measurement	http://www.ebi.ac.uk/efo/EFO_0007774
EFO_0007775	thrombin-antithrombin complex measurement	http://www.ebi.ac.uk/efo/EFO_0007775
EFO_0007776	prothrombin fragments F1+2 measurement	http://www.ebi.ac.uk/efo/EFO_0007776
EFO_0007777	base metabolic rate measurement	http://www.ebi.ac.uk/efo/EFO_0007777
EFO_0007778	urinary albumin to creatinine ratio	http://www.ebi.ac.uk/efo/EFO_0007778
EFO_0007779	response to pazopanib	http://www.ebi.ac.uk/efo/EFO_0007779
HP_0012594	Moderate albuminuria	http://purl.obolibrary.org/obo/HP_0012594
EFO_0005543	glioma	http://www.ebi.ac.uk/efo/EFO_0005543
EFO_0007837	anti-citrullinated protein antibody seropositivity	http://www.ebi.ac.uk/efo/EFO_0007837
EFO_1000860	cerebral atherosclerosis	http://www.ebi.ac.uk/efo/EFO_1000860
EFO_1001493	cardiac embolism	http://www.ebi.ac.uk/efo/EFO_1001493
EFO_1001494	psoriasis vulgaris	http://www.ebi.ac.uk/efo/EFO_1001494
EFO_1001495	small artery occlusion	http://www.ebi.ac.uk/efo/EFO_1001495
EFO_0000318	cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0000318
EFO_0007794	nicotine metabolite ratio	http://www.ebi.ac.uk/efo/EFO_0007794
EFO_0007795	anxiety disorder measurement	http://www.ebi.ac.uk/efo/EFO_0007795
EFO_0007796	parental longevity	http://www.ebi.ac.uk/efo/EFO_0007796
EFO_1001510	specific language impairment	http://www.ebi.ac.uk/efo/EFO_1001510
EFO_0007797	language measurement	http://www.ebi.ac.uk/efo/EFO_0007797
EFO_0007798	linguistic error measurement	http://www.ebi.ac.uk/efo/EFO_0007798
EFO_0007799	syntactic complexity measurement	http://www.ebi.ac.uk/efo/EFO_0007799
EFO_0003827	pulmonary embolism	http://www.ebi.ac.uk/efo/EFO_0003827
EFO_0007800	body fat percentage	http://www.ebi.ac.uk/efo/EFO_0007800
EFO_0007801	lycopene measurement	http://www.ebi.ac.uk/efo/EFO_0007801
EFO_0007802	obsessive-compulsive symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007802
EFO_0007803	emotional symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007803
EFO_0007804	LDL cholesterol change measurement	http://www.ebi.ac.uk/efo/EFO_0007804
EFO_0007805	HDL cholesterol change measurement	http://www.ebi.ac.uk/efo/EFO_0007805
EFO_0007806	total cholesterol change measurement	http://www.ebi.ac.uk/efo/EFO_0007806
EFO_0007807	erythrocyte cadmium measurement	http://www.ebi.ac.uk/efo/EFO_0007807
EFO_0007809	response to flupirtine	http://www.ebi.ac.uk/efo/EFO_0007809
EFO_0007808	response to bortezomib	http://www.ebi.ac.uk/efo/EFO_0007808
EFO_1001512	endometrial carcinoma	http://www.ebi.ac.uk/efo/EFO_1001512
Orphanet_54247	posterior cortical atrophy	http://www.orpha.net/ORDO/Orphanet_54247
EFO_0007820	cognitive behavioural therapy	http://www.ebi.ac.uk/efo/EFO_0007820
EFO_0007821	hair morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007821
EFO_0007822	hair colour measurement	http://www.ebi.ac.uk/efo/EFO_0007822
EFO_0007823	facial hair thickness measurement	http://www.ebi.ac.uk/efo/EFO_0007823
EFO_0007824	hair shape measurement	http://www.ebi.ac.uk/efo/EFO_0007824
EFO_0007825	balding measurement	http://www.ebi.ac.uk/efo/EFO_0007825
EFO_0007826	aggressive behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0007826
EFO_0007827	nighttime rest measurement	http://www.ebi.ac.uk/efo/EFO_0007827
EFO_0007828	daytime rest measurement	http://www.ebi.ac.uk/efo/EFO_0007828
EFO_0007829	eating behaviour	http://www.ebi.ac.uk/efo/EFO_0007829
EFO_0007830	food addiction measurement	http://www.ebi.ac.uk/efo/EFO_0007830
EFO_0004297	clinical laboratory measurement	http://www.ebi.ac.uk/efo/EFO_0004297
EFO_0000196	metastatic prostate cancer	http://www.ebi.ac.uk/efo/EFO_0000196
EFO_0000708	squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0000708
EFO_0000181	head and neck squamous cell carcinoma	http://www.ebi.ac.uk/efo/EFO_0000181
HP_0002014	diarrhea	http://purl.obolibrary.org/obo/HP_0002014
EFO_0007840	pesticide exposure measurement	http://www.ebi.ac.uk/efo/EFO_0007840
EFO_0007841	facial morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007841
EFO_0007842	chin morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007842
EFO_0007844	forehead morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007844
EFO_0007845	lip morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007845
EFO_0007847	cheekbone morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007847
EFO_0007848	apolipoprotein A-IV measurement	http://www.ebi.ac.uk/efo/EFO_0007848
EFO_0007849	functional brain measurement	http://www.ebi.ac.uk/efo/EFO_0007849
EFO_0007850	solar lentigines measurement	http://www.ebi.ac.uk/efo/EFO_0007850
HP_0011950	Bronchiolitis	http://purl.obolibrary.org/obo/HP_0011950
EFO_1001901	neuroendocrine neoplasm	http://www.ebi.ac.uk/efo/EFO_1001901
EFO_0005220	pulmonary neuroendocrine tumor	http://www.ebi.ac.uk/efo/EFO_0005220
EFO_1000045	pancreatic neuroendocrine tumor	http://www.ebi.ac.uk/efo/EFO_1000045
EFO_1001928	small intestine neuroendocrine tumor	http://www.ebi.ac.uk/efo/EFO_1001928
EFO_0007869	wellbeing measurement	http://www.ebi.ac.uk/efo/EFO_0007869
EFO_1001870	late-onset Alzheimers disease	http://www.ebi.ac.uk/efo/EFO_1001870
EFO_0004952	disease recurrence	http://www.ebi.ac.uk/efo/EFO_0004952
GO_1903493	response to clopidogrel	http://purl.obolibrary.org/obo/GO_1903493
HP_0012199	Cluster headache	http://purl.obolibrary.org/obo/HP_0012199
EFO_0007870	response to norepinephrine-dopamine reuptake inhibitor	http://www.ebi.ac.uk/efo/EFO_0007870
EFO_0007871	response to escitalopram	http://www.ebi.ac.uk/efo/EFO_0007871
EFO_1001929	selective IgA deficiency disease	http://www.ebi.ac.uk/efo/EFO_1001929
EFO_1001930	idiopathic osteonecrosis of the femoral head	http://www.ebi.ac.uk/efo/EFO_1001930
EFO_0007872	caffeine metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0007872
EFO_0007873	cartilage thickness measurement	http://www.ebi.ac.uk/efo/EFO_0007873
EFO_0007874	gut microbiome measurement	http://www.ebi.ac.uk/efo/EFO_0007874
EFO_0007875	excessive daytime sleepiness measurement	http://www.ebi.ac.uk/efo/EFO_0007875
EFO_0007876	insomnia measurement	http://www.ebi.ac.uk/efo/EFO_0007876
EFO_0007877	risky sexual behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0007877
EFO_0007878	alcohol consumption measurement	http://www.ebi.ac.uk/efo/EFO_0007878
EFO_0007879	petaloid toenail	http://www.ebi.ac.uk/efo/EFO_0007879
EFO_0007880	response to dendritic cell-based immunotherapy	http://www.ebi.ac.uk/efo/EFO_0007880
EFO_1001931	oropharynx cancer	http://www.ebi.ac.uk/efo/EFO_1001931
EFO_0000764	HIV infection	http://www.ebi.ac.uk/efo/EFO_0000764
EFO_0007321	hypopharynx cancer	http://www.ebi.ac.uk/efo/EFO_0007321
EFO_0005577	pharynx cancer	http://www.ebi.ac.uk/efo/EFO_0005577
EFO_0005570	oral cavity cancer	http://www.ebi.ac.uk/efo/EFO_0005570
HP_0011868	Sciatica	http://purl.obolibrary.org/obo/HP_0011868
EFO_0007881	job-related exhaustion measurement	http://www.ebi.ac.uk/efo/EFO_0007881
EFO_0007882	microbiome measurement	http://www.ebi.ac.uk/efo/EFO_0007882
EFO_0007883	taxonomic microbiome measurement	http://www.ebi.ac.uk/efo/EFO_0007883
EFO_0007884	functional microbiome measurement	http://www.ebi.ac.uk/efo/EFO_0007884
EFO_1001976	cardioembolic stroke	http://www.ebi.ac.uk/efo/EFO_1001976
EFO_0007886	DDT metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0007886
EFO_0007885	JT interval	http://www.ebi.ac.uk/efo/EFO_0007885
EFO_0007904	susceptibility to childhood ear infection measurement	http://www.ebi.ac.uk/efo/EFO_0007904
EFO_0007905	joint hypermobility measurement	http://www.ebi.ac.uk/efo/EFO_0007905
EFO_0007906	synophrys measurement	http://www.ebi.ac.uk/efo/EFO_0007906
Orphanet_85443	AL amyloidosis	http://www.orpha.net/ORDO/Orphanet_85443
EFO_1001999	systemic juvenile idiopathic arthritis	http://www.ebi.ac.uk/efo/EFO_1001999
EFO_0007907	methadone dose measurement	http://www.ebi.ac.uk/efo/EFO_0007907
EFO_0007908	traffic air pollution measurement	http://www.ebi.ac.uk/efo/EFO_0007908
EFO_0007909	CHGA cleavage product measurement	http://www.ebi.ac.uk/efo/EFO_0007909
EFO_0007910	CHGB cleavage product measurement	http://www.ebi.ac.uk/efo/EFO_0007910
EFO_0007911	personality trait measurement	http://www.ebi.ac.uk/efo/EFO_0007911
EFO_0007912	conscientiousness measurement	http://www.ebi.ac.uk/efo/EFO_0007912
EFO_0007913	extraversion measurement	http://www.ebi.ac.uk/efo/EFO_0007913
EFO_0007914	openness measurement	http://www.ebi.ac.uk/efo/EFO_0007914
EFO_0007915	agreeableness measurement	http://www.ebi.ac.uk/efo/EFO_0007915
EFO_0007916	response to tricyclic antidepressant	http://www.ebi.ac.uk/efo/EFO_0007916
EFO_0007917	response to tetracyclic antidepressant	http://www.ebi.ac.uk/efo/EFO_0007917
EFO_0007918	response to anti-tuberculosis drug	http://www.ebi.ac.uk/efo/EFO_0007918
EFO_0007919	response to diclofenac	http://www.ebi.ac.uk/efo/EFO_0007919
EFO_0007920	response to fluoroquinolones	http://www.ebi.ac.uk/efo/EFO_0007920
EFO_0007921	response to nitrofurantoin	http://www.ebi.ac.uk/efo/EFO_0007921
EFO_0007922	response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0007922
EFO_0007923	response to terbinafine	http://www.ebi.ac.uk/efo/EFO_0007923
EFO_1002000	Takotsubo cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_1002000
EFO_0007924	tonsillectomy risk measurement	http://www.ebi.ac.uk/efo/EFO_0007924
EFO_0007933	radius bone mineral density	http://www.ebi.ac.uk/efo/EFO_0007933
HP_0000225	gingival bleeding	http://purl.obolibrary.org/obo/HP_0000225
EFO_0007946	tiredness measurement	http://www.ebi.ac.uk/efo/EFO_0007946
EFO_0007947	serum galactose-deficient IgA1 measurement	http://www.ebi.ac.uk/efo/EFO_0007947
EFO_0007948	HIV-associated neurocognitive disorder	http://www.ebi.ac.uk/efo/EFO_0007948
EFO_0007949	acute-on-chronic liver failure	http://www.ebi.ac.uk/efo/EFO_0007949
EFO_1002006	treatment-resistant hypertension	http://www.ebi.ac.uk/efo/EFO_1002006
HP_0002619	Varicose veins	http://purl.obolibrary.org/obo/HP_0002619
GO_0060279	positive regulation of ovulation	http://purl.obolibrary.org/obo/GO_0060279
Orphanet_141136	Hemifacial microsomia	http://www.orpha.net/ORDO/Orphanet_141136
HP_0001657	prolonged QT interval	http://purl.obolibrary.org/obo/HP_0001657
EFO_0007978	red blood cell density measurement	http://www.ebi.ac.uk/efo/EFO_0007978
EFO_0007979	childhood trauma measurement	http://www.ebi.ac.uk/efo/EFO_0007979
EFO_0007980	cerebral blood flow measurement	http://www.ebi.ac.uk/efo/EFO_0007980
EFO_0007981	response to thiazide	http://www.ebi.ac.uk/efo/EFO_0007981
EFO_0007982	mild neurocognitive disorder	http://www.ebi.ac.uk/efo/EFO_0007982
EFO_0007983	asymptomatic neurocognitive impairment	http://www.ebi.ac.uk/efo/EFO_0007983
EFO_0008341	snoring measurement	http://www.ebi.ac.uk/efo/EFO_0008341
EFO_0008342	parental emotion expression measurmement	http://www.ebi.ac.uk/efo/EFO_0008342
EFO_0008343	sex interaction measurement	http://www.ebi.ac.uk/efo/EFO_0008343
EFO_0008344	response to placebo	http://www.ebi.ac.uk/efo/EFO_0008344
EFO_0008345	response to duloxetine	http://www.ebi.ac.uk/efo/EFO_0008345
EFO_0008346	family history of upper gastrointestinal cancer	http://www.ebi.ac.uk/efo/EFO_0008346
EFO_0008347	response to trastuzumab	http://www.ebi.ac.uk/efo/EFO_0008347
EFO_0008348	response to ranibizumab	http://www.ebi.ac.uk/efo/EFO_0008348
EFO_0008349	thiazide-induced hyponatremia	http://www.ebi.ac.uk/efo/EFO_0008349
EFO_1002014	melancholia	http://www.ebi.ac.uk/efo/EFO_1002014
EFO_1002015	HPV-associated cervical carcinoma	http://www.ebi.ac.uk/efo/EFO_1002015
EFO_1002017	differentiated thyroid carcinoma	http://www.ebi.ac.uk/efo/EFO_1002017
EFO_0007781	stressful life event measurement	http://www.ebi.ac.uk/efo/EFO_0007781
EFO_0006988	endophenotype	http://www.ebi.ac.uk/efo/EFO_0006988
EFO_0006817	yang deficiency	http://www.ebi.ac.uk/efo/EFO_0006817
EFO_0006825	trans/cis-18:2 fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0006825
HP_0000726	dementia	http://purl.obolibrary.org/obo/HP_0000726
EFO_0006823	total trans-18:1 fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0006823
EFO_0005951	sexual dimorphism	http://www.ebi.ac.uk/efo/EFO_0005951
EFO_0007852	thiopurine methyltransferase activity measurement	http://www.ebi.ac.uk/efo/EFO_0007852
EFO_0006811	linolenic acid measurement	http://www.ebi.ac.uk/efo/EFO_0006811
HP_0002108	spontaneous pneumothorax	http://purl.obolibrary.org/obo/HP_0002108
EFO_0007683	response to CAPOX-B	http://www.ebi.ac.uk/efo/EFO_0007683
EFO_0007843	nose morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007843
EFO_0008209	leukocyte immunoglobulin-like receptor subfamily B member 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008209
EFO_0006828	plasma renin activity measurement	http://www.ebi.ac.uk/efo/EFO_0006828
EFO_0008199	Kunitz-type protease inhibitor 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008199
EFO_0006836	rapid kidney function decline	http://www.ebi.ac.uk/efo/EFO_0006836
EFO_0006342	aggressive periodontitis	http://www.ebi.ac.uk/efo/EFO_0006342
EFO_1001050	multiple system atrophy	http://www.ebi.ac.uk/efo/EFO_1001050
EFO_0007758	intermittent Staphylococcus aureus carrier status	http://www.ebi.ac.uk/efo/EFO_0007758
EFO_0007855	facial width measurement	http://www.ebi.ac.uk/efo/EFO_0007855
HP_0002315	Headache	http://purl.obolibrary.org/obo/HP_0002315
EFO_0007786	menstrual cycle measurement	http://www.ebi.ac.uk/efo/EFO_0007786
EFO_0007787	plasma betaine measurement	http://www.ebi.ac.uk/efo/EFO_0007787
EFO_0003961	hormone replacement therapy	http://www.ebi.ac.uk/efo/EFO_0003961
EFO_0004804	birth rate	http://www.ebi.ac.uk/efo/EFO_0004804
EFO_0007773	cutaneous psoriasis measurement	http://www.ebi.ac.uk/efo/EFO_0007773
EFO_0007760	eicosapentaenoic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007760
EFO_0007970	estrone measurement	http://www.ebi.ac.uk/efo/EFO_0007970
EFO_0007975	gondoic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007975
EFO_0007124	salivary gland lesion	http://www.ebi.ac.uk/efo/EFO_0007124
EFO_0007793	BMI-adjusted leptin measurement	http://www.ebi.ac.uk/efo/EFO_0007793
HP_0000540	hypermetropia	http://purl.obolibrary.org/obo/HP_0000540
EFO_0006313	chemotherapy-induced oral mucositis	http://www.ebi.ac.uk/efo/EFO_0006313
EFO_0006799	Lewy body dementia measurement	http://www.ebi.ac.uk/efo/EFO_0006799
EFO_0006790	cerebral amyloid angiopathy	http://www.ebi.ac.uk/efo/EFO_0006790
EFO_0006796	very long-chain saturated fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0006796
EFO_1000650	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650
EFO_0003918	obstructive sleep apnea	http://www.ebi.ac.uk/efo/EFO_0003918
EFO_0008385	visual acuity measurement	http://www.ebi.ac.uk/efo/EFO_0008385
EFO_0008384	tumor necrosis factor receptor II measurement	http://www.ebi.ac.uk/efo/EFO_0008384
EFO_0008383	treatment outcome measurement	http://www.ebi.ac.uk/efo/EFO_0008383
EFO_0008382	TP53 mutation status	http://www.ebi.ac.uk/efo/EFO_0008382
EFO_0008381	total cortical area measurement	http://www.ebi.ac.uk/efo/EFO_0008381
EFO_0008380	perceived unattractiveness to mosquitos measurement	http://www.ebi.ac.uk/efo/EFO_0008380
EFO_0008379	P wave terminal force measurement	http://www.ebi.ac.uk/efo/EFO_0008379
EFO_0008378	mosquito bite reaction size measurement	http://www.ebi.ac.uk/efo/EFO_0008378
EFO_0008377	mosquito bite reaction itch intensity measurement	http://www.ebi.ac.uk/efo/EFO_0008377
EFO_0008376	mosquito bite measurement	http://www.ebi.ac.uk/efo/EFO_0008376
EFO_0008375	macula measurement	http://www.ebi.ac.uk/efo/EFO_0008375
EFO_0008374	liver amyloid deposition measurement	http://www.ebi.ac.uk/efo/EFO_0008374
EFO_0008373	left ventricular ejection fraction measurement	http://www.ebi.ac.uk/efo/EFO_0008373
EFO_0008372	laterality measurement	http://www.ebi.ac.uk/efo/EFO_0008372
EFO_0008371	kidney amyloid deposition measurement	http://www.ebi.ac.uk/efo/EFO_0008371
EFO_0008370	infant white matter volume measurement	http://www.ebi.ac.uk/efo/EFO_0008370
EFO_0008369	infant intracranial volume measurement	http://www.ebi.ac.uk/efo/EFO_0008369
EFO_0008368	infant grey matter volume measurement	http://www.ebi.ac.uk/efo/EFO_0008368
EFO_0008367	infant cerebrospinal fluid volume measurement	http://www.ebi.ac.uk/efo/EFO_0008367
EFO_0008366	IgG isotype profile measurement	http://www.ebi.ac.uk/efo/EFO_0008366
EFO_0008365	heart amyloid deposition measurement	http://www.ebi.ac.uk/efo/EFO_0008365
EFO_0008364	generational effect measurement	http://www.ebi.ac.uk/efo/EFO_0008364
EFO_0008363	gamma-linoleic acid measurement	http://www.ebi.ac.uk/efo/EFO_0008363
EFO_0008362	farm exposure measurement	http://www.ebi.ac.uk/efo/EFO_0008362
EFO_0008361	environmental tobacco smoke exposure measurement	http://www.ebi.ac.uk/efo/EFO_0008361
EFO_0008360	environmental exposure measurement	http://www.ebi.ac.uk/efo/EFO_0008360
EFO_0008359	eicosadienoic acid measurement	http://www.ebi.ac.uk/efo/EFO_0008359
EFO_0008358	dorsolateral prefrontal cortex functional measurement	http://www.ebi.ac.uk/efo/EFO_0008358
EFO_0008357	docosatetranoic acid measurement	http://www.ebi.ac.uk/efo/EFO_0008357
EFO_0008356	dihomo-gamma-linoleic acid measurement	http://www.ebi.ac.uk/efo/EFO_0008356
EFO_0008355	dietary heme iron intake measurement	http://www.ebi.ac.uk/efo/EFO_0008355
EFO_0008354	cognitive function measurement	http://www.ebi.ac.uk/efo/EFO_0008354
EFO_0008353	cellular adhesion molecule measurement	http://www.ebi.ac.uk/efo/EFO_0008353
EFO_0008352	C9orf72 mutation status	http://www.ebi.ac.uk/efo/EFO_0008352
EFO_0008351	amyloid deposition measurement	http://www.ebi.ac.uk/efo/EFO_0008351
EFO_0008350	alpha-linoleic acid measurement	http://www.ebi.ac.uk/efo/EFO_0008350
EFO_0007326	infectious mononucleosis	http://www.ebi.ac.uk/efo/EFO_0007326
EFO_0007204	chickenpox	http://www.ebi.ac.uk/efo/EFO_0007204
EFO_0007477	scarlet fever	http://www.ebi.ac.uk/efo/EFO_0007477
EFO_0007305	hepatitis A	http://www.ebi.ac.uk/efo/EFO_0007305
EFO_0003103	urinary tract infection	http://www.ebi.ac.uk/efo/EFO_0003103
EFO_1001160	rheumatic fever	http://www.ebi.ac.uk/efo/EFO_1001160
EFO_0007214	common cold	http://www.ebi.ac.uk/efo/EFO_0007214
EFO_1001017	limited scleroderma	http://www.ebi.ac.uk/efo/EFO_1001017
EFO_0000404	diffuse scleroderma	http://www.ebi.ac.uk/efo/EFO_0000404
EFO_1002019	oligoarticular juvenile idiopathic arthritis	http://www.ebi.ac.uk/efo/EFO_1002019
EFO_1002020	polyarticular juvenile idiopathic arthritis, rheumatoid factor negative	http://www.ebi.ac.uk/efo/EFO_1002020
EFO_1001249	non-alcoholic steatohepatitis	http://www.ebi.ac.uk/efo/EFO_1001249
EFO_0007490	spinal stenosis	http://www.ebi.ac.uk/efo/EFO_0007490
EFO_1002021	ankle injury	http://www.ebi.ac.uk/efo/EFO_1002021
EFO_0008386	body odor measurement	http://www.ebi.ac.uk/efo/EFO_0008386
EFO_0008387	caudate nucleus measurement	http://www.ebi.ac.uk/efo/EFO_0008387
EFO_0008388	gamma wave measurement	http://www.ebi.ac.uk/efo/EFO_0008388
EFO_0008389	putamen measurement	http://www.ebi.ac.uk/efo/EFO_0008389
EFO_0008390	prothrombin time measurement	http://www.ebi.ac.uk/efo/EFO_0008390
EFO_0008391	erythropoetin measurement	http://www.ebi.ac.uk/efo/EFO_0008391
EFO_0008392	triiodothyronine measurement	http://www.ebi.ac.uk/efo/EFO_0008392
EFO_0008393	reaction time measurement	http://www.ebi.ac.uk/efo/EFO_0008393
EFO_0008394	verbal-numerical reasoning measurement	http://www.ebi.ac.uk/efo/EFO_0008394
EFO_0008395	response to darapladib	http://www.ebi.ac.uk/efo/EFO_0008395
EFO_0008396	response to reward	http://www.ebi.ac.uk/efo/EFO_0008396
EFO_0008397	response to disappointment	http://www.ebi.ac.uk/efo/EFO_0008397
EFO_0004980	appendicular lean mass	http://www.ebi.ac.uk/efo/EFO_0004980
EFO_0008398	T wave morphology measurement	http://www.ebi.ac.uk/efo/EFO_0008398
EFO_0008399	mean fractional anisotropy measurement	http://www.ebi.ac.uk/efo/EFO_0008399
EFO_0008400	susceptibility to chickenpox measurement	http://www.ebi.ac.uk/efo/EFO_0008400
EFO_0008401	susceptibility to shingles measurement	http://www.ebi.ac.uk/efo/EFO_0008401
EFO_0008402	susceptibility to cold sores measurement	http://www.ebi.ac.uk/efo/EFO_0008402
EFO_0008403	susceptibility to mononucleosis measurement	http://www.ebi.ac.uk/efo/EFO_0008403
EFO_0008404	susceptibility to mumps measurement	http://www.ebi.ac.uk/efo/EFO_0008404
EFO_0008405	susceptibility to hepatitis B infection measurement	http://www.ebi.ac.uk/efo/EFO_0008405
EFO_0008406	susceptibility to plantar warts measurement	http://www.ebi.ac.uk/efo/EFO_0008406
EFO_0008407	susceptibility to Mycobacterium tuberculosis infection measurement	http://www.ebi.ac.uk/efo/EFO_0008407
EFO_0008408	susceptibility to strep throat measurement	http://www.ebi.ac.uk/efo/EFO_0008408
EFO_0008409	susceptibility to scarlet fever measurement	http://www.ebi.ac.uk/efo/EFO_0008409
EFO_0008410	susceptibility to pneumonia measurement	http://www.ebi.ac.uk/efo/EFO_0008410
EFO_0008411	susceptibility to bacterial meningitis measurement	http://www.ebi.ac.uk/efo/EFO_0008411
EFO_0008412	susceptibility to vaginal yeast infection measurement	http://www.ebi.ac.uk/efo/EFO_0008412
EFO_0008413	susceptibility to urinary tract infection measurement	http://www.ebi.ac.uk/efo/EFO_0008413
EFO_1000218	digestive system carcinoma	http://www.ebi.ac.uk/efo/EFO_1000218
EFO_0007945	agoraphobia symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007945
Orphanet_2828	Young adult-onset Parkinsonism	http://www.orpha.net/ORDO/Orphanet_2828
EFO_0003931	bone fracture	http://www.ebi.ac.uk/efo/EFO_0003931
EFO_0008010	[Pyruvate dehydrogenase acetyl-transferring] kinase isozyme 1, mitochondrial measurement	http://www.ebi.ac.uk/efo/EFO_0008010
EFO_0008009	1,5 anhydroglucitol measurement	http://www.ebi.ac.uk/efo/EFO_0008009
EFO_0008011	a disintegrin and metalloproteinase with thrombospondin motifs 13	http://www.ebi.ac.uk/efo/EFO_0008011
EFO_0008012	Abelson tyrosine-protein kinase 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008012
EFO_0008013	acid sphingomyelinase-like phosphodiesterase 3a measurement	http://www.ebi.ac.uk/efo/EFO_0008013
EFO_0008014	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008014
EFO_0008015	afamin measurement	http://www.ebi.ac.uk/efo/EFO_0008015
EFO_0008007	age at assessment	http://www.ebi.ac.uk/efo/EFO_0008007
EFO_0008016	Agouti-related protein measurement	http://www.ebi.ac.uk/efo/EFO_0008016
EFO_0008017	alcohol dehydrogenase [NADP+] measurement	http://www.ebi.ac.uk/efo/EFO_0008017
EFO_1002013	alcoholic pancreatitis	http://www.ebi.ac.uk/efo/EFO_1002013
EFO_0008018	alpha-1-antichymotrypsin complex measurement	http://www.ebi.ac.uk/efo/EFO_0008018
EFO_0008019	alpha-1-antichymotrypsin measurement	http://www.ebi.ac.uk/efo/EFO_0008019
EFO_0008020	alpha-2-HS-glycoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0008020
EFO_0008021	alpha-2-macroglobulin receptor-associated protein measurement	http://www.ebi.ac.uk/efo/EFO_0008021
EFO_0008022	angiogenin measurement	http://www.ebi.ac.uk/efo/EFO_0008022
EFO_0008023	angiopoietin-1 receptor, soluble measurement	http://www.ebi.ac.uk/efo/EFO_0008023
EFO_0008024	angiostatin measurement	http://www.ebi.ac.uk/efo/EFO_0008024
EFO_0008025	angiotensinogen measurement	http://www.ebi.ac.uk/efo/EFO_0008025
EFO_0008026	annexin A1 measurement	http://www.ebi.ac.uk/efo/EFO_0008026
EFO_0008027	annexin A2 measurement	http://www.ebi.ac.uk/efo/EFO_0008027
EFO_0008028	apolipoprotein E isoform E2 measurement	http://www.ebi.ac.uk/efo/EFO_0008028
EFO_0008029	apolipoprotein E measurement	http://www.ebi.ac.uk/efo/EFO_0008029
EFO_0008030	arylsulfatase B measurement	http://www.ebi.ac.uk/efo/EFO_0008030
EFO_0008031	aspartate aminotransferase, cytoplasmic measurement	http://www.ebi.ac.uk/efo/EFO_0008031
EFO_0008032	basal cell adhesion molecule measurement	http://www.ebi.ac.uk/efo/EFO_0008032
EFO_0000284	benign prostatic hyperplasia	http://www.ebi.ac.uk/efo/EFO_0000284
EFO_0008033	beta-Ala-His dipeptidase measurement	http://www.ebi.ac.uk/efo/EFO_0008033
EFO_0008034	beta-endorphin measurement	http://www.ebi.ac.uk/efo/EFO_0008034
EFO_0008035	beta-nerve growth factor measurement	http://www.ebi.ac.uk/efo/EFO_0008035
EFO_0008036	BMI-adjusted fasting blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0008036
EFO_0008037	BMI-adjusted fasting blood insulin measurement	http://www.ebi.ac.uk/efo/EFO_0008037
EFO_0008038	BMI-adjusted hip bone size	http://www.ebi.ac.uk/efo/EFO_0008038
EFO_0008039	BMI-adjusted hip circumference	http://www.ebi.ac.uk/efo/EFO_0008039
HP_0012076	borderline personality disorder	http://purl.obolibrary.org/obo/HP_0012076
EFO_0008040	breast cancer anti-estrogen resistance protein 3 measurement	http://www.ebi.ac.uk/efo/EFO_0008040
EFO_0008041	C-C motif chemokine 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008041
EFO_0008042	C-C motif chemokine 14 measurement	http://www.ebi.ac.uk/efo/EFO_0008042
EFO_0008043	C-C motif chemokine 15 measurement	http://www.ebi.ac.uk/efo/EFO_0008043
EFO_0008044	C-C motif chemokine 16 measurement	http://www.ebi.ac.uk/efo/EFO_0008044
EFO_0008045	C-C motif chemokine 17 measurement	http://www.ebi.ac.uk/efo/EFO_0008045
EFO_0008046	C-C motif chemokine 18 measurement	http://www.ebi.ac.uk/efo/EFO_0008046
EFO_0008047	C-C motif chemokine 19 measurement	http://www.ebi.ac.uk/efo/EFO_0008047
EFO_0008048	C-C motif chemokine 21 measurement	http://www.ebi.ac.uk/efo/EFO_0008048
EFO_0008049	C-C motif chemokine 23 measurement	http://www.ebi.ac.uk/efo/EFO_0008049
EFO_0008050	C-C motif chemokine 25 measurement	http://www.ebi.ac.uk/efo/EFO_0008050
EFO_0008051	C-C motif chemokine 3 measurement	http://www.ebi.ac.uk/efo/EFO_0008051
EFO_0008053	C-C motif chemokine 5 measurement	http://www.ebi.ac.uk/efo/EFO_0008053
EFO_0008054	C-C motif chemokine 7 measurement	http://www.ebi.ac.uk/efo/EFO_0008054
EFO_0008055	C-C motif chemokine 8 measurement	http://www.ebi.ac.uk/efo/EFO_0008055
EFO_0008056	C-X-C motif chemokine 10 measurement	http://www.ebi.ac.uk/efo/EFO_0008056
EFO_0008057	C-X-C motif chemokine 11 measurement	http://www.ebi.ac.uk/efo/EFO_0008057
EFO_0008058	C-X-C motif chemokine 5 measurement	http://www.ebi.ac.uk/efo/EFO_0008058
EFO_0008059	C-X-C motif chemokine 6 measurement	http://www.ebi.ac.uk/efo/EFO_0008059
EFO_0008060	cadherin-5 measurement	http://www.ebi.ac.uk/efo/EFO_0008060
EFO_0008061	calcineurin measurement	http://www.ebi.ac.uk/efo/EFO_0008061
EFO_0008062	calcium/calmodulin-dependent protein kinase type 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008062
EFO_0008063	calcium/calmodulin-dependent protein kinase type 1D measurement	http://www.ebi.ac.uk/efo/EFO_0008063
EFO_0008064	calpain I measurement	http://www.ebi.ac.uk/efo/EFO_0008064
EFO_0008065	calpastatin measurement	http://www.ebi.ac.uk/efo/EFO_0008065
EFO_0008066	carbohydrate sulfotransferase 15 measurement	http://www.ebi.ac.uk/efo/EFO_0008066
EFO_0008067	carbonic anhydrase 13 measurement	http://www.ebi.ac.uk/efo/EFO_0008067
EFO_0008068	carbonic anhydrase 6 measurement	http://www.ebi.ac.uk/efo/EFO_0008068
EFO_0008069	carboxypeptidase B2 measurement	http://www.ebi.ac.uk/efo/EFO_0008069
EFO_0008070	caspase-3 measurement	http://www.ebi.ac.uk/efo/EFO_0008070
EFO_0008072	cathepsin B measurement	http://www.ebi.ac.uk/efo/EFO_0008072
EFO_0008073	cathepsin S measurement	http://www.ebi.ac.uk/efo/EFO_0008073
EFO_0008074	cathepsin Z measurement	http://www.ebi.ac.uk/efo/EFO_0008074
EFO_0008075	cation-independent mannose-6-phosphate receptor measurement	http://www.ebi.ac.uk/efo/EFO_0008075
EFO_0008076	CD109 antigen measurement	http://www.ebi.ac.uk/efo/EFO_0008076
EFO_0008078	CD27 antigen measurement	http://www.ebi.ac.uk/efo/EFO_0008078
EFO_0008079	cell adhesion molecule-related/down-regulated by oncogenes measurement	http://www.ebi.ac.uk/efo/EFO_0008079
EFO_0008080	cerebrospinal fluid volume measurement	http://www.ebi.ac.uk/efo/EFO_0008080
EFO_0008081	cGMP-specific 3,5-cyclic phosphodiesterase measurement	http://www.ebi.ac.uk/efo/EFO_0008081
EFO_0008082	chemokine (C-C motif) ligand 27 measurement	http://www.ebi.ac.uk/efo/EFO_0008082
EFO_0008083	chemokine (C-X-C motif) ligand 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008083
EFO_0008084	chitotriosidase-1 measurement	http://www.ebi.ac.uk/efo/EFO_0008084
EFO_0008085	Ck-beta-8-1 measurement	http://www.ebi.ac.uk/efo/EFO_0008085
EFO_0008086	CMRF35-like molecule 6 measurement	http://www.ebi.ac.uk/efo/EFO_0008086
EFO_0008087	coagulation factor V measurement	http://www.ebi.ac.uk/efo/EFO_0008087
EFO_0008088	collectin-11 measurement	http://www.ebi.ac.uk/efo/EFO_0008088
EFO_0008089	complement C1q subcomponent measurement	http://www.ebi.ac.uk/efo/EFO_0008089
EFO_0008090	complement C1r subcomponent measurement	http://www.ebi.ac.uk/efo/EFO_0008090
EFO_0008091	complement C1s subcomponent measurement	http://www.ebi.ac.uk/efo/EFO_0008091
EFO_0008092	complement C4b measurement	http://www.ebi.ac.uk/efo/EFO_0008092
EFO_0008093	complement component C7 measurement	http://www.ebi.ac.uk/efo/EFO_0008093
EFO_0008094	complement component C8 measurement	http://www.ebi.ac.uk/efo/EFO_0008094
EFO_0008095	complement decay-accelerating factor measurement	http://www.ebi.ac.uk/efo/EFO_0008095
EFO_0008096	complement factor B measurement	http://www.ebi.ac.uk/efo/EFO_0008096
EFO_0008097	complement factor H measurement	http://www.ebi.ac.uk/efo/EFO_0008097
EFO_0008098	complement factor H-related protein 5 measurement	http://www.ebi.ac.uk/efo/EFO_0008098
EFO_0008099	complement factor I measurement	http://www.ebi.ac.uk/efo/EFO_0008099
EFO_0008100	contactin-2 measurement	http://www.ebi.ac.uk/efo/EFO_0008100
EFO_0008101	contactin-5 measurement	http://www.ebi.ac.uk/efo/EFO_0008101
EFO_0008102	copine-1 measurement	http://www.ebi.ac.uk/efo/EFO_0008102
EFO_0008103	cystatin-D measurement	http://www.ebi.ac.uk/efo/EFO_0008103
EFO_0008104	cystatin-F measurement	http://www.ebi.ac.uk/efo/EFO_0008104
EFO_0008105	cystatin-SA measurement	http://www.ebi.ac.uk/efo/EFO_0008105
EFO_0008106	cystatin-SN measurement	http://www.ebi.ac.uk/efo/EFO_0008106
EFO_0008107	death-associated protein kinase 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008107
EFO_0008108	dermatopontin measurement	http://www.ebi.ac.uk/efo/EFO_0008108
EFO_0008109	Dickkopf-related protein 3 measurement	http://www.ebi.ac.uk/efo/EFO_0008109
EFO_0008110	Dickkopf-related protein 4 measurement	http://www.ebi.ac.uk/efo/EFO_0008110
EFO_0008111	diet measurement	http://www.ebi.ac.uk/efo/EFO_0008111
EFO_0008112	dual specificity mitogen-activated protein kinase kinase 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008112
EFO_0008113	dual specificity mitogen-activated protein kinase kinase 4 measurement	http://www.ebi.ac.uk/efo/EFO_0008113
EFO_0008114	dynein light chain roadblock-type 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008114
EFO_0008115	ectonucleoside triphosphate diphosphohydrolase 5 measurement	http://www.ebi.ac.uk/efo/EFO_0008115
EFO_0008116	EGF-like module-containing mucin-like hormone receptor-like 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008116
EFO_0008117	elafin measurement	http://www.ebi.ac.uk/efo/EFO_0008117
EFO_0008118	endoglin measurement	http://www.ebi.ac.uk/efo/EFO_0008118
EFO_0008119	endoplasmic reticulum aminopeptidase 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008119
EFO_0008120	endothelial cell-selective adhesion molecule measurement	http://www.ebi.ac.uk/efo/EFO_0008120
EFO_0008121	endothelin-converting enzyme 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008121
EFO_0008122	eotaxin measurement	http://www.ebi.ac.uk/efo/EFO_0008122
EFO_0008123	ephrin type-A receptor 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008123
EFO_0008124	ephrin type-B receptor 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008124
EFO_0008125	estrogen receptor measurement	http://www.ebi.ac.uk/efo/EFO_0008125
EFO_0008126	extracellular matrix protein 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008126
EFO_0008127	Fc receptor-like protein 3 measurement	http://www.ebi.ac.uk/efo/EFO_0008127
EFO_0008128	fetuin-B measurement	http://www.ebi.ac.uk/efo/EFO_0008128
EFO_0008129	fibroblast growth factor 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008129
EFO_0008130	fibroblast growth factor basic measurement	http://www.ebi.ac.uk/efo/EFO_0008130
EFO_0008131	fibronectin fragment 3 measurement	http://www.ebi.ac.uk/efo/EFO_0008131
EFO_0008132	fibronectin fragment 4 measurement	http://www.ebi.ac.uk/efo/EFO_0008132
EFO_0008133	fibronectin measurement	http://www.ebi.ac.uk/efo/EFO_0008133
EFO_0008134	ficolin-1 measurement	http://www.ebi.ac.uk/efo/EFO_0008134
EFO_0008135	ficolin-2 measurement	http://www.ebi.ac.uk/efo/EFO_0008135
EFO_0008136	galactoside 34-L-fucosyltransferase measurement	http://www.ebi.ac.uk/efo/EFO_0008136
EFO_0008137	galectin-3 measurement	http://www.ebi.ac.uk/efo/EFO_0008137
EFO_0008138	GDNF family receptor alpha-2 measurement	http://www.ebi.ac.uk/efo/EFO_0008138
EFO_0008139	glypican-5 measurement	http://www.ebi.ac.uk/efo/EFO_0008139
EFO_0008140	gp41 C34 peptide, HIV measurement	http://www.ebi.ac.uk/efo/EFO_0008140
EFO_0008141	granulins measurement	http://www.ebi.ac.uk/efo/EFO_0008141
EFO_0008142	granulocyte colony-stimulating factor measurement	http://www.ebi.ac.uk/efo/EFO_0008142
EFO_0008144	granulysin measurement	http://www.ebi.ac.uk/efo/EFO_0008144
EFO_0008145	granzyme A measurement	http://www.ebi.ac.uk/efo/EFO_0008145
EFO_0008146	growth-regulated alpha protein measurement	http://www.ebi.ac.uk/efo/EFO_0008146
EFO_0008147	gwas_trait	http://www.ebi.ac.uk/efo/EFO_0008147
EFO_0008148	hemojuvelin measurement	http://www.ebi.ac.uk/efo/EFO_0008148
EFO_0008149	hemopexin measurement	http://www.ebi.ac.uk/efo/EFO_0008149
EFO_0008150	heparin cofactor 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008150
EFO_0008151	hepatitis A virus cellular receptor 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008151
EFO_0008152	hepatocyte growth factor activator measurement	http://www.ebi.ac.uk/efo/EFO_0008152
EFO_0008153	hepatocyte growth factor receptor measurement	http://www.ebi.ac.uk/efo/EFO_0008153
EFO_0008154	hepatocyte growth factor-like protein measurement	http://www.ebi.ac.uk/efo/EFO_0008154
EFO_0008155	histidine-rich glycoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0008155
EFO_0008156	human Chorionic Gonadotropin measurement	http://www.ebi.ac.uk/efo/EFO_0008156
EFO_0008157	inorganic pyrophosphatase measurement	http://www.ebi.ac.uk/efo/EFO_0008157
EFO_0008158	inosine-5-monophosphate dehydrogenase 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008158
EFO_0008159	inosine-5-monophosphate dehydrogenase 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008159
EFO_0008160	insulin receptor measurement	http://www.ebi.ac.uk/efo/EFO_0008160
EFO_0008161	insulin-like growth factor-binding protein 7 measurement	http://www.ebi.ac.uk/efo/EFO_0008161
EFO_0008162	integrin alpha-I: beta-1 complex measurement	http://www.ebi.ac.uk/efo/EFO_0008162
EFO_0008163	intercellular adhesion molecule 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008163
EFO_0008164	intercellular adhesion molecule 5 measurement	http://www.ebi.ac.uk/efo/EFO_0008164
EFO_0008165	interferon gamma measurement	http://www.ebi.ac.uk/efo/EFO_0008165
EFO_0008167	interleukin 1 Receptor accessory protein measurement	http://www.ebi.ac.uk/efo/EFO_0008167
EFO_0008168	interleukin 1 receptor-like 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008168
EFO_0008169	interleukin 1 receptor-like 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008169
EFO_0008170	interleukin 12 receptor subunit beta-1 measurement	http://www.ebi.ac.uk/efo/EFO_0008170
EFO_0008171	interleukin 13 measurement	http://www.ebi.ac.uk/efo/EFO_0008171
EFO_0007934	creatinine clearance measurement	http://www.ebi.ac.uk/efo/EFO_0007934
EFO_0007935	urinary uric acid to creatinine ratio	http://www.ebi.ac.uk/efo/EFO_0007935
EFO_0007936	disease prognosis measurement	http://www.ebi.ac.uk/efo/EFO_0007936
EFO_1002002	high altitude pulmonary edema	http://www.ebi.ac.uk/efo/EFO_1002002
EFO_1001161	rheumatic heart disease	http://www.ebi.ac.uk/efo/EFO_1001161
EFO_0007955	mouth morphology measurement	http://www.ebi.ac.uk/efo/EFO_0007955
EFO_0007956	monocyte:lymphocyte ratio	http://www.ebi.ac.uk/efo/EFO_0007956
EFO_1002009	macular telangiectasia type 2	http://www.ebi.ac.uk/efo/EFO_1002009
EFO_0007959	fetal genotype effect measurement	http://www.ebi.ac.uk/efo/EFO_0007959
EFO_0007960	organochlorine pesticide measurement	http://www.ebi.ac.uk/efo/EFO_0007960
EFO_0007961	polybrominated biphenyl measurement	http://www.ebi.ac.uk/efo/EFO_0007961
EFO_0007962	polybrominated diphenyl ether measurement	http://www.ebi.ac.uk/efo/EFO_0007962
EFO_0007963	abnormal paneth cell measurement	http://www.ebi.ac.uk/efo/EFO_0007963
EFO_0007964	gestational serum measurement	http://www.ebi.ac.uk/efo/EFO_0007964
EFO_0007965	response to combination chemotherapy	http://www.ebi.ac.uk/efo/EFO_0007965
EFO_1001434	Tendinopathy	http://www.ebi.ac.uk/efo/EFO_1001434
EFO_1002012	ligament rupture	http://www.ebi.ac.uk/efo/EFO_1002012
EFO_0007966	clopidogrel metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0007966
EFO_0007967	blood osmolality measurement	http://www.ebi.ac.uk/efo/EFO_0007967
EFO_0007968	tissue factor pathway inhibitor measurement	http://www.ebi.ac.uk/efo/EFO_0007968
EFO_0007969	cognitive inhibition measurement	http://www.ebi.ac.uk/efo/EFO_0007969
EFO_0007971	estrone conjugate measurement	http://www.ebi.ac.uk/efo/EFO_0007971
EFO_0007972	androstenedione measurement	http://www.ebi.ac.uk/efo/EFO_0007972
EFO_0007973	palmitoleic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007973
EFO_0007974	vaccenic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007974
EFO_0007976	erucic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007976
EFO_0007977	nervonic acid measurement	http://www.ebi.ac.uk/efo/EFO_0007977
EFO_0007998	cognitive impairment measurement	http://www.ebi.ac.uk/efo/EFO_0007998
EFO_1001459	diabetic foot	http://www.ebi.ac.uk/efo/EFO_1001459
EFO_0007999	lower body strength measurement	http://www.ebi.ac.uk/efo/EFO_0007999
EFO_0008000	peak insulin response measurement	http://www.ebi.ac.uk/efo/EFO_0008000
EFO_0008001	insulin secretion measurement	http://www.ebi.ac.uk/efo/EFO_0008001
EFO_0008002	physical activity measurement	http://www.ebi.ac.uk/efo/EFO_0008002
EFO_0008003	heart rate variability measurement	http://www.ebi.ac.uk/efo/EFO_0008003
EFO_0008004	resting metabolic rate measurement	http://www.ebi.ac.uk/efo/EFO_0008004
EFO_0008005	energy expenditure measurement	http://www.ebi.ac.uk/efo/EFO_0008005
EFO_0008006	skin aging measurement	http://www.ebi.ac.uk/efo/EFO_0008006
EFO_0008172	interleukin 15 receptor subunit alpha measurement	http://www.ebi.ac.uk/efo/EFO_0008172
EFO_0008173	interleukin 16 measurement	http://www.ebi.ac.uk/efo/EFO_0008173
EFO_0008174	interleukin 17 measurement	http://www.ebi.ac.uk/efo/EFO_0008174
EFO_0008175	interleukin 17 receptor A measurement	http://www.ebi.ac.uk/efo/EFO_0008175
EFO_0008176	interleukin 17 receptor B measurement	http://www.ebi.ac.uk/efo/EFO_0008176
EFO_0008177	interleukin 17 receptor D measurement	http://www.ebi.ac.uk/efo/EFO_0008177
EFO_0008178	interleukin 18 receptor 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008178
EFO_0008179	interleukin 18 receptor accessory protein measurement	http://www.ebi.ac.uk/efo/EFO_0008179
EFO_0008180	interleukin 19 measurement	http://www.ebi.ac.uk/efo/EFO_0008180
EFO_0008181	interleukin 23 receptor measurement	http://www.ebi.ac.uk/efo/EFO_0008181
EFO_0008182	interleukin 25 measurement	http://www.ebi.ac.uk/efo/EFO_0008182
EFO_0008183	interleukin 27 receptor subunit alpha measurement	http://www.ebi.ac.uk/efo/EFO_0008183
EFO_0008184	interleukin 4 measurement	http://www.ebi.ac.uk/efo/EFO_0008184
EFO_0008185	interleukin 5 measurement	http://www.ebi.ac.uk/efo/EFO_0008185
EFO_0008186	interleukin 5 receptor subunit alpha measurement	http://www.ebi.ac.uk/efo/EFO_0008186
EFO_0008187	interleukin 6 receptor subunit alpha measurement	http://www.ebi.ac.uk/efo/EFO_0008187
EFO_0008188	interleukin 6 receptor subunit beta measurement	http://www.ebi.ac.uk/efo/EFO_0008188
EFO_0008189	interleukin 7 measurement	http://www.ebi.ac.uk/efo/EFO_0008189
EFO_0008190	interleukin 7 receptor subunit alpha measurement	http://www.ebi.ac.uk/efo/EFO_0008190
EFO_0008191	interleukin 8 measurement	http://www.ebi.ac.uk/efo/EFO_0008191
EFO_0008192	interleukin 9 measurement	http://www.ebi.ac.uk/efo/EFO_0008192
EFO_0008193	interstitial collagenase measurement	http://www.ebi.ac.uk/efo/EFO_0008193
EFO_0008194	kallikrein-12 measurement	http://www.ebi.ac.uk/efo/EFO_0008194
EFO_0008195	kallikrein-7 measurement	http://www.ebi.ac.uk/efo/EFO_0008195
EFO_0008196	kallistatin measurement	http://www.ebi.ac.uk/efo/EFO_0008196
EFO_0008197	killer cell immunoglobulin-like receptor 2DL4 measurement	http://www.ebi.ac.uk/efo/EFO_0008197
EFO_0008198	kininogen-1 measurement	http://www.ebi.ac.uk/efo/EFO_0008198
EFO_0008200	Kunitz-type protease inhibitor 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008200
EFO_0008201	kynureninase measurement	http://www.ebi.ac.uk/efo/EFO_0008201
EFO_0008202	L-Selectin measurement	http://www.ebi.ac.uk/efo/EFO_0008202
EFO_0008203	lactadherin measurement	http://www.ebi.ac.uk/efo/EFO_0008203
EFO_0008204	left ventricular diastolic function measurement	http://www.ebi.ac.uk/efo/EFO_0008204
EFO_0008205	left ventricular structural measurement	http://www.ebi.ac.uk/efo/EFO_0008205
EFO_0008206	left ventricular systolic function measurement	http://www.ebi.ac.uk/efo/EFO_0008206
EFO_0008207	leucine carboxyl methyltransferase 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008207
EFO_0008208	leukocyte immunoglobulin-like receptor subfamily B member 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008208
EFO_0008210	low affinity immunoglobulin epsilon Fc receptor measurement	http://www.ebi.ac.uk/efo/EFO_0008210
EFO_0008211	low affinity immunoglobulin gamma Fc region receptor II-a/b measurement	http://www.ebi.ac.uk/efo/EFO_0008211
EFO_0008212	low affinity immunoglobulin gamma Fc region receptor III-B measurement	http://www.ebi.ac.uk/efo/EFO_0008212
EFO_0008213	low molecular weight phosphotyrosine protein phosphatase measurement	http://www.ebi.ac.uk/efo/EFO_0008213
EFO_0008008	lower urinary tract symptom	http://www.ebi.ac.uk/efo/EFO_0008008
EFO_0008214	lymphotactin measurement	http://www.ebi.ac.uk/efo/EFO_0008214
EFO_0008215	lysosomal protective protein measurement	http://www.ebi.ac.uk/efo/EFO_0008215
EFO_0008216	lysozyme C measurement	http://www.ebi.ac.uk/efo/EFO_0008216
EFO_0008217	macrophage colony stimulating factor measurement	http://www.ebi.ac.uk/efo/EFO_0008217
EFO_0008218	macrophage inflammatory protein 1a measurement	http://www.ebi.ac.uk/efo/EFO_0008218
EFO_0008219	macrophage inflammatory protein 1b measurement	http://www.ebi.ac.uk/efo/EFO_0008219
EFO_0008220	macrophage metalloelastase measurement	http://www.ebi.ac.uk/efo/EFO_0008220
EFO_0008221	macrophage migration inhibitory factor measurement	http://www.ebi.ac.uk/efo/EFO_0008221
EFO_0008222	macrophage scavenger receptor types I and II measurement	http://www.ebi.ac.uk/efo/EFO_0008222
EFO_0008223	mannan-binding lectin serine protease 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008223
EFO_0008224	mannose-binding protein C measurement	http://www.ebi.ac.uk/efo/EFO_0008224
EFO_0008225	MAP kinase-activated protein kinase 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008225
EFO_0008226	MAP kinase-activated protein kinase 3 measurement	http://www.ebi.ac.uk/efo/EFO_0008226
EFO_0008227	matrilysin measurement	http://www.ebi.ac.uk/efo/EFO_0008227
EFO_0008228	mediator of RNA polymerase II transcription subunit 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008228
EFO_0008229	melanoma-derived growth regulatory protein measurement	http://www.ebi.ac.uk/efo/EFO_0008229
EFO_0008230	mental development measurement	http://www.ebi.ac.uk/efo/EFO_0008230
EFO_0008231	metalloproteinase inhibitor 3 measurement	http://www.ebi.ac.uk/efo/EFO_0008231
EFO_0008232	methionine aminopeptidase 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008232
EFO_0008233	MHC class I polypeptide-related sequence A measurement	http://www.ebi.ac.uk/efo/EFO_0008233
EFO_0008234	MHC class I polypeptide-related sequence B measurement	http://www.ebi.ac.uk/efo/EFO_0008234
EFO_0008235	monocyte chemotactic protein 3 measurement	http://www.ebi.ac.uk/efo/EFO_0008235
EFO_0008236	monokine induced by gamma interferon measurement	http://www.ebi.ac.uk/efo/EFO_0008236
EFO_0008237	motor development measurement	http://www.ebi.ac.uk/efo/EFO_0008237
EFO_0008238	myeloid cell surface antigen CD33 measurement	http://www.ebi.ac.uk/efo/EFO_0008238
EFO_0008239	N-acetyl-D-glucosamine kinase measurement	http://www.ebi.ac.uk/efo/EFO_0008239
EFO_0008240	N-acylethanolamine-hydrolyzing acid amidase measurement	http://www.ebi.ac.uk/efo/EFO_0008240
EFO_0008241	NAD-dependent protein deacetylase sirtuin-2 measurement	http://www.ebi.ac.uk/efo/EFO_0008241
EFO_0008242	NADPH--cytochrome P450 reductase measurement	http://www.ebi.ac.uk/efo/EFO_0008242
EFO_0008243	natural cytotoxicity triggering receptor 3 measurement	http://www.ebi.ac.uk/efo/EFO_0008243
EFO_0008244	neurexophilin-1 measurement	http://www.ebi.ac.uk/efo/EFO_0008244
EFO_0008245	neurodevelopmental measurement	http://www.ebi.ac.uk/efo/EFO_0008245
EFO_0008246	neurogenic locus notch homolog protein 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008246
EFO_0008247	neutral ceramidase measurement	http://www.ebi.ac.uk/efo/EFO_0008247
EFO_0008248	neutrophil collagenase measurement	http://www.ebi.ac.uk/efo/EFO_0008248
EFO_0008249	nidogen-1 measurement	http://www.ebi.ac.uk/efo/EFO_0008249
EFO_0008250	NKG2-D type II integral membrane protein measurement	http://www.ebi.ac.uk/efo/EFO_0008250
EFO_0008251	non-receptor tyrosine-protein kinase TYK2 measurement	http://www.ebi.ac.uk/efo/EFO_0008251
EFO_0008252	OCIA domain-containing protein 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008252
EFO_0008253	OX-2 membrane glycoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0008253
EFO_0008254	P-Selectin measurement	http://www.ebi.ac.uk/efo/EFO_0008254
EFO_0008255	particulate matter air pollution measurement	http://www.ebi.ac.uk/efo/EFO_0008255
EFO_0008256	peptidyl-prolyl cis-trans isomerase D measurement	http://www.ebi.ac.uk/efo/EFO_0008256
EFO_0008257	peptidyl-prolyl cis-trans isomerase E measurement	http://www.ebi.ac.uk/efo/EFO_0008257
EFO_0008258	persulfide dioxygenase ETHE1, mitochondrial measurement	http://www.ebi.ac.uk/efo/EFO_0008258
EFO_0008259	phospholipase A2, membrane associated measurement	http://www.ebi.ac.uk/efo/EFO_0008259
EFO_0008260	plasma kallikrein measurement	http://www.ebi.ac.uk/efo/EFO_0008260
EFO_0008261	plasma protease C1 inhibitor measurement	http://www.ebi.ac.uk/efo/EFO_0008261
EFO_0008262	platelet glycoprotein 4 measurement	http://www.ebi.ac.uk/efo/EFO_0008262
EFO_0008263	platelet glycoprotein VI measurement	http://www.ebi.ac.uk/efo/EFO_0008263
EFO_0008264	platelet-derived growth factor BB measurement	http://www.ebi.ac.uk/efo/EFO_0008264
EFO_0008265	platelet-derived growth factor receptor beta measurement	http://www.ebi.ac.uk/efo/EFO_0008265
EFO_0008266	plexin-C1 measurement	http://www.ebi.ac.uk/efo/EFO_0008266
EFO_0008267	polymeric immunoglobulin receptor measurement	http://www.ebi.ac.uk/efo/EFO_0008267
EFO_0008268	programmed cell death 1 ligand 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008268
EFO_0008269	properdin measurement	http://www.ebi.ac.uk/efo/EFO_0008269
EFO_0008270	proprotein convertase subtilisin/kexin type 7 measurement	http://www.ebi.ac.uk/efo/EFO_0008270
EFO_0008271	protein jagged-1 measurement	http://www.ebi.ac.uk/efo/EFO_0008271
EFO_0008272	proto-oncogene tyrosine-protein kinase receptor Ret measurement	http://www.ebi.ac.uk/efo/EFO_0008272
EFO_0008273	repulsive guidance molecule A measurement	http://www.ebi.ac.uk/efo/EFO_0008273
EFO_0008274	retinoic acid receptor responder protein 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008274
EFO_0008275	S-formylglutathione hydrolase measurement	http://www.ebi.ac.uk/efo/EFO_0008275
EFO_0008276	scavenger receptor class F member 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008276
EFO_0008277	Secreted frizzled-related protein 3 measurement	http://www.ebi.ac.uk/efo/EFO_0008277
EFO_0008278	semaphorin-3A measurement	http://www.ebi.ac.uk/efo/EFO_0008278
EFO_0008279	semaphorin-3E measurement	http://www.ebi.ac.uk/efo/EFO_0008279
EFO_0008280	serine protease 27 measurement	http://www.ebi.ac.uk/efo/EFO_0008280
EFO_0008281	serine/threonine-protein kinase 17B measurement	http://www.ebi.ac.uk/efo/EFO_0008281
EFO_0008282	serum amyloid A-1 protein measurement	http://www.ebi.ac.uk/efo/EFO_0008282
EFO_0008283	serum amyloid P-component measurement	http://www.ebi.ac.uk/efo/EFO_0008283
EFO_0008284	sialic acid-binding Ig-like lectin 14 measurement	http://www.ebi.ac.uk/efo/EFO_0008284
EFO_0008285	sialic acid-binding Ig-like lectin 6 measurement	http://www.ebi.ac.uk/efo/EFO_0008285
EFO_0008286	sialic acid-binding Ig-like lectin 9 measurement	http://www.ebi.ac.uk/efo/EFO_0008286
EFO_0008287	SLAM family member 7 measurement	http://www.ebi.ac.uk/efo/EFO_0008287
EFO_0008288	small nuclear ribonucleoprotein F measurement	http://www.ebi.ac.uk/efo/EFO_0008288
EFO_0008289	SPARC-like protein 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008289
EFO_0008290	spondin-1 measurement	http://www.ebi.ac.uk/efo/EFO_0008290
EFO_0008291	stem Cell Factor measurement	http://www.ebi.ac.uk/efo/EFO_0008291
EFO_0008292	stem Cell Growth Factor beta measurement	http://www.ebi.ac.uk/efo/EFO_0008292
EFO_0008293	stromal cell-derived factor 1 alpha measurement	http://www.ebi.ac.uk/efo/EFO_0008293
EFO_0008294	superoxide dismutase [Mn], mitochondrial measurement	http://www.ebi.ac.uk/efo/EFO_0008294
EFO_0008295	T-lymphocyte surface antigen Ly-9 measurement	http://www.ebi.ac.uk/efo/EFO_0008295
EFO_0008296	tenascin measurement	http://www.ebi.ac.uk/efo/EFO_0008296
EFO_0008297	teratocarcinoma-derived growth factor 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008297
EFO_0008298	thioredoxin domain-containing protein 12 measurement	http://www.ebi.ac.uk/efo/EFO_0008298
EFO_0007925	response to paliperidone	http://www.ebi.ac.uk/efo/EFO_0007925
EFO_1002001	core binding factor acute myeloid leukemia	http://www.ebi.ac.uk/efo/EFO_1002001
EFO_0007926	hyper-inflammatory immune response	http://www.ebi.ac.uk/efo/EFO_0007926
EFO_0007927	schizophrenia symptom severity measurement	http://www.ebi.ac.uk/efo/EFO_0007927
EFO_0007928	ventricular rate measurement	http://www.ebi.ac.uk/efo/EFO_0007928
EFO_0007929	triglyceride:HDL cholesterol ratio	http://www.ebi.ac.uk/efo/EFO_0007929
EFO_0007930	LDL cholesterol:HDL cholesterol ratio	http://www.ebi.ac.uk/efo/EFO_0007930
EFO_0007931	non-HDL cholesterol:HDL cholesterol ratio	http://www.ebi.ac.uk/efo/EFO_0007931
EFO_0007932	multiple keratinocyte carcinoma susceptibility measurement	http://www.ebi.ac.uk/efo/EFO_0007932
EFO_1001892	generalized anxiety disorder	http://www.ebi.ac.uk/efo/EFO_1001892
EFO_1000042	ovarian clear cell adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_1000042
EFO_0007937	blood protein measurement	http://www.ebi.ac.uk/efo/EFO_0007937
EFO_0007938	coronary atherosclerosis measurement	http://www.ebi.ac.uk/efo/EFO_0007938
EFO_0007939	respiratory symptom measurement	http://www.ebi.ac.uk/efo/EFO_0007939
EFO_0007940	chronic venous insufficiency	http://www.ebi.ac.uk/efo/EFO_0007940
EFO_0007941	LDH-related sciatica symptom severity measurement	http://www.ebi.ac.uk/efo/EFO_0007941
EFO_0007942	hip osteoarthritis symptom severity measurement	http://www.ebi.ac.uk/efo/EFO_0007942
EFO_1002003	hypersensitivity reaction disease	http://www.ebi.ac.uk/efo/EFO_1002003
EFO_1002004	drug hypersensitivity syndrome	http://www.ebi.ac.uk/efo/EFO_1002004
EFO_1002005	lumbar disc herniation	http://www.ebi.ac.uk/efo/EFO_1002005
EFO_0007943	response to platinum-based neoadjuvant chemotherapy	http://www.ebi.ac.uk/efo/EFO_0007943
HP_0040187	Neonatal sepsis	http://purl.obolibrary.org/obo/HP_0040187
EFO_0002689	antiphospholipid syndrome	http://www.ebi.ac.uk/efo/EFO_0002689
EFO_0003917	premature birth	http://www.ebi.ac.uk/efo/EFO_0003917
EFO_0007957	urinary 1,3-butadiene measurement	http://www.ebi.ac.uk/efo/EFO_0007957
EFO_1002010	TP53 Positive Breast Carcinoma	http://www.ebi.ac.uk/efo/EFO_1002010
EFO_1002011	adult onset asthma	http://www.ebi.ac.uk/efo/EFO_1002011
EFO_0007984	platelet component distribution width	http://www.ebi.ac.uk/efo/EFO_0007984
EFO_0007985	platelet crit	http://www.ebi.ac.uk/efo/EFO_0007985
EFO_0007986	reticulocyte count	http://www.ebi.ac.uk/efo/EFO_0007986
EFO_0007987	granulocyte count	http://www.ebi.ac.uk/efo/EFO_0007987
EFO_0007988	myeloid white cell count	http://www.ebi.ac.uk/efo/EFO_0007988
EFO_0007989	monocyte percentage of leukocytes	http://www.ebi.ac.uk/efo/EFO_0007989
EFO_0007990	neutrophil percentage of leukocytes	http://www.ebi.ac.uk/efo/EFO_0007990
EFO_0007991	eosinophil percentage of leukocytes	http://www.ebi.ac.uk/efo/EFO_0007991
EFO_0007992	basophil percentage of leukocytes	http://www.ebi.ac.uk/efo/EFO_0007992
EFO_0007993	lymphocyte percentage of leukocytes	http://www.ebi.ac.uk/efo/EFO_0007993
EFO_0007994	neutrophil percentage of granulocytes	http://www.ebi.ac.uk/efo/EFO_0007994
EFO_0007995	basophil percentage of granulocytes	http://www.ebi.ac.uk/efo/EFO_0007995
EFO_0007996	eosinophil percentage of granulocytes	http://www.ebi.ac.uk/efo/EFO_0007996
EFO_0007997	granulocyte percentage of myeloid white cells	http://www.ebi.ac.uk/efo/EFO_0007997
EFO_1000616	uveal melanoma	http://www.ebi.ac.uk/efo/EFO_1000616
EFO_0008299	thrombospondin-2 measurement	http://www.ebi.ac.uk/efo/EFO_0008299
EFO_0008300	TNF-related apoptosis-inducing ligand measurement	http://www.ebi.ac.uk/efo/EFO_0008300
EFO_0008301	toll-like receptor 4:Lymphocyte antigen 96 complex measurement	http://www.ebi.ac.uk/efo/EFO_0008301
EFO_0008302	transforming growth factor-beta-induced protein ig-h3 measurement	http://www.ebi.ac.uk/efo/EFO_0008302
EFO_0008303	transmembrane glycoprotein NMB measurement	http://www.ebi.ac.uk/efo/EFO_0008303
EFO_0008304	trefoil factor 3 measurement	http://www.ebi.ac.uk/efo/EFO_0008304
EFO_0008305	trypsin-2 measurement	http://www.ebi.ac.uk/efo/EFO_0008305
EFO_0008306	tryptase beta-2 measurement	http://www.ebi.ac.uk/efo/EFO_0008306
EFO_0008307	tuberculin skin test reactivity measurement	http://www.ebi.ac.uk/efo/EFO_0008307
EFO_0008308	tumor necrosis factor beta measurement	http://www.ebi.ac.uk/efo/EFO_0008308
EFO_0008309	tumor necrosis factor receptor superfamily member 19L measurement	http://www.ebi.ac.uk/efo/EFO_0008309
EFO_0008310	tumor necrosis factor receptor superfamily member EDAR measurement	http://www.ebi.ac.uk/efo/EFO_0008310
EFO_0008311	tumor necrosis factor-inducible gene 6 protein measurement	http://www.ebi.ac.uk/efo/EFO_0008311
EFO_0008312	tyrosine-protein kinase receptor Tie-1, soluble measurement	http://www.ebi.ac.uk/efo/EFO_0008312
EFO_0008313	UMP-CMP kinase measurement	http://www.ebi.ac.uk/efo/EFO_0008313
EFO_0008314	vascular endothelial growth factor receptor 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008314
EFO_0008315	vascular endothelial growth factor receptor 3 measurement	http://www.ebi.ac.uk/efo/EFO_0008315
EFO_0008316	vaso-occlusive pain measurement	http://www.ebi.ac.uk/efo/EFO_0008316
EFO_0008317	very low density lipoprotein cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008317
EFO_0008318	vitamin K-dependent protein C measurement	http://www.ebi.ac.uk/efo/EFO_0008318
EFO_0008319	WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008319
EFO_0008320	white matter volume measurement	http://www.ebi.ac.uk/efo/EFO_0008320
EFO_0008321	WNT1-inducible-signaling pathway protein 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008321
EFO_0008326	a disintegrin and metalloproteinase with thrombospondin motifs 5 measurement	http://www.ebi.ac.uk/efo/EFO_0008326
EFO_0008327	alpha-1-antitrypsin measurement	http://www.ebi.ac.uk/efo/EFO_0008327
EFO_0008328	chronotype measurement	http://www.ebi.ac.uk/efo/EFO_0008328
EFO_0008329	facial emotion recognition measurement	http://www.ebi.ac.uk/efo/EFO_0008329
EFO_0008330	fear of pain measurement	http://www.ebi.ac.uk/efo/EFO_0008330
EFO_0008331	interleukin 2 measurement	http://www.ebi.ac.uk/efo/EFO_0008331
EFO_0008332	interleukin 2 receptor antagonist measurement	http://www.ebi.ac.uk/efo/EFO_0008332
EFO_0008333	T wave amplitude	http://www.ebi.ac.uk/efo/EFO_0008333
EFO_0008334	TpTe measurement	http://www.ebi.ac.uk/efo/EFO_0008334
EFO_0008335	ventricular repolarisation duration measurement	http://www.ebi.ac.uk/efo/EFO_0008335
EFO_1000172	cervical squamous cell carcinoma	http://www.ebi.ac.uk/efo/EFO_1000172
EFO_0008322	decreased susceptibility to bacterial infection	http://www.ebi.ac.uk/efo/EFO_0008322
EFO_0008323	hypocretin deficiency	http://www.ebi.ac.uk/efo/EFO_0008323
EFO_0008324	response to sulfasalazine	http://www.ebi.ac.uk/efo/EFO_0008324
EFO_0008325	response to sotalol	http://www.ebi.ac.uk/efo/EFO_0008325
Orphanet_399	Huntington disease	http://www.orpha.net/ORDO/Orphanet_399
EFO_0008336	disease progression measurement	http://www.ebi.ac.uk/efo/EFO_0008336
EFO_0008337	psychosis predisposition measurement	http://www.ebi.ac.uk/efo/EFO_0008337
EFO_0008338	fear of severe pain measurement	http://www.ebi.ac.uk/efo/EFO_0008338
EFO_0008339	fear of medical pain measurement	http://www.ebi.ac.uk/efo/EFO_0008339
EFO_0008340	fear of minor pain measurement	http://www.ebi.ac.uk/efo/EFO_0008340
EFO_0004615	apolipoprotein B measurement	http://www.ebi.ac.uk/efo/EFO_0004615
EFO_1000965	Henoch-Schoenlein purpura	http://www.ebi.ac.uk/efo/EFO_1000965
EFO_0003913	angina pectoris	http://www.ebi.ac.uk/efo/EFO_0003913
EFO_0003951	percutaneous transluminal coronary angioplasty	http://www.ebi.ac.uk/efo/EFO_0003951
EFO_0001425	ischemic cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0001425
EFO_0000501	follicular thyroid carcinoma	http://www.ebi.ac.uk/efo/EFO_0000501
EFO_0000641	papillary thyroid carcinoma	http://www.ebi.ac.uk/efo/EFO_0000641
EFO_0001355	infant	http://www.ebi.ac.uk/efo/EFO_0001355
EFO_1001345	Hepatitis, Alcoholic	http://www.ebi.ac.uk/efo/EFO_1001345
EFO_0004703	age at menarche	http://www.ebi.ac.uk/efo/EFO_0004703
EFO_0004712	podoconiosis	http://www.ebi.ac.uk/efo/EFO_0004712
EFO_0004719	pemphigus vulgaris	http://www.ebi.ac.uk/efo/EFO_0004719
EFO_0004728	serum amyloid a protein measurement	http://www.ebi.ac.uk/efo/EFO_0004728
EFO_0004742	renal system measurement	http://www.ebi.ac.uk/efo/EFO_0004742
EFO_0004748	thyroid stimulating hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004748
EFO_0004828	genetic variation	http://www.ebi.ac.uk/efo/EFO_0004828
GO_0036272	response to gemcitabine	http://purl.obolibrary.org/obo/GO_0036272
EFO_0004891	callous character	http://www.ebi.ac.uk/efo/EFO_0004891
EFO_0004522	adhesion molecule measurement	http://www.ebi.ac.uk/efo/EFO_0004522
EFO_0004550	amygdala reactivity measurement	http://www.ebi.ac.uk/efo/EFO_0004550
EFO_0004910	CYP3A4 activity	http://www.ebi.ac.uk/efo/EFO_0004910
EFO_0005001	phenylalanine measurement	http://www.ebi.ac.uk/efo/EFO_0005001
EFO_0005055	QRS duration	http://www.ebi.ac.uk/efo/EFO_0005055
EFO_0005200	antiphospholipid antibody measurement	http://www.ebi.ac.uk/efo/EFO_0005200
EFO_0005203	eating disorder	http://www.ebi.ac.uk/efo/EFO_0005203
EFO_0005207	congenital heart disease	http://www.ebi.ac.uk/efo/EFO_0005207
EFO_0005239	aortic valve calcification	http://www.ebi.ac.uk/efo/EFO_0005239
EFO_0005245	body weight loss	http://www.ebi.ac.uk/efo/EFO_0005245
EFO_0000770	malignant pleural mesothelioma	http://www.ebi.ac.uk/efo/EFO_0000770
EFO_0000637	osteosarcoma	http://www.ebi.ac.uk/efo/EFO_0000637
EFO_0005271	sleep duration	http://www.ebi.ac.uk/efo/EFO_0005271
EFO_0005278	cardiovascular disease biomarker measurement	http://www.ebi.ac.uk/efo/EFO_0005278
EFO_0005296	migraine without aura	http://www.ebi.ac.uk/efo/EFO_0005296
EFO_0005301	reading and spelling ability	http://www.ebi.ac.uk/efo/EFO_0005301
Orphanet_130	Brugada syndrome	http://www.orpha.net/ORDO/Orphanet_130
EFO_0000699	Sjogren syndrome	http://www.ebi.ac.uk/efo/EFO_0000699
EFO_0001421	liver disease	http://www.ebi.ac.uk/efo/EFO_0001421
EFO_0005400	chemotherapy-induced alopecia	http://www.ebi.ac.uk/efo/EFO_0005400
EFO_0005406	colorectal adenoma	http://www.ebi.ac.uk/efo/EFO_0005406
EFO_0005412	functional impairment measurement	http://www.ebi.ac.uk/efo/EFO_0005412
EFO_0005418	serum dimethylarginine measurement	http://www.ebi.ac.uk/efo/EFO_0005418
EFO_0005426	autism spectrum disorder symptom	http://www.ebi.ac.uk/efo/EFO_0005426
EFO_0005524	large artery stroke	http://www.ebi.ac.uk/efo/EFO_0005524
EFO_0005530	Trypanosoma cruzi seropositivity	http://www.ebi.ac.uk/efo/EFO_0005530
Orphanet_93957	limb dystonia	http://www.orpha.net/ORDO/Orphanet_93957
EFO_0005653	serum metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0005653
EFO_0005655	response to cytosine arabinoside	http://www.ebi.ac.uk/efo/EFO_0005655
EFO_0005663	urinary uromodulin measurement	http://www.ebi.ac.uk/efo/EFO_0005663
EFO_0005668	anterior chamber depth measurement	http://www.ebi.ac.uk/efo/EFO_0005668
EFO_0005673	chronic mucus hypersecretion	http://www.ebi.ac.uk/efo/EFO_0005673
EFO_0005680	omega-6 polyunsaturated fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0005680
EFO_0005691	plasma trimethylamine N-oxide measurement	http://www.ebi.ac.uk/efo/EFO_0005691
HP_0011142	age-related nuclear cataract	http://purl.obolibrary.org/obo/HP_0011142
Orphanet_179	Birdshot chorioretinopathy	http://www.orpha.net/ORDO/Orphanet_179
EFO_0005611	opioid dependence	http://www.ebi.ac.uk/efo/EFO_0005611
EFO_0008052	C-C motif chemokine 3-like 1 measurement	http://www.ebi.ac.uk/efo/EFO_0008052
EFO_0008077	CD209 antigen measurement	http://www.ebi.ac.uk/efo/EFO_0008077
EFO_0008071	catalase measurement	http://www.ebi.ac.uk/efo/EFO_0008071
EFO_0007944	allergen exposure measurement	http://www.ebi.ac.uk/efo/EFO_0007944
EFO_0006865	urgency urinary incontinence	http://www.ebi.ac.uk/efo/EFO_0006865
EFO_0006338	pit and fissure surface dental caries	http://www.ebi.ac.uk/efo/EFO_0006338
EFO_0009864	metabolic network measurement	http://www.ebi.ac.uk/efo/EFO_0009864
EFO_1002031	Hodgkins lymphoma, mixed cellularity	http://www.ebi.ac.uk/efo/EFO_1002031
EFO_0008467	behavioural inhibitory control measurement	http://www.ebi.ac.uk/efo/EFO_0008467
EFO_0008468	midregional pro atrial natriuretic peptide measurement	http://www.ebi.ac.uk/efo/EFO_0008468
EFO_0008469	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio	http://www.ebi.ac.uk/efo/EFO_0008469
EFO_0008470	dietary potassium intake measurement	http://www.ebi.ac.uk/efo/EFO_0008470
EFO_0008473	insulin response measurement	http://www.ebi.ac.uk/efo/EFO_0008473
EFO_0008474	spine bone mineral density change measurement	http://www.ebi.ac.uk/efo/EFO_0008474
EFO_0008475	mood instability measurement	http://www.ebi.ac.uk/efo/EFO_0008475
EFO_0008476	delayed reward discounting measurement	http://www.ebi.ac.uk/efo/EFO_0008476
EFO_0008483	response to trauma exposure	http://www.ebi.ac.uk/efo/EFO_0008483
EFO_0008485	homosexuality	http://www.ebi.ac.uk/efo/EFO_0008485
EFO_0008486	male homosexuality	http://www.ebi.ac.uk/efo/EFO_0008486
EFO_0000473	epigenetic status	http://www.ebi.ac.uk/efo/EFO_0000473
EFO_0008538	helping behavior measurement	http://www.ebi.ac.uk/efo/EFO_0008538
EFO_0008578	sperm motility measurement	http://www.ebi.ac.uk/efo/EFO_0008578
EFO_1002040	corneal astigmatism	http://www.ebi.ac.uk/efo/EFO_1002040
EFO_0008580	response to taxane	http://www.ebi.ac.uk/efo/EFO_0008580
EFO_0008582	thrombin activatable fibrinolysis inhibitor activation peptide measurement	http://www.ebi.ac.uk/efo/EFO_0008582
EFO_0008579	risk-taking behaviour	http://www.ebi.ac.uk/efo/EFO_0008579
EFO_1001909	Plantar Fasciitis	http://www.ebi.ac.uk/efo/EFO_1001909
EFO_1000481	Plantar Fibromatosis	http://www.ebi.ac.uk/efo/EFO_1000481
EFO_0009104	hyperuricemia	http://www.ebi.ac.uk/efo/EFO_0009104
EFO_0009087	non-typhoidal Salmonella bacteremia	http://www.ebi.ac.uk/efo/EFO_0009087
EFO_0009105	high altitude adaptation	http://www.ebi.ac.uk/efo/EFO_0009105
EFO_0009130	clostridium difficile infection	http://www.ebi.ac.uk/efo/EFO_0009130
EFO_0009131	response to polyunsaturated fatty acid supplementation	http://www.ebi.ac.uk/efo/EFO_0009131
EFO_0009132	cholesterol efflux capacity measurement	http://www.ebi.ac.uk/efo/EFO_0009132
EFO_0009133	cholesteryl ester transfer protein measurement	http://www.ebi.ac.uk/efo/EFO_0009133
EFO_0009134	trimethyllysine measurement	http://www.ebi.ac.uk/efo/EFO_0009134
EFO_0009184	heart rate response to exercise	http://www.ebi.ac.uk/efo/EFO_0009184
EFO_0009185	heart rate response to recovery post exercise	http://www.ebi.ac.uk/efo/EFO_0009185
EFO_1001754	Abruptio Placentae	http://www.ebi.ac.uk/efo/EFO_1001754
EFO_0009287	interventricular septum thickness	http://www.ebi.ac.uk/efo/EFO_0009287
EFO_0009291	E/A ratio	http://www.ebi.ac.uk/efo/EFO_0009291
EFO_0004364	neurobehavioral manifestations	http://www.ebi.ac.uk/efo/EFO_0004364
EFO_0001072	memory impairment	http://www.ebi.ac.uk/efo/EFO_0001072
Orphanet_79364	Alopecia	http://www.orpha.net/ORDO/Orphanet_79364
EFO_0000701	skin disease	http://www.ebi.ac.uk/efo/EFO_0000701
EFO_0008422	susceptibility to infectious disease measurement	http://www.ebi.ac.uk/efo/EFO_0008422
EFO_0009362	nicotine withdrawal measurement	http://www.ebi.ac.uk/efo/EFO_0009362
EFO_0009374	energy intake measurement	http://www.ebi.ac.uk/efo/EFO_0009374
EFO_0009458	alcohol use disorder measurement	http://www.ebi.ac.uk/efo/EFO_0009458
EFO_0009460	ACPA-negative rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0009460
EFO_0009459	ACPA-positive rheumatoid arthritis	http://www.ebi.ac.uk/efo/EFO_0009459
EFO_1000830	bacterial endocarditis	http://www.ebi.ac.uk/efo/EFO_1000830
EFO_0009466	Lfgrens syndrome	http://www.ebi.ac.uk/efo/EFO_0009466
EFO_0009467	response to anti-vascular endothelial growth factor drug	http://www.ebi.ac.uk/efo/EFO_0009467
EFO_0009480	coping behaviour measurement	http://www.ebi.ac.uk/efo/EFO_0009480
EFO_0007292	Guillain-Barre syndrome	http://www.ebi.ac.uk/efo/EFO_0007292
EFO_0009189	hyperthyroidism	http://www.ebi.ac.uk/efo/EFO_0009189
EFO_0009584	AQP4-IgG-positive neuromyelitis optica	http://www.ebi.ac.uk/efo/EFO_0009584
EFO_0009585	AQP4-IgG-negative neuromyelitis optica	http://www.ebi.ac.uk/efo/EFO_0009585
EFO_0009586	skin hydration measurement	http://www.ebi.ac.uk/efo/EFO_0009586
EFO_0009587	anhedonia measurement	http://www.ebi.ac.uk/efo/EFO_0009587
EFO_0009592	social interaction measurement	http://www.ebi.ac.uk/efo/EFO_0009592
EFO_0009589	worry measurement	http://www.ebi.ac.uk/efo/EFO_0009589
EFO_0009594	irritability measurement	http://www.ebi.ac.uk/efo/EFO_0009594
EFO_0009598	feeling miserable measurement	http://www.ebi.ac.uk/efo/EFO_0009598
EFO_0009593	mood change measurement	http://www.ebi.ac.uk/efo/EFO_0009593
EFO_0009588	"feeling ""fed-up"" measurement"	http://www.ebi.ac.uk/efo/EFO_0009588
EFO_0009597	feeling nervous measurement	http://www.ebi.ac.uk/efo/EFO_0009597
EFO_0009596	feeling tense measurement	http://www.ebi.ac.uk/efo/EFO_0009596
EFO_0009599	feeling emotionally hurt measurement	http://www.ebi.ac.uk/efo/EFO_0009599
EFO_0009595	guilt measurement	http://www.ebi.ac.uk/efo/EFO_0009595
EFO_0009591	verbal memory measurement	http://www.ebi.ac.uk/efo/EFO_0009591
EFO_0009590	visual memory measurement	http://www.ebi.ac.uk/efo/EFO_0009590
EFO_0009603	stroke outcome severity measurement	http://www.ebi.ac.uk/efo/EFO_0009603
Orphanet_558	Marfan syndrome	http://www.orpha.net/ORDO/Orphanet_558
EFO_0007144	amebiasis	http://www.ebi.ac.uk/efo/EFO_0007144
Orphanet_101081	Charcot-Marie-Tooth disease type 1A	http://www.orpha.net/ORDO/Orphanet_101081
EFO_0009693	thiopurine metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0009693
EFO_0009707	fractures, ununited	http://www.ebi.ac.uk/efo/EFO_0009707
EFO_0009703	red blood cell folate measurement	http://www.ebi.ac.uk/efo/EFO_0009703
EFO_0007262	epilepsy with generalized tonic-clonic seizures	http://www.ebi.ac.uk/efo/EFO_0007262
EFO_0009702	intra-individual reaction time variability measurement	http://www.ebi.ac.uk/efo/EFO_0009702
EFO_0009706	latent autoimmune diabetes in adults	http://www.ebi.ac.uk/efo/EFO_0009706
EFO_1000294	HER2 positive breast carcinoma	http://www.ebi.ac.uk/efo/EFO_1000294
EFO_0009750	dissociation measurement	http://www.ebi.ac.uk/efo/EFO_0009750
EFO_0009748	response to ketamine	http://www.ebi.ac.uk/efo/EFO_0009748
EFO_0009749	age at first sexual intercourse measurement	http://www.ebi.ac.uk/efo/EFO_0009749
EFO_0009751	facial asymmetry measurement	http://www.ebi.ac.uk/efo/EFO_0009751
EFO_0009752	visuospatial impairment	http://www.ebi.ac.uk/efo/EFO_0009752
EFO_0009759	Chronic Obstructive Asthma	http://www.ebi.ac.uk/efo/EFO_0009759
Orphanet_307	Juvenile myoclonic epilepsy	http://www.orpha.net/ORDO/Orphanet_307
Orphanet_1941	Juvenile absence epilepsy	http://www.orpha.net/ORDO/Orphanet_1941
Orphanet_64280	Childhood absence epilepsy	http://www.orpha.net/ORDO/Orphanet_64280
EFO_0004769	anti-Mullerian hormone measurement	http://www.ebi.ac.uk/efo/EFO_0004769
EFO_0005512	estrogen receptor status	http://www.ebi.ac.uk/efo/EFO_0005512
EFO_0009761	periprosthetic osteolysis	http://www.ebi.ac.uk/efo/EFO_0009761
EFO_0009583	place of residence measurement	http://www.ebi.ac.uk/efo/EFO_0009583
EFO_0004264	vascular disease	http://www.ebi.ac.uk/efo/EFO_0004264
EFO_0004324	body weights and measures	http://www.ebi.ac.uk/efo/EFO_0004324
HP_0003119	Abnormal circulating lipid concentration	http://purl.obolibrary.org/obo/HP_0003119
EFO_0009790	asparaginase activity measurement	http://www.ebi.ac.uk/efo/EFO_0009790
EFO_0009791	fatty acid desaturase enzyme activity measurement	http://www.ebi.ac.uk/efo/EFO_0009791
EFO_0009792	valine measurement	http://www.ebi.ac.uk/efo/EFO_0009792
EFO_0009793	isoleucine measurement	http://www.ebi.ac.uk/efo/EFO_0009793
EFO_0009794	NRF2 measurement	http://www.ebi.ac.uk/efo/EFO_0009794
EFO_0009795	serum urea measurement	http://www.ebi.ac.uk/efo/EFO_0009795
EFO_0009796	response to supplemental oxygen	http://www.ebi.ac.uk/efo/EFO_0009796
EFO_0009797	lung disease associated with cystic fibrosis	http://www.ebi.ac.uk/efo/EFO_0009797
HP_0030775	Modic type vertebral endplate changes	http://purl.obolibrary.org/obo/HP_0030775
EFO_0007149	appendicitis	http://www.ebi.ac.uk/efo/EFO_0007149
EFO_0009865	transcriptome measurement	http://www.ebi.ac.uk/efo/EFO_0009865
EFO_0009881	nonischemic cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0009881
EFO_0009863	anxiety measurement	http://www.ebi.ac.uk/efo/EFO_0009863
EFO_0009882	urinary potassium to creatinine ratio	http://www.ebi.ac.uk/efo/EFO_0009882
EFO_0009883	urinary sodium to creatinine ratio	http://www.ebi.ac.uk/efo/EFO_0009883
EFO_0009884	urinary sodium to potassium ratio	http://www.ebi.ac.uk/efo/EFO_0009884
EFO_0009885	frailty measurement	http://www.ebi.ac.uk/efo/EFO_0009885
HP_0000360	tinnitus	http://purl.obolibrary.org/obo/HP_0000360
MONDO_0021107	narcolepsy	http://purl.obolibrary.org/obo/MONDO_0021107
MONDO_0024647	urolithiasis	http://purl.obolibrary.org/obo/MONDO_0024647
EFO_0009891	carbamazepine metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0009891
EFO_0009890	lean mass-adjusted fat body mass	http://www.ebi.ac.uk/efo/EFO_0009890
EFO_0009896	anti-thyroglobulin antibody measurement	http://www.ebi.ac.uk/efo/EFO_0009896
HP_0000155	oral ulcer	http://purl.obolibrary.org/obo/HP_0000155
EFO_0009902	handedness	http://www.ebi.ac.uk/efo/EFO_0009902
MONDO_0044887	central nervous system non-hodgkin lymphoma	http://purl.obolibrary.org/obo/MONDO_0044887
HP_0002253	colonic diverticula	http://purl.obolibrary.org/obo/HP_0002253
EFO_0009923	Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement	http://www.ebi.ac.uk/efo/EFO_0009923
EFO_0009924	Drugs used in diabetes use measurement	http://www.ebi.ac.uk/efo/EFO_0009924
EFO_0009925	Antithrombotic agent use measurement	http://www.ebi.ac.uk/efo/EFO_0009925
EFO_0009926	Vasodilators used in cardiac diseases use measurement	http://www.ebi.ac.uk/efo/EFO_0009926
EFO_0009927	Antihypertensive use measurement	http://www.ebi.ac.uk/efo/EFO_0009927
EFO_0009928	Diuretic use measurement	http://www.ebi.ac.uk/efo/EFO_0009928
EFO_0009929	Beta blocking agent use measurement	http://www.ebi.ac.uk/efo/EFO_0009929
EFO_0009930	Calcium channel blocker use measurement	http://www.ebi.ac.uk/efo/EFO_0009930
EFO_0009931	Agents acting on the renin-angiotensin system use measurement	http://www.ebi.ac.uk/efo/EFO_0009931
EFO_0009932	HMG CoA reductase inhibitor use measurement	http://www.ebi.ac.uk/efo/EFO_0009932
EFO_0009933	Thyroid preparation use measurement	http://www.ebi.ac.uk/efo/EFO_0009933
EFO_0009934	Immunosuppressant use measurement	http://www.ebi.ac.uk/efo/EFO_0009934
EFO_0009935	Non-steroidal anti-inflammatory and antirheumatic product use measurement	http://www.ebi.ac.uk/efo/EFO_0009935
EFO_0009936	Drugs affecting bone structure and mineralization use measurement	http://www.ebi.ac.uk/efo/EFO_0009936
EFO_0009937	Opioid use measurement	http://www.ebi.ac.uk/efo/EFO_0009937
EFO_0009938	Anilide use measurement	http://www.ebi.ac.uk/efo/EFO_0009938
EFO_0009939	Antimigraine preparation use measurement	http://www.ebi.ac.uk/efo/EFO_0009939
EFO_0009940	Antidepressant use measurement	http://www.ebi.ac.uk/efo/EFO_0009940
EFO_0009941	Inhalant adrenergic use measurement	http://www.ebi.ac.uk/efo/EFO_0009941
EFO_0009942	Glucocorticoid use measurement	http://www.ebi.ac.uk/efo/EFO_0009942
EFO_0009943	Antihistamine use measurement	http://www.ebi.ac.uk/efo/EFO_0009943
EFO_0009944	Antiglaucoma preparations and miotics use measurement	http://www.ebi.ac.uk/efo/EFO_0009944
EFO_0009945	psychological resilience measurement	http://www.ebi.ac.uk/efo/EFO_0009945
EFO_0009946	low density lipoprotein triglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0009946
EFO_0009947	nucleoside diphosphate kinase A measurement	http://www.ebi.ac.uk/efo/EFO_0009947
EFO_0009948	chorioamnionitis	http://www.ebi.ac.uk/efo/EFO_0009948
EFO_0009949	KANNO antigen measurement	http://www.ebi.ac.uk/efo/EFO_0009949
EFO_0009952	post-operative atrial fibrillation	http://www.ebi.ac.uk/efo/EFO_0009952
EFO_0009953	post-operative myocardial infarction	http://www.ebi.ac.uk/efo/EFO_0009953
EFO_0009954	post-operative delirium	http://www.ebi.ac.uk/efo/EFO_0009954
EFO_0009955	post-operative acute kidney injury	http://www.ebi.ac.uk/efo/EFO_0009955
EFO_0009956	post-operative stroke	http://www.ebi.ac.uk/efo/EFO_0009956
EFO_0009951	response to surgery	http://www.ebi.ac.uk/efo/EFO_0009951
EFO_0005323	post-operative sign or symptom	http://www.ebi.ac.uk/efo/EFO_0005323
HP_0012664	Reduced ejection fraction	http://purl.obolibrary.org/obo/HP_0012664
EFO_1000749	pemphigus	http://www.ebi.ac.uk/efo/EFO_1000749
EFO_0009958	response to bisphosphonate	http://www.ebi.ac.uk/efo/EFO_0009958
EFO_0009960	atypical femoral fracture	http://www.ebi.ac.uk/efo/EFO_0009960
EFO_0008414	susceptibility to measles measurement	http://www.ebi.ac.uk/efo/EFO_0008414
EFO_0008415	susceptibility to hepatitis A infection measurement	http://www.ebi.ac.uk/efo/EFO_0008415
EFO_0008416	susceptibility to rheumatic fever measurement	http://www.ebi.ac.uk/efo/EFO_0008416
EFO_0008417	susceptibility to common cold measurement	http://www.ebi.ac.uk/efo/EFO_0008417
EFO_0008418	susceptibility to rubella infection measurement	http://www.ebi.ac.uk/efo/EFO_0008418
EFO_0008419	susceptibility to chronic sinus infection measurement	http://www.ebi.ac.uk/efo/EFO_0008419
EFO_0008420	parietal cortex measurement	http://www.ebi.ac.uk/efo/EFO_0008420
EFO_0008421	non-alcoholic fatty liver disease severity measurement	http://www.ebi.ac.uk/efo/EFO_0008421
EFO_0008423	IgG monogalactosylation measurement	http://www.ebi.ac.uk/efo/EFO_0008423
EFO_0008424	IgG digalactosylation measurement	http://www.ebi.ac.uk/efo/EFO_0008424
EFO_0008425	IgG galactosylation measurement	http://www.ebi.ac.uk/efo/EFO_0008425
EFO_0008426	IgG bisecting N-acetyl glucosamine measurement	http://www.ebi.ac.uk/efo/EFO_0008426
EFO_0008427	IgG fucosylation measurement	http://www.ebi.ac.uk/efo/EFO_0008427
EFO_0008428	IgG sialylation measurement	http://www.ebi.ac.uk/efo/EFO_0008428
EFO_0008429	IgG disialylation measurement	http://www.ebi.ac.uk/efo/EFO_0008429
EFO_0008430	IgG monosialylation measurement	http://www.ebi.ac.uk/efo/EFO_0008430
EFO_0008431	maximal voluntary ventilation	http://www.ebi.ac.uk/efo/EFO_0008431
EFO_0008432	lipoprotein-associated phospholipase A(2) change measurement	http://www.ebi.ac.uk/efo/EFO_0008432
EFO_0008433	pursuit maintenance gain measurement	http://www.ebi.ac.uk/efo/EFO_0008433
EFO_0008434	initial pursuit acceleration	http://www.ebi.ac.uk/efo/EFO_0008434
EFO_0008435	gestational weight gain measurement	http://www.ebi.ac.uk/efo/EFO_0008435
EFO_0008436	late gestational weight gain	http://www.ebi.ac.uk/efo/EFO_0008436
EFO_0008437	early gestational weight gain	http://www.ebi.ac.uk/efo/EFO_0008437
EFO_0008438	growth hormone measurement	http://www.ebi.ac.uk/efo/EFO_0008438
EFO_1000024	chronic rhinosinusitis	http://www.ebi.ac.uk/efo/EFO_1000024
EFO_0008484	response to carbamazepine	http://www.ebi.ac.uk/efo/EFO_0008484
EFO_1002029	chronic rhinosinusitis with nasal polyps	http://www.ebi.ac.uk/efo/EFO_1002029
EFO_1002030	chronic rhinosinusitis without nasal polyps	http://www.ebi.ac.uk/efo/EFO_1002030
EFO_1000039	meningeal tuberculosis	http://www.ebi.ac.uk/efo/EFO_1000039
EFO_0008529	kynurenine measurement	http://www.ebi.ac.uk/efo/EFO_0008529
EFO_0008530	kynurenine:tryptophan ratio	http://www.ebi.ac.uk/efo/EFO_0008530
EFO_0008531	GLP-1-stimulated insulin response	http://www.ebi.ac.uk/efo/EFO_0008531
EFO_0008532	clinically amyopathic dermatomyositis	http://www.ebi.ac.uk/efo/EFO_0008532
EFO_0008539	vitamin D dietary intake measurement	http://www.ebi.ac.uk/efo/EFO_0008539
EFO_0008541	response to opioid	http://www.ebi.ac.uk/efo/EFO_0008541
EFO_0008542	complement C3d subcomponent measurement	http://www.ebi.ac.uk/efo/EFO_0008542
EFO_0008543	c3d:C3 ratio	http://www.ebi.ac.uk/efo/EFO_0008543
EFO_0008544	analgesia requirement measurement	http://www.ebi.ac.uk/efo/EFO_0008544
EFO_0009010	HSV2 virologic severity measurement	http://www.ebi.ac.uk/efo/EFO_0009010
EFO_0000266	aortic stenosis	http://www.ebi.ac.uk/efo/EFO_0000266
EFO_0009092	breast milk measurement	http://www.ebi.ac.uk/efo/EFO_0009092
EFO_0009093	choroidal melanoma	http://www.ebi.ac.uk/efo/EFO_0009093
EFO_0009094	idiopathic dilated cardiomyopathy	http://www.ebi.ac.uk/efo/EFO_0009094
EFO_0009115	tobacco smoke exposure measurement	http://www.ebi.ac.uk/efo/EFO_0009115
EFO_0009116	vitamin supplement exposure measurement	http://www.ebi.ac.uk/efo/EFO_0009116
EFO_0009113	alcohol exposure measurement	http://www.ebi.ac.uk/efo/EFO_0009113
EFO_0009114	in utero exposure measurement	http://www.ebi.ac.uk/efo/EFO_0009114
EFO_1001267	aortic coarctation	http://www.ebi.ac.uk/efo/EFO_1001267
EFO_1001132	pseudotumor cerebri	http://www.ebi.ac.uk/efo/EFO_1001132
EFO_0003928	necrotizing enterocolitis	http://www.ebi.ac.uk/efo/EFO_0003928
EFO_0009267	delirium	http://www.ebi.ac.uk/efo/EFO_0009267
EFO_0009256	standard deviation of the normal-to-normal inter beat intervals	http://www.ebi.ac.uk/efo/EFO_0009256
EFO_0009257	root mean square of the successive differences of inter beat intervals	http://www.ebi.ac.uk/efo/EFO_0009257
EFO_0009258	peak-valley respiratory sinus arrhythmia or high frequency power	http://www.ebi.ac.uk/efo/EFO_0009258
EFO_0009260	non-melanoma skin carcinoma	http://www.ebi.ac.uk/efo/EFO_0009260
HP_0000975	Hyperhidrosis	http://purl.obolibrary.org/obo/HP_0000975
EFO_0009312	proprotein convertase subtilisin/kexin type 9 measurementhyperhidrosis	http://www.ebi.ac.uk/efo/EFO_0009312
Orphanet_275752	Sickle cell disease and related diseases	http://www.orpha.net/ORDO/Orphanet_275752
EFO_0009361	colorectal mucinous adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0009361
EFO_0007537	vestibular neuronitis	http://www.ebi.ac.uk/efo/EFO_0007537
EFO_0009381	fibroblast growth factor 23 measurement	http://www.ebi.ac.uk/efo/EFO_0009381
EFO_0009382	metabolically healthy obesity	http://www.ebi.ac.uk/efo/EFO_0009382
EFO_0008601	pemphigus foliaceus	http://www.ebi.ac.uk/efo/EFO_0008601
EFO_1001857	Takayasu arteritis	http://www.ebi.ac.uk/efo/EFO_1001857
EFO_0009390	sum of neutrophil and eosinophil counts	http://www.ebi.ac.uk/efo/EFO_0009390
EFO_0009391	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391
EFO_0009392	glucose metabolism decline measurement	http://www.ebi.ac.uk/efo/EFO_0009392
EFO_0009393	breast pressure measurement	http://www.ebi.ac.uk/efo/EFO_0009393
EFO_0009394	hippocampal CA1 volume	http://www.ebi.ac.uk/efo/EFO_0009394
EFO_0009395	hippocampal CA3 volume	http://www.ebi.ac.uk/efo/EFO_0009395
EFO_0009396	hippocampal CA4 volume	http://www.ebi.ac.uk/efo/EFO_0009396
EFO_0009397	hippocampus molecular layer volume	http://www.ebi.ac.uk/efo/EFO_0009397
EFO_0009398	hippocampal tail volume	http://www.ebi.ac.uk/efo/EFO_0009398
EFO_0009399	subiculum volume	http://www.ebi.ac.uk/efo/EFO_0009399
EFO_0009400	presubiculum volume	http://www.ebi.ac.uk/efo/EFO_0009400
EFO_0009401	hippocampal amigdala transition area volume	http://www.ebi.ac.uk/efo/EFO_0009401
EFO_0009402	hippocampus fimbria volume	http://www.ebi.ac.uk/efo/EFO_0009402
HP_0002829	arthralgia	http://purl.obolibrary.org/obo/HP_0002829
EFO_1001938	B-cell non-Hodgkins lymphoma	http://www.ebi.ac.uk/efo/EFO_1001938
HP_0009762	facial wrinkling	http://purl.obolibrary.org/obo/HP_0009762
HP_0025258	Stiff neck	http://purl.obolibrary.org/obo/HP_0025258
HP_0100608	metrorrhagia	http://purl.obolibrary.org/obo/HP_0100608
EFO_0009408	abnormal vaginal discharge smell	http://www.ebi.ac.uk/efo/EFO_0009408
EFO_0009409	abnormal vaginal discharge itching	http://www.ebi.ac.uk/efo/EFO_0009409
HP_0030914	abnormal peristalsis	http://purl.obolibrary.org/obo/HP_0030914
NCIT_C74532	nervousness	http://purl.obolibrary.org/obo/NCIT_C74532
NCIT_C95746	sleepiness	http://purl.obolibrary.org/obo/NCIT_C95746
NCIT_C117245	decreased attention	http://purl.obolibrary.org/obo/NCIT_C117245
EFO_0009410	uterine fibroid measurement	http://www.ebi.ac.uk/efo/EFO_0009410
EFO_0009411	CCL13 measurement	http://www.ebi.ac.uk/efo/EFO_0009411
EFO_0009413	CCL15 measurement	http://www.ebi.ac.uk/efo/EFO_0009413
EFO_0009414	CCL17 measurement	http://www.ebi.ac.uk/efo/EFO_0009414
EFO_0009415	CCL19 measurement	http://www.ebi.ac.uk/efo/EFO_0009415
EFO_0009416	CCL21 measurement	http://www.ebi.ac.uk/efo/EFO_0009416
EFO_0009417	CCL23 measurement	http://www.ebi.ac.uk/efo/EFO_0009417
EFO_0009418	CCL24 measurement	http://www.ebi.ac.uk/efo/EFO_0009418
EFO_0009419	CX3CL1 measurement	http://www.ebi.ac.uk/efo/EFO_0009419
EFO_0009420	CXCL12 measurement	http://www.ebi.ac.uk/efo/EFO_0009420
EFO_0009421	CXCL13 measurement	http://www.ebi.ac.uk/efo/EFO_0009421
EFO_0009422	CXCL5 measurement	http://www.ebi.ac.uk/efo/EFO_0009422
EFO_0009423	CXCL6 measurement	http://www.ebi.ac.uk/efo/EFO_0009423
EFO_0009412	interleukin 1 alpha measurement	http://www.ebi.ac.uk/efo/EFO_0009412
HP_0000964	Eczema	http://purl.obolibrary.org/obo/HP_0000964
EFO_0000684	respiratory system disease	http://www.ebi.ac.uk/efo/EFO_0000684
EFO_0009694	beta-lactam allergy measurement	http://www.ebi.ac.uk/efo/EFO_0009694
EFO_0009695	household income	http://www.ebi.ac.uk/efo/EFO_0009695
EFO_0009696	social deprivation	http://www.ebi.ac.uk/efo/EFO_0009696
HP_0003418	back pain	http://purl.obolibrary.org/obo/HP_0003418
EFO_0009697	pathological complete response	http://www.ebi.ac.uk/efo/EFO_0009697
EFO_0009698	gestational blood glucose measurement	http://www.ebi.ac.uk/efo/EFO_0009698
EFO_0009699	foot muscle strength measurement	http://www.ebi.ac.uk/efo/EFO_0009699
EFO_0009700	visual perception measurement	http://www.ebi.ac.uk/efo/EFO_0009700
EFO_0009701	visceral:total adipose tissue ratio	http://www.ebi.ac.uk/efo/EFO_0009701
EFO_0004918	age at diagnosis	http://www.ebi.ac.uk/efo/EFO_0004918
Orphanet_908	fragile X syndrome	http://www.orpha.net/ORDO/Orphanet_908
EFO_0009704	radiation-induced brain injury	http://www.ebi.ac.uk/efo/EFO_0009704
EFO_0009705	small intestine enteropathy	http://www.ebi.ac.uk/efo/EFO_0009705
EFO_0004277	brain infarction	http://www.ebi.ac.uk/efo/EFO_0004277
EFO_1000811	anterior uveitis	http://www.ebi.ac.uk/efo/EFO_1000811
EFO_0009636	cesarean section	http://www.ebi.ac.uk/efo/EFO_0009636
EFO_0009756	autoimmune type 1 diabetes	http://www.ebi.ac.uk/efo/EFO_0009756
EFO_0009757	idiopathic type 1 diabetes	http://www.ebi.ac.uk/efo/EFO_0009757
EFO_0009758	fulminant type 1 diabetes	http://www.ebi.ac.uk/efo/EFO_0009758
EFO_0009764	eye colour measurement	http://www.ebi.ac.uk/efo/EFO_0009764
EFO_0009762	healthspan	http://www.ebi.ac.uk/efo/EFO_0009762
EFO_0009718	peak expiratory flow	http://www.ebi.ac.uk/efo/EFO_0009718
EFO_0009765	alanine measurement	http://www.ebi.ac.uk/efo/EFO_0009765
EFO_0009766	asparagine measurement	http://www.ebi.ac.uk/efo/EFO_0009766
EFO_0009767	glycine measurement	http://www.ebi.ac.uk/efo/EFO_0009767
EFO_0009768	glutamine measurement	http://www.ebi.ac.uk/efo/EFO_0009768
EFO_0009769	histidine measurement	http://www.ebi.ac.uk/efo/EFO_0009769
EFO_0009770	leucine measurement	http://www.ebi.ac.uk/efo/EFO_0009770
EFO_0009771	methionine measurement	http://www.ebi.ac.uk/efo/EFO_0009771
EFO_0009773	proline measurement	http://www.ebi.ac.uk/efo/EFO_0009773
EFO_0009774	serine measurement	http://www.ebi.ac.uk/efo/EFO_0009774
EFO_0009775	threonine measurement	http://www.ebi.ac.uk/efo/EFO_0009775
EFO_0009776	ornithine measurement	http://www.ebi.ac.uk/efo/EFO_0009776
EFO_0009777	citrulline measurement	http://www.ebi.ac.uk/efo/EFO_0009777
EFO_1000391	Nasal cavity polyp	http://www.ebi.ac.uk/efo/EFO_1000391
EFO_0009778	tri-iodothyronine measurement	http://www.ebi.ac.uk/efo/EFO_0009778
EFO_0009779	tri-iodothyronine/thyroxine ratio measurement	http://www.ebi.ac.uk/efo/EFO_0009779
EFO_0009782	progesterone-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_0009782
EFO_0009781	progesterone-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_0009781
EFO_0009780	HER2 negative breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0009780
EFO_0009783	carotid atherosclerosis	http://www.ebi.ac.uk/efo/EFO_0009783
EFO_0009784	central serous retinopathy	http://www.ebi.ac.uk/efo/EFO_0009784
EFO_0009785	remission	http://www.ebi.ac.uk/efo/EFO_0009785
EFO_0009806	total hip arthroplasty	http://www.ebi.ac.uk/efo/EFO_0009806
EFO_0004143	carpal tunnel syndrome	http://www.ebi.ac.uk/efo/EFO_0004143
MONDO_0001475	neutropenia	http://purl.obolibrary.org/obo/MONDO_0001475
EFO_0009860	chromosomal aberration frequency	http://www.ebi.ac.uk/efo/EFO_0009860
EFO_0009861	chromosome-type aberration frequency	http://www.ebi.ac.uk/efo/EFO_0009861
EFO_0009862	chromatid-type aberration frequency	http://www.ebi.ac.uk/efo/EFO_0009862
EFO_0009854	treatment resistant depression	http://www.ebi.ac.uk/efo/EFO_0009854
EFO_0009855	frontal fibrosing alopecia	http://www.ebi.ac.uk/efo/EFO_0009855
EFO_0009856	lichen planopilaris	http://www.ebi.ac.uk/efo/EFO_0009856
EFO_0009857	ruminative stress response	http://www.ebi.ac.uk/efo/EFO_0009857
EFO_0009858	brooding stress response	http://www.ebi.ac.uk/efo/EFO_0009858
EFO_0009859	reflective stress response	http://www.ebi.ac.uk/efo/EFO_0009859
EFO_0009894	carbamazepine-induced hyponatremia	http://www.ebi.ac.uk/efo/EFO_0009894
EFO_0009895	oxcarbazepine-induced hyponatremia	http://www.ebi.ac.uk/efo/EFO_0009895
EFO_0009893	response to oxcarbazepine	http://www.ebi.ac.uk/efo/EFO_0009893
EFO_0009892	facial attractiveness measurement	http://www.ebi.ac.uk/efo/EFO_0009892
EFO_0007536	vesicoureteral reflux	http://www.ebi.ac.uk/efo/EFO_0007536
EFO_0009388	sum of basophil and neutrophil counts	http://www.ebi.ac.uk/efo/EFO_0009388
EFO_0008446	platelet-to-lymphocyte ratio	http://www.ebi.ac.uk/efo/EFO_0008446
EFO_0008447	neutrophil-to-lymphocyte ratio	http://www.ebi.ac.uk/efo/EFO_0008447
EFO_0008449	magnesium:creatinine ratio measurement	http://www.ebi.ac.uk/efo/EFO_0008449
EFO_0008450	fractional excretion of magnesium measurement	http://www.ebi.ac.uk/efo/EFO_0008450
EFO_0008451	activities of daily living score measurement	http://www.ebi.ac.uk/efo/EFO_0008451
EFO_0008452	mid-arm muscle circumference measurement	http://www.ebi.ac.uk/efo/EFO_0008452
EFO_0008453	calf circumference measurement	http://www.ebi.ac.uk/efo/EFO_0008453
EFO_0008454	short physical performance battery score measurement	http://www.ebi.ac.uk/efo/EFO_0008454
EFO_0008455	sleep apnea measurement during REM sleep	http://www.ebi.ac.uk/efo/EFO_0008455
EFO_0008456	sleep apnea measurement during non-REM sleep	http://www.ebi.ac.uk/efo/EFO_0008456
CHEBI_35705	immunosuppressive agent	http://purl.obolibrary.org/obo/CHEBI_35705
EFO_0008457	cannabis dependence measurement	http://www.ebi.ac.uk/efo/EFO_0008457
EFO_0008458	tacrolimus measurement	http://www.ebi.ac.uk/efo/EFO_0008458
EFO_0008459	response to mepolizumab	http://www.ebi.ac.uk/efo/EFO_0008459
EFO_0008462	pregnancy induced alloimmunization	http://www.ebi.ac.uk/efo/EFO_0008462
EFO_0008460	colorectal health	http://www.ebi.ac.uk/efo/EFO_0008460
EFO_0008463	glucagon measurement	http://www.ebi.ac.uk/efo/EFO_0008463
EFO_0008464	glucose-dependent insulinotropic peptide measurement	http://www.ebi.ac.uk/efo/EFO_0008464
EFO_0008465	glucagon-like peptide-1 measurement	http://www.ebi.ac.uk/efo/EFO_0008465
EFO_0008487	lateral ventricle volume measurement	http://www.ebi.ac.uk/efo/EFO_0008487
EFO_1000786	osteoarthritis, hip	http://www.ebi.ac.uk/efo/EFO_1000786
EFO_0008466	Matrix Metalloproteinase 8 Measurement	http://www.ebi.ac.uk/efo/EFO_0008466
EFO_0008534	tryptophan measurement	http://www.ebi.ac.uk/efo/EFO_0008534
EFO_0008535	post-traumatic stress disorder symptom measurement	http://www.ebi.ac.uk/efo/EFO_0008535
EFO_0008536	anti-centromere-antibody-positive systemic scleroderma	http://www.ebi.ac.uk/efo/EFO_0008536
EFO_0008537	anti-topoisomerase-I-antibody-positive systemic scleroderma	http://www.ebi.ac.uk/efo/EFO_0008537
EFO_0005221	cholangiocarcinoma	http://www.ebi.ac.uk/efo/EFO_0005221
EFO_0008589	esterified cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008589
EFO_0008591	free cholesterol measurement	http://www.ebi.ac.uk/efo/EFO_0008591
EFO_0008592	high density lipoprotein particle size measurement	http://www.ebi.ac.uk/efo/EFO_0008592
EFO_0008593	low density lipoprotein particle size measurement	http://www.ebi.ac.uk/efo/EFO_0008593
EFO_0008594	very low density lipoprotein particle size measurement	http://www.ebi.ac.uk/efo/EFO_0008594
EFO_0008595	intermediate density lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0008595
EFO_0008596	chylomicron measurement	http://www.ebi.ac.uk/efo/EFO_0008596
EFO_1000637	acute respiratory distress syndrome	http://www.ebi.ac.uk/efo/EFO_1000637
EFO_0009095	psychological measurement	http://www.ebi.ac.uk/efo/EFO_0009095
EFO_0009096	negative domain measurement	http://www.ebi.ac.uk/efo/EFO_0009096
EFO_0009097	positive domain measurement	http://www.ebi.ac.uk/efo/EFO_0009097
EFO_0009098	cognitive domain measurement	http://www.ebi.ac.uk/efo/EFO_0009098
EFO_0009099	arousal domain measurement	http://www.ebi.ac.uk/efo/EFO_0009099
EFO_0009100	social domain measurement	http://www.ebi.ac.uk/efo/EFO_0009100
EFO_0009101	age at first birth measurement	http://www.ebi.ac.uk/efo/EFO_0009101
EFO_0009102	number of children ever born measurement	http://www.ebi.ac.uk/efo/EFO_0009102
EFO_0009103	theory of mind measurement	http://www.ebi.ac.uk/efo/EFO_0009103
EFO_1000764	seborrheic dermatitis	http://www.ebi.ac.uk/efo/EFO_1000764
EFO_0009176	adrenal suppression measurement	http://www.ebi.ac.uk/efo/EFO_0009176
EFO_0009177	myopic maculopathy severity measurement	http://www.ebi.ac.uk/efo/EFO_0009177
EFO_0009178	neurofilament light chain measurement	http://www.ebi.ac.uk/efo/EFO_0009178
EFO_0009179	beta-secretase 1 measurement	http://www.ebi.ac.uk/efo/EFO_0009179
EFO_0009175	response to synacthen	http://www.ebi.ac.uk/efo/EFO_0009175
EFO_0009180	rosacea severity measurement	http://www.ebi.ac.uk/efo/EFO_0009180
EFO_0009181	growth differentiation factor 15 measurement	http://www.ebi.ac.uk/efo/EFO_0009181
EFO_0009182	psychotic symptom measurement	http://www.ebi.ac.uk/efo/EFO_0009182
EFO_0009183	empathy measurement	http://www.ebi.ac.uk/efo/EFO_0009183
PATO_0001422	dead	http://purl.obolibrary.org/obo/PATO_0001422
EFO_1000971	hyperemesis gravidarum	http://www.ebi.ac.uk/efo/EFO_1000971
EFO_0009261	response to aripiprazole	http://www.ebi.ac.uk/efo/EFO_0009261
EFO_0009264	maximum cigarettes per day measurement	http://www.ebi.ac.uk/efo/EFO_0009264
EFO_0009263	nicotine withdrawal symptom count	http://www.ebi.ac.uk/efo/EFO_0009263
EFO_0009262	nicotine dependence symptom count	http://www.ebi.ac.uk/efo/EFO_0009262
EFO_0009265	nausea and vomiting of pregnancy severity measurement	http://www.ebi.ac.uk/efo/EFO_0009265
EFO_0009266	refractory celiac disease	http://www.ebi.ac.uk/efo/EFO_0009266
EFO_0009268	family history of Alzheimers disease	http://www.ebi.ac.uk/efo/EFO_0009268
EFO_0009269	ADAMTS13 measurement	http://www.ebi.ac.uk/efo/EFO_0009269
EFO_0009270	heel bone mineral density	http://www.ebi.ac.uk/efo/EFO_0009270
EFO_0009271	Epstein Barr virus nuclear antigen-1 seropositivity	http://www.ebi.ac.uk/efo/EFO_0009271
EFO_0009272	Epstein Barr viral capsid antigen seropositivity	http://www.ebi.ac.uk/efo/EFO_0009272
EFO_0009273	anti-Epstein Barr virus antibody measurement	http://www.ebi.ac.uk/efo/EFO_0009273
EFO_0009274	Epstein Barr viral capsid antigen IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009274
EFO_0009277	supraventricular ectopy	http://www.ebi.ac.uk/efo/EFO_0009277
EFO_0009276	ventricular ectopy	http://www.ebi.ac.uk/efo/EFO_0009276
EFO_0009275	premature cardiac contractions	http://www.ebi.ac.uk/efo/EFO_0009275
EFO_0009278	cranial vault morphology measurement	http://www.ebi.ac.uk/efo/EFO_0009278
EFO_0009279	response to tenofovir	http://www.ebi.ac.uk/efo/EFO_0009279
EFO_0009281	choroidal thickness measurement	http://www.ebi.ac.uk/efo/EFO_0009281
EFO_0009282	sodium measurement	http://www.ebi.ac.uk/efo/EFO_0009282
EFO_0009283	potassium measurement	http://www.ebi.ac.uk/efo/EFO_0009283
EFO_0009284	chloride measurement	http://www.ebi.ac.uk/efo/EFO_0009284
EFO_0009285	fractional shortening	http://www.ebi.ac.uk/efo/EFO_0009285
EFO_0009286	heart relative wall thickness	http://www.ebi.ac.uk/efo/EFO_0009286
EFO_0009288	posterior wall thickness	http://www.ebi.ac.uk/efo/EFO_0009288
EFO_0009289	left ventricular mass	http://www.ebi.ac.uk/efo/EFO_0009289
EFO_0009290	left ventricular mass index	http://www.ebi.ac.uk/efo/EFO_0009290
EFO_0009303	fructosamine measurement	http://www.ebi.ac.uk/efo/EFO_0009303
EFO_0009304	percent glycated albumin	http://www.ebi.ac.uk/efo/EFO_0009304
EFO_0009305	total glycated albumin	http://www.ebi.ac.uk/efo/EFO_0009305
EFO_0009306	atazanavir measurement	http://www.ebi.ac.uk/efo/EFO_0009306
EFO_0009308	response to long-chain n-3 PUFA dietary supplementation	http://www.ebi.ac.uk/efo/EFO_0009308
HP_0001007	Hirsutism	http://purl.obolibrary.org/obo/HP_0001007
EFO_1001231	uveitis	http://www.ebi.ac.uk/efo/EFO_1001231
EFO_0009321	diabetic macular edema	http://www.ebi.ac.uk/efo/EFO_0009321
EFO_0009322	proliferative diabetic retinopathy	http://www.ebi.ac.uk/efo/EFO_0009322
EFO_0009328	cerebral cortex growth measurement	http://www.ebi.ac.uk/efo/EFO_0009328
EFO_0009334	prefrontal cortex growth measurement	http://www.ebi.ac.uk/efo/EFO_0009334
EFO_0009335	white matter growth measurement	http://www.ebi.ac.uk/efo/EFO_0009335
EFO_0009325	basal ganglia growth measurement	http://www.ebi.ac.uk/efo/EFO_0009325
EFO_0009327	cerebellum growth measurement	http://www.ebi.ac.uk/efo/EFO_0009327
EFO_0009326	brain growth measurement	http://www.ebi.ac.uk/efo/EFO_0009326
EFO_0009332	executive function measurement	http://www.ebi.ac.uk/efo/EFO_0009332
EFO_0009330	Chlamydia trachomatis seropositivity	http://www.ebi.ac.uk/efo/EFO_0009330
EFO_0009331	erosive tooth wear measurement	http://www.ebi.ac.uk/efo/EFO_0009331
EFO_0009324	APOL1 risk genotype carrier status	http://www.ebi.ac.uk/efo/EFO_0009324
EFO_0009323	alpha synuclein measurement	http://www.ebi.ac.uk/efo/EFO_0009323
EFO_0009336	velopharyngeal dysfunction	http://www.ebi.ac.uk/efo/EFO_0009336
Orphanet_98896	Duchenne muscular dystrophy	http://www.orpha.net/ORDO/Orphanet_98896
EFO_1001436	thyroid nodule	http://www.ebi.ac.uk/efo/EFO_1001436
EFO_0009338	Epstein-Barr virus early antigen seropositivity	http://www.ebi.ac.uk/efo/EFO_0009338
EFO_0009339	Herpes simplex virus 2 seropositivity	http://www.ebi.ac.uk/efo/EFO_0009339
EFO_0009340	Varicella zoster virus seropositivity	http://www.ebi.ac.uk/efo/EFO_0009340
EFO_0009341	Helicobacter pylori seropositivity	http://www.ebi.ac.uk/efo/EFO_0009341
EFO_0009342	Measles virus seropositivity	http://www.ebi.ac.uk/efo/EFO_0009342
EFO_0009343	Mumps virus seropositivity	http://www.ebi.ac.uk/efo/EFO_0009343
EFO_0009344	Rubella virus seropositivity	http://www.ebi.ac.uk/efo/EFO_0009344
EFO_0009345	Hepatitis B virus surface antigen seropositivity	http://www.ebi.ac.uk/efo/EFO_0009345
EFO_0009346	Hepatitis B virus core antigen seropositivity	http://www.ebi.ac.uk/efo/EFO_0009346
EFO_0009347	Anti-cytomegalovirus IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009347
EFO_0009348	Anti-Epstein-Barr virus early antigen IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009348
EFO_0009349	Anti-herpes simplex virus 1 IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009349
EFO_0009350	Anti-herpes simplex virus 2 IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009350
EFO_0009351	Anti-varicella zoster virus IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009351
EFO_0009352	Anti-Helicobacter pylori IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009352
EFO_0009353	Anti-Toxoplasma gondii IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009353
EFO_0009354	Anti-influenza A virus IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009354
EFO_0009355	Anti-measles virus IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009355
EFO_0009356	Anti-mumps virus IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009356
EFO_0009357	Anti-rubella virus IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009357
EFO_0009358	Anti-hepatitis B virus surface antigen IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009358
EFO_0009359	Anti-hepatitis B virus core antigen IgG measurement	http://www.ebi.ac.uk/efo/EFO_0009359
EFO_0009360	eyelid sagging measurement	http://www.ebi.ac.uk/efo/EFO_0009360
EFO_1001240	vulvovaginitis	http://www.ebi.ac.uk/efo/EFO_1001240
EFO_0009363	chronic central serous retinopathy	http://www.ebi.ac.uk/efo/EFO_0009363
EFO_0009364	non-allergic rhinitis	http://www.ebi.ac.uk/efo/EFO_0009364
EFO_0009365	vaginal discharge	http://www.ebi.ac.uk/efo/EFO_0009365
EFO_0009370	radon exposure measurement	http://www.ebi.ac.uk/efo/EFO_0009370
EFO_0009366	quality of life during menstruation measurement	http://www.ebi.ac.uk/efo/EFO_0009366
EFO_0009367	glucose metabolism measurement	http://www.ebi.ac.uk/efo/EFO_0009367
EFO_0009368	factor VII activating protease measurement	http://www.ebi.ac.uk/efo/EFO_0009368
EFO_0009369	diffusing capacity of the lung for carbon monoxide	http://www.ebi.ac.uk/efo/EFO_0009369
EFO_0009371	ketogenic diet	http://www.ebi.ac.uk/efo/EFO_0009371
EFO_0009372	response to ketogenic diet	http://www.ebi.ac.uk/efo/EFO_0009372
EFO_0009373	edema	http://www.ebi.ac.uk/efo/EFO_0009373
EFO_1001460	diverticulitis	http://www.ebi.ac.uk/efo/EFO_1001460
EFO_0009389	sum of eosinophil and basophil counts	http://www.ebi.ac.uk/efo/EFO_0009389
EFO_0009403	granule cell layer dentate gyrus volume	http://www.ebi.ac.uk/efo/EFO_0009403
EFO_0009404	hippocampal fissure volume	http://www.ebi.ac.uk/efo/EFO_0009404
EFO_0009405	parasubiculum volume	http://www.ebi.ac.uk/efo/EFO_0009405
EFO_0009435	arthritis disease activity score measurement	http://www.ebi.ac.uk/efo/EFO_0009435
EFO_0009436	offspring survival measurement	http://www.ebi.ac.uk/efo/EFO_0009436
EFO_0009437	offspring mortality measurement	http://www.ebi.ac.uk/efo/EFO_0009437
EFO_0009438	number of pregnancies measurement	http://www.ebi.ac.uk/efo/EFO_0009438
EFO_0009439	multiple births measurement	http://www.ebi.ac.uk/efo/EFO_0009439
EFO_0009440	age at last pregnancy measurement	http://www.ebi.ac.uk/efo/EFO_0009440
EFO_0009441	Waldenstrom macroglobulinemia	http://www.ebi.ac.uk/efo/EFO_0009441
EFO_0009443	BRCAX breast cancer	http://www.ebi.ac.uk/efo/EFO_0009443
EFO_0009959	diverticular disease	http://www.ebi.ac.uk/efo/EFO_0009959
EFO_0009961	Insulinogenic index measurement	http://www.ebi.ac.uk/efo/EFO_0009961
MONDO_0012511	preterm premature rupture of the membranes	http://purl.obolibrary.org/obo/MONDO_0012511
EFO_0010057	vascular cell adhesion molecule-1 measurement	http://www.ebi.ac.uk/efo/EFO_0010057
EFO_0010059	cerebral microbleeds	http://www.ebi.ac.uk/efo/EFO_0010059
EFO_0010060	chronic human papillomavirus infection	http://www.ebi.ac.uk/efo/EFO_0010060
Orphanet_538	lymphangioleiomyomatosis	http://www.orpha.net/ORDO/Orphanet_538
EFO_0010065	response to intravenous immunoglobulin therapy	http://www.ebi.ac.uk/efo/EFO_0010065
EFO_0010062	response to salmeterol	http://www.ebi.ac.uk/efo/EFO_0010062
EFO_0010068	respiratory symptom change measurement	http://www.ebi.ac.uk/efo/EFO_0010068
EFO_0010071	cardiac troponin I measurement	http://www.ebi.ac.uk/efo/EFO_0010071
EFO_0010070	nerve conduction amplitude	http://www.ebi.ac.uk/efo/EFO_0010070
EFO_0010069	nerve conduction velocity	http://www.ebi.ac.uk/efo/EFO_0010069
EFO_0010067	corneal resistance factor	http://www.ebi.ac.uk/efo/EFO_0010067
EFO_0010066	corneal hysteresis	http://www.ebi.ac.uk/efo/EFO_0010066
EFO_0010076	femoral neck size	http://www.ebi.ac.uk/efo/EFO_0010076
EFO_0010075	intertrochanteric region size	http://www.ebi.ac.uk/efo/EFO_0010075
EFO_0010074	trochanter size	http://www.ebi.ac.uk/efo/EFO_0010074
EFO_0010078	dentures	http://www.ebi.ac.uk/efo/EFO_0010078
EFO_0010073	number of teeth measurement	http://www.ebi.ac.uk/efo/EFO_0010073
EFO_0010072	toothache	http://www.ebi.ac.uk/efo/EFO_0010072
EFO_0010077	response to belimumab	http://www.ebi.ac.uk/efo/EFO_0010077
EFO_0010079	corneal endothelial cell measurement	http://www.ebi.ac.uk/efo/EFO_0010079
EFO_0010080	geographic atrophy lesion growth	http://www.ebi.ac.uk/efo/EFO_0010080
EFO_0010152	response to phenylephrine	http://www.ebi.ac.uk/efo/EFO_0010152
EFO_0010154	platinum measurement	http://www.ebi.ac.uk/efo/EFO_0010154
EFO_0010176	keratinocyte carcinoma	http://www.ebi.ac.uk/efo/EFO_0010176
EFO_0010177	lobar intracerebral hemorrhage	http://www.ebi.ac.uk/efo/EFO_0010177
EFO_0010178	non-lobar intracerebral hemorrhage	http://www.ebi.ac.uk/efo/EFO_0010178
EFO_0010219	aldosterone measurement	http://www.ebi.ac.uk/efo/EFO_0010219
EFO_0010220	17-hydroxyprogesterone measurement	http://www.ebi.ac.uk/efo/EFO_0010220
EFO_0010221	systemising measurement	http://www.ebi.ac.uk/efo/EFO_0010221
EFO_0010222	ceramide measurement	http://www.ebi.ac.uk/efo/EFO_0010222
EFO_0010223	diglyceride measurement	http://www.ebi.ac.uk/efo/EFO_0010223
EFO_0010224	lysophosphatidylcholine measurement	http://www.ebi.ac.uk/efo/EFO_0010224
EFO_0010225	lysophosphatidylethanolamine measurement	http://www.ebi.ac.uk/efo/EFO_0010225
EFO_0010226	phosphatidylcholine measurement	http://www.ebi.ac.uk/efo/EFO_0010226
EFO_0010227	phosphatidylcholine ether measurement	http://www.ebi.ac.uk/efo/EFO_0010227
EFO_0010228	phosphatidylethanolamine measurement	http://www.ebi.ac.uk/efo/EFO_0010228
EFO_0010229	phosphatidylethanolamine ether measurement	http://www.ebi.ac.uk/efo/EFO_0010229
EFO_0010230	phosphatidylinositol measurement	http://www.ebi.ac.uk/efo/EFO_0010230
EFO_0010231	sterol measurement	http://www.ebi.ac.uk/efo/EFO_0010231
EFO_0010232	osteocalcin measurement	http://www.ebi.ac.uk/efo/EFO_0010232
EFO_0010233	genotoxic compound exposure measurement	http://www.ebi.ac.uk/efo/EFO_0010233
EFO_1000831	bacterial meningitis	http://www.ebi.ac.uk/efo/EFO_1000831
EFO_0010339	FVC change measurement	http://www.ebi.ac.uk/efo/EFO_0010339
EFO_0006861	male breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0006861
EFO_0010551	xanthurenate measurement	http://www.ebi.ac.uk/efo/EFO_0010551
EFO_0010552	social environment measurement	http://www.ebi.ac.uk/efo/EFO_0010552
EFO_0010553	cocaine use measurement	http://www.ebi.ac.uk/efo/EFO_0010553
EFO_0010554	retinal vasculature measurement	http://www.ebi.ac.uk/efo/EFO_0010554
EFO_0010555	left ventricular stroke volume measurement	http://www.ebi.ac.uk/efo/EFO_0010555
EFO_0010556	left ventricular mass to end-diastolic volume ratio	http://www.ebi.ac.uk/efo/EFO_0010556
EFO_0010603	cancer antigen 125 measurement	http://www.ebi.ac.uk/efo/EFO_0010603
EFO_0010611	cathepsin D measurement	http://www.ebi.ac.uk/efo/EFO_0010611
EFO_0010612	kit ligand measurement	http://www.ebi.ac.uk/efo/EFO_0010612
EFO_0010613	tumor necrosis factor ligand superfamily member 14 measurement	http://www.ebi.ac.uk/efo/EFO_0010613
EFO_0010614	follistatin measurement	http://www.ebi.ac.uk/efo/EFO_0010614
EFO_0010615	galanin peptides measurement	http://www.ebi.ac.uk/efo/EFO_0010615
EFO_0010616	renin measurement	http://www.ebi.ac.uk/efo/EFO_0010616
EFO_0010617	tumor necrosis factor ligand superfamily member 11 measurement	http://www.ebi.ac.uk/efo/EFO_0010617
EFO_0010618	pappalysin1 measurement	http://www.ebi.ac.uk/efo/EFO_0010618
EFO_0010619	cathepsin L1 measurement	http://www.ebi.ac.uk/efo/EFO_0010619
EFO_0010620	dickkopfrelated protein 1 measurement	http://www.ebi.ac.uk/efo/EFO_0010620
EFO_0010621	stromelysin2 measurement	http://www.ebi.ac.uk/efo/EFO_0010621
EFO_0010622	kallikrein6 measurement	http://www.ebi.ac.uk/efo/EFO_0010622
EFO_0010623	tissue factor measurement	http://www.ebi.ac.uk/efo/EFO_0010623
EFO_0010624	tumor necrosis factor receptor superfamily member 1B measurement	http://www.ebi.ac.uk/efo/EFO_0010624
EFO_0010625	xaapro aminopeptidase 2 measurement	http://www.ebi.ac.uk/efo/EFO_0010625
EFO_0010626	placenta growth factor measurement	http://www.ebi.ac.uk/efo/EFO_0010626
EFO_0010627	proadrenomedullin measurement	http://www.ebi.ac.uk/efo/EFO_0010627
EFO_0010628	natriuretic peptides B measurement	http://www.ebi.ac.uk/efo/EFO_0010628
EFO_0006927	severe aplastic anemia	http://www.ebi.ac.uk/efo/EFO_0006927
EFO_0010638	atopic asthma	http://www.ebi.ac.uk/efo/EFO_0010638
EFO_0010640	chronic post-operative pain measurement	http://www.ebi.ac.uk/efo/EFO_0010640
EFO_0010648	response to vitamin B3	http://www.ebi.ac.uk/efo/EFO_0010648
HP_0000020	urinary incontinence	http://purl.obolibrary.org/obo/HP_0000020
EFO_0009523	fecal incontinence	http://www.ebi.ac.uk/efo/EFO_0009523
EFO_0010707	trans-3-hydroxycotinine measurement	http://www.ebi.ac.uk/efo/EFO_0010707
MONDO_0043424	digestive system infectious disease	http://purl.obolibrary.org/obo/MONDO_0043424
EFO_0010723	ocular sarcoidosis	http://www.ebi.ac.uk/efo/EFO_0010723
HP_0030834	shoulder pain	http://purl.obolibrary.org/obo/HP_0030834
HP_0030833	neck pain	http://purl.obolibrary.org/obo/HP_0030833
EFO_1001281	Buruli Ulcer	http://www.ebi.ac.uk/efo/EFO_1001281
EFO_0010724	lifestyle measurement	http://www.ebi.ac.uk/efo/EFO_0010724
EFO_0010725	aseptic loosening	http://www.ebi.ac.uk/efo/EFO_0010725
EFO_0010726	total joint arthroplasty	http://www.ebi.ac.uk/efo/EFO_0010726
Orphanet_101997	primary immunodeficiency	http://www.orpha.net/ORDO/Orphanet_101997
EFO_0010729	sun exposure measurement	http://www.ebi.ac.uk/efo/EFO_0010729
EFO_0010730	response to bezlotoxumab	http://www.ebi.ac.uk/efo/EFO_0010730
MONDO_0100096	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096
EFO_1001289	Cholecystitis, Acute	http://www.ebi.ac.uk/efo/EFO_1001289
EFO_0007135	adult-onset Still's disease	http://www.ebi.ac.uk/efo/EFO_0007135
EFO_0010731	response to low calorie diet	http://www.ebi.ac.uk/efo/EFO_0010731
EFO_0010733	polyunsaturated fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0010733
EFO_0010732	omega-6:omega-3 polyunsaturated fatty acid ratio	http://www.ebi.ac.uk/efo/EFO_0010732
Orphanet_96346	anorectal malformation	http://www.orpha.net/ORDO/Orphanet_96346
EFO_0010735	response to angiotensin receptor blocker	http://www.ebi.ac.uk/efo/EFO_0010735
EFO_0010736	cortical surface area measurement	http://www.ebi.ac.uk/efo/EFO_0010736
EFO_0010742	protein binding measurement	http://www.ebi.ac.uk/efo/EFO_0010742
EFO_0010745	semen measurement	http://www.ebi.ac.uk/efo/EFO_0010745
EFO_0010744	testis size	http://www.ebi.ac.uk/efo/EFO_0010744
EFO_0010743	sperm measurement	http://www.ebi.ac.uk/efo/EFO_0010743
EFO_0010746	Inhibin B measurement	http://www.ebi.ac.uk/efo/EFO_0010746
EFO_0010747	response to levodopa	http://www.ebi.ac.uk/efo/EFO_0010747
EFO_0010748	response to zonisamide	http://www.ebi.ac.uk/efo/EFO_0010748
EFO_0010749	motor function measurement	http://www.ebi.ac.uk/efo/EFO_0010749
EFO_0010750	PHF-tau measurement	http://www.ebi.ac.uk/efo/EFO_0010750
EFO_0010758	anti-Kaposi's sarcoma-associated herpesvirus antibody measurement	http://www.ebi.ac.uk/efo/EFO_0010758
EFO_0007294	hand, foot and mouth disease	http://www.ebi.ac.uk/efo/EFO_0007294
EFO_0010804	vascular endothelial growth factor A measurement	http://www.ebi.ac.uk/efo/EFO_0010804
EFO_0010803	urokinase-type plasminogen activator measurement	http://www.ebi.ac.uk/efo/EFO_0010803
EFO_0010802	tumor necrosis factor receptor superfamily member 9 measurement	http://www.ebi.ac.uk/efo/EFO_0010802
EFO_0010801	tumor necrosis factor ligand superfamily member 12 measurement	http://www.ebi.ac.uk/efo/EFO_0010801
EFO_0010800	tumor necrosis factor ligand superfamily member 10 measurement	http://www.ebi.ac.uk/efo/EFO_0010800
EFO_0010799	transforming growth factor-beta measurement	http://www.ebi.ac.uk/efo/EFO_0010799
EFO_0010798	transforming growth factor-alpha measurement	http://www.ebi.ac.uk/efo/EFO_0010798
EFO_0010797	sulfotrasferase 1A1 measurement	http://www.ebi.ac.uk/efo/EFO_0010797
EFO_0010796	STAM binding protein measurement	http://www.ebi.ac.uk/efo/EFO_0010796
EFO_0010795	sirtuin-2 measurement	http://www.ebi.ac.uk/efo/EFO_0010795
EFO_0010794	signaling lymphocytic activation molecule 1 measurement	http://www.ebi.ac.uk/efo/EFO_0010794
EFO_0010793	programmed death-ligand 1 measurement	http://www.ebi.ac.uk/efo/EFO_0010793
EFO_0010792	oncostatin-M measurement	http://www.ebi.ac.uk/efo/EFO_0010792
EFO_0010791	neurotrophin-3 measurement	http://www.ebi.ac.uk/efo/EFO_0010791
EFO_0010790	monocyte chemotactic protein-4 measurement	http://www.ebi.ac.uk/efo/EFO_0010790
EFO_0010789	monocyte chemotactic protein-2 measurement	http://www.ebi.ac.uk/efo/EFO_0010789
EFO_0010788	leukemia inhibitory factor receptor measurement	http://www.ebi.ac.uk/efo/EFO_0010788
EFO_0010787	interleukin-12 subunit B measurement	http://www.ebi.ac.uk/efo/EFO_0010787
EFO_0010786	interleukin-10 receptor B measurement	http://www.ebi.ac.uk/efo/EFO_0010786
EFO_0010785	fms related receptor tyrosine kinase-3 ligand measurement	http://www.ebi.ac.uk/efo/EFO_0010785
EFO_0010784	fibroblast growth factor 5 measurement	http://www.ebi.ac.uk/efo/EFO_0010784
EFO_0010783	fibroblast growth factor 21 measurement	http://www.ebi.ac.uk/efo/EFO_0010783
EFO_0010782	fibroblast growth factor 19 measurement	http://www.ebi.ac.uk/efo/EFO_0010782
EFO_0010781	delta/notch like EGF Repeat Containing protein measurement	http://www.ebi.ac.uk/efo/EFO_0010781
EFO_0010780	CXCL9 measurement	http://www.ebi.ac.uk/efo/EFO_0010780
EFO_0010779	CXCL11 measurement	http://www.ebi.ac.uk/efo/EFO_0010779
EFO_0010778	CXCL10 measurement	http://www.ebi.ac.uk/efo/EFO_0010778
EFO_0010777	CXCL1 measurement	http://www.ebi.ac.uk/efo/EFO_0010777
EFO_0010776	CUB domain containing protein 1 measurement	http://www.ebi.ac.uk/efo/EFO_0010776
EFO_0010775	colony stimulating factor 1 measurement	http://www.ebi.ac.uk/efo/EFO_0010775
EFO_0010774	CD6 measurement	http://www.ebi.ac.uk/efo/EFO_0010774
EFO_0010773	CD5 measurement	http://www.ebi.ac.uk/efo/EFO_0010773
EFO_0010772	CD244 measurement	http://www.ebi.ac.uk/efo/EFO_0010772
EFO_0010770	CCL3 measurement	http://www.ebi.ac.uk/efo/EFO_0010770
EFO_0010769	CCL28 measurement	http://www.ebi.ac.uk/efo/EFO_0010769
EFO_0010768	CCL25 measurement	http://www.ebi.ac.uk/efo/EFO_0010768
EFO_0010766	CCL20 measurement	http://www.ebi.ac.uk/efo/EFO_0010766
EFO_0010764	caspase-8 measurement	http://www.ebi.ac.uk/efo/EFO_0010764
EFO_0010763	axin-1 measurement	http://www.ebi.ac.uk/efo/EFO_0010763
EFO_0010762	advanced glycosylation end product-specific receptor ligand measurement	http://www.ebi.ac.uk/efo/EFO_0010762
EFO_0010761	adenosine deaminase measurement	http://www.ebi.ac.uk/efo/EFO_0010761
EFO_0010760	4E-BP1 measurement	http://www.ebi.ac.uk/efo/EFO_0010760
EFO_0007445	Plasmodium vivax malaria	http://www.ebi.ac.uk/efo/EFO_0007445
MONDO_0000873	lymphoblastic lymphoma	http://purl.obolibrary.org/obo/MONDO_0000873
HP_0100716	Self-injurious behavior	http://purl.obolibrary.org/obo/HP_0100716
EFO_0010808	response to tafenoquine	http://www.ebi.ac.uk/efo/EFO_0010808
EFO_0010811	carbohydrate intake measurement	http://www.ebi.ac.uk/efo/EFO_0010811
EFO_0010810	protein intake measurement	http://www.ebi.ac.uk/efo/EFO_0010810
EFO_0010809	fat intake measurement	http://www.ebi.ac.uk/efo/EFO_0010809
1001114	pneumococcal meningitis	http://www.ebi.ac.uk/efo/EFO_1001114
EFO_0010049	asthma symptoms measurement	http://www.ebi.ac.uk/efo/EFO_0010049
EFO_0010050	thyroglobulin measurement	http://www.ebi.ac.uk/efo/EFO_0010050
EFO_0010051	response to immunosuppressant	http://www.ebi.ac.uk/efo/EFO_0010051
EFO_0010052	response to tacrolimus	http://www.ebi.ac.uk/efo/EFO_0010052
EFO_0010053	response to cyclosporine	http://www.ebi.ac.uk/efo/EFO_0010053
EFO_0010054	response to mycophenolic acid	http://www.ebi.ac.uk/efo/EFO_0010054
EFO_0010055	response to calcineurin inhibitor	http://www.ebi.ac.uk/efo/EFO_0010055
EFO_0010056	liver iron measurement	http://www.ebi.ac.uk/efo/EFO_0010056
HP_0002573	Hematochezia	http://purl.obolibrary.org/obo/HP_0002573
HP_0000016	Urinary retention	http://purl.obolibrary.org/obo/HP_0000016
HP_0000790	Hematuria	http://purl.obolibrary.org/obo/HP_0000790
HP_0000079	Abnormality of the urinary system	http://purl.obolibrary.org/obo/HP_0000079
HP_0003076	glycosuria	http://purl.obolibrary.org/obo/HP_0003076
EFO_0010083	dentate gyrus volume measurement	http://www.ebi.ac.uk/efo/EFO_0010083
HP_0002919	ketonuria	http://purl.obolibrary.org/obo/HP_0002919
EFO_0010138	nitrite measurement	http://www.ebi.ac.uk/efo/EFO_0010138
EFO_0010137	leukocyte esterase measurement	http://www.ebi.ac.uk/efo/EFO_0010137
EFO_0010136	urinary pH measurement	http://www.ebi.ac.uk/efo/EFO_0010136
EFO_0010135	urine specific gravity measurement	http://www.ebi.ac.uk/efo/EFO_0010135
EFO_0006845	liver disease biomarker	http://www.ebi.ac.uk/efo/EFO_0006845
EFO_1001295	microscopic colitis	http://www.ebi.ac.uk/efo/EFO_1001295
EFO_0010235	response to proton-pump inhibitor	http://www.ebi.ac.uk/efo/EFO_0010235
EFO_0010245	oxytocin measurement	http://www.ebi.ac.uk/efo/EFO_0010245
EFO_0010244	uveal melanoma disease severity	http://www.ebi.ac.uk/efo/EFO_0010244
EFO_0010269	amenorrhea	http://www.ebi.ac.uk/efo/EFO_0010269
EFO_0010271	bacterial pathogen genotype measurement	http://www.ebi.ac.uk/efo/EFO_0010271
CHEBI_3663	cholesteryl palmitate	http://purl.obolibrary.org/obo/CHEBI_3663
CHEBI_82750	cholesteryl stearate	http://purl.obolibrary.org/obo/CHEBI_82750
CHEBI_132002	cholesteryl octadecadienoate	http://purl.obolibrary.org/obo/CHEBI_132002
CHEBI_132004	cholesteryl octadecatrienoate	http://purl.obolibrary.org/obo/CHEBI_132004
CHEBI_138331	cholesteryl icosatrienoate	http://purl.obolibrary.org/obo/CHEBI_138331
CHEBI_132006	cholesteryl icosatetraenoate	http://purl.obolibrary.org/obo/CHEBI_132006
CHEBI_132007	cholesteryl icosapentaenoate	http://purl.obolibrary.org/obo/CHEBI_132007
CHEBI_143616	sphingomyelin 16:1	http://purl.obolibrary.org/obo/CHEBI_143616
CHEBI_143615	sphingomyelin 14:0	http://purl.obolibrary.org/obo/CHEBI_143615
CHEBI_143617	sphingomyelin 18:0	http://purl.obolibrary.org/obo/CHEBI_143617
CHEBI_143618	sphingomyelin 18:1	http://purl.obolibrary.org/obo/CHEBI_143618
EFO_0010444	triacylglycerol 60:12 measurement	http://www.ebi.ac.uk/efo/EFO_0010444
EFO_0010344	cholesteryl ester 18:1 measurement	http://www.ebi.ac.uk/efo/EFO_0010344
EFO_0010343	cholesteryl ester 18:0 measurement	http://www.ebi.ac.uk/efo/EFO_0010343
EFO_0010342	cholesteryl ester 16:1 measurement	http://www.ebi.ac.uk/efo/EFO_0010342
EFO_0010341	cholesteryl ester 16:0 measurement	http://www.ebi.ac.uk/efo/EFO_0010341
EFO_0010340	cholesteryl ester 14:0 measurement	http://www.ebi.ac.uk/efo/EFO_0010340
HANCESTRO_0014	Hispanic or Latin American	http://purl.obolibrary.org/obo/HANCESTRO_0014
EFO_0010559	anti-drug antibody measurement	http://www.ebi.ac.uk/efo/EFO_0010559
EFO_0010570	ventricular enlargement measurement	http://www.ebi.ac.uk/efo/EFO_0010570
EFO_1000789	osteoarthritis, hand	http://www.ebi.ac.uk/efo/EFO_1000789
EFO_1000710	hidradenitis suppurativa	http://www.ebi.ac.uk/efo/EFO_1000710
EFO_0010602	brain age measurement	http://www.ebi.ac.uk/efo/EFO_0010602
EFO_0010583	alpha fetoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0010583
EFO_0010584	cancer antigen 19.9 measurement	http://www.ebi.ac.uk/efo/EFO_0010584
EFO_0010585	cancer antigen 15.3 measurement	http://www.ebi.ac.uk/efo/EFO_0010585
EFO_0010610	tumor necrosis factor receptor superfamily member 6 measurement	http://www.ebi.ac.uk/efo/EFO_0010610
EFO_0010637	salivary metabolite measurement	http://www.ebi.ac.uk/efo/EFO_0010637
EFO_0010641	3-ureidopropionate measurement	http://www.ebi.ac.uk/efo/EFO_0010641
MONDO_0015474	cryptosporidiosis	http://purl.obolibrary.org/obo/MONDO_0015474
EFO_0010443	triacylglycerol 58:9 measurement	http://www.ebi.ac.uk/efo/EFO_0010443
EFO_0010442	triacylglycerol 58:8 measurement	http://www.ebi.ac.uk/efo/EFO_0010442
EFO_0010441	triacylglycerol 58:7 measurement	http://www.ebi.ac.uk/efo/EFO_0010441
OMIT_0001676	Adenosine Diphosphate	http://purl.obolibrary.org/obo/OMIT_0001676
EFO_0010440	triacylglycerol 58:6 measurement	http://www.ebi.ac.uk/efo/EFO_0010440
EFO_0010439	triacylglycerol 58:12 measurement	http://www.ebi.ac.uk/efo/EFO_0010439
EFO_0010438	triacylglycerol 58:11 measurement	http://www.ebi.ac.uk/efo/EFO_0010438
EFO_0010437	triacylglycerol 58:10 measurement	http://www.ebi.ac.uk/efo/EFO_0010437
EFO_0010436	triacylglycerol 56:9 measurement	http://www.ebi.ac.uk/efo/EFO_0010436
EFO_0010435	triacylglycerol 56:8 measurement	http://www.ebi.ac.uk/efo/EFO_0010435
EFO_0010434	triacylglycerol 56:7 measurement	http://www.ebi.ac.uk/efo/EFO_0010434
EFO_0010433	triacylglycerol 56:6 measurement	http://www.ebi.ac.uk/efo/EFO_0010433
EFO_0010432	triacylglycerol 56:5 measurement	http://www.ebi.ac.uk/efo/EFO_0010432
EFO_0010431	triacylglycerol 56:4 measurement	http://www.ebi.ac.uk/efo/EFO_0010431
EFO_0010430	triacylglycerol 56:3 measurement	http://www.ebi.ac.uk/efo/EFO_0010430
EFO_0010429	triacylglycerol 56:2 measurement	http://www.ebi.ac.uk/efo/EFO_0010429
EFO_0010428	triacylglycerol 56:10 measurement	http://www.ebi.ac.uk/efo/EFO_0010428
EFO_0010427	triacylglycerol 54:9 measurement	http://www.ebi.ac.uk/efo/EFO_0010427
EFO_0010426	triacylglycerol 54:8 measurement	http://www.ebi.ac.uk/efo/EFO_0010426
EFO_0010425	triacylglycerol 54:7 measurement	http://www.ebi.ac.uk/efo/EFO_0010425
EFO_0010424	triacylglycerol 54:6 measurement	http://www.ebi.ac.uk/efo/EFO_0010424
EFO_0010423	triacylglycerol 54:5 measurement	http://www.ebi.ac.uk/efo/EFO_0010423
EFO_0010422	triacylglycerol 54:4 measurement	http://www.ebi.ac.uk/efo/EFO_0010422
EFO_0010421	triacylglycerol 54:3 measurement	http://www.ebi.ac.uk/efo/EFO_0010421
EFO_0010420	triacylglycerol 54:2 measurement	http://www.ebi.ac.uk/efo/EFO_0010420
EFO_0010419	triacylglycerol 54:1 measurement	http://www.ebi.ac.uk/efo/EFO_0010419
EFO_0010418	triacylglycerol 52:6 measurement	http://www.ebi.ac.uk/efo/EFO_0010418
EFO_0010417	triacylglycerol 52:5 measurement	http://www.ebi.ac.uk/efo/EFO_0010417
EFO_0010416	triacylglycerol 52:4 measurement	http://www.ebi.ac.uk/efo/EFO_0010416
EFO_0010415	triacylglycerol 52:3 measurement	http://www.ebi.ac.uk/efo/EFO_0010415
EFO_0010414	triacylglycerol 52:2 measurement	http://www.ebi.ac.uk/efo/EFO_0010414
EFO_0010413	triacylglycerol 52:1 measurement	http://www.ebi.ac.uk/efo/EFO_0010413
EFO_0010412	triacylglycerol 50:5 measurement	http://www.ebi.ac.uk/efo/EFO_0010412
EFO_0010411	triacylglycerol 50:4 measurement	http://www.ebi.ac.uk/efo/EFO_0010411
EFO_0010410	triacylglycerol 50:3 measurement	http://www.ebi.ac.uk/efo/EFO_0010410
EFO_0010409	triacylglycerol 50:2 measurement	http://www.ebi.ac.uk/efo/EFO_0010409
EFO_0010408	triacylglycerol 50:1 measurement	http://www.ebi.ac.uk/efo/EFO_0010408
EFO_0010407	triacylglycerol 48:4 measurement	http://www.ebi.ac.uk/efo/EFO_0010407
EFO_0010406	triacylglycerol 48:3 measurement	http://www.ebi.ac.uk/efo/EFO_0010406
EFO_0010405	triacylglycerol 48:2 measurement	http://www.ebi.ac.uk/efo/EFO_0010405
EFO_0010404	triacylglycerol 48:1 measurement	http://www.ebi.ac.uk/efo/EFO_0010404
EFO_0010403	triacylglycerol 48:0 measurement	http://www.ebi.ac.uk/efo/EFO_0010403
EFO_0010402	triacylglycerol 46:2 measurement	http://www.ebi.ac.uk/efo/EFO_0010402
EFO_0010401	triacylglycerol 46:1 measurement	http://www.ebi.ac.uk/efo/EFO_0010401
EFO_0010400	triacylglycerol 46:0 measurement	http://www.ebi.ac.uk/efo/EFO_0010400
EFO_0010399	triacylglycerol 44:1 measurement	http://www.ebi.ac.uk/efo/EFO_0010399
EFO_0010398	sphingomyelin 24:1 measurement	http://www.ebi.ac.uk/efo/EFO_0010398
EFO_0010397	sphingomyelin 24:0 measurement	http://www.ebi.ac.uk/efo/EFO_0010397
EFO_0010396	sphingomyelin 22:1 measurement	http://www.ebi.ac.uk/efo/EFO_0010396
EFO_0010395	sphingomyelin 22:0 measurement	http://www.ebi.ac.uk/efo/EFO_0010395
EFO_0010394	sphingomyelin 18:1 measurement	http://www.ebi.ac.uk/efo/EFO_0010394
EFO_0010393	sphingomyelin 18:0 measurement	http://www.ebi.ac.uk/efo/EFO_0010393
EFO_0010392	sphingomyelin 16:1 measurement	http://www.ebi.ac.uk/efo/EFO_0010392
EFO_0010391	sphingomyelin 16:0 measurement	http://www.ebi.ac.uk/efo/EFO_0010391
EFO_0010390	sphingomyelin 14:0 measurement	http://www.ebi.ac.uk/efo/EFO_0010390
EFO_0010389	phosphatidylcholine 40:6 measurement	http://www.ebi.ac.uk/efo/EFO_0010389
EFO_0010388	phosphatidylcholine 38:6 measurement	http://www.ebi.ac.uk/efo/EFO_0010388
EFO_0010387	phosphatidylcholine 38:5 measurement	http://www.ebi.ac.uk/efo/EFO_0010387
EFO_0010386	phosphatidylcholine 38:4 measurement	http://www.ebi.ac.uk/efo/EFO_0010386
EFO_0010385	phosphatidylcholine 38:3 measurement	http://www.ebi.ac.uk/efo/EFO_0010385
EFO_0010384	phosphatidylcholine 38:2 measurement	http://www.ebi.ac.uk/efo/EFO_0010384
EFO_0010383	phosphatidylcholine 36:5 measurement	http://www.ebi.ac.uk/efo/EFO_0010383
EFO_0010382	phosphatidylcholine 36:4 measurement	http://www.ebi.ac.uk/efo/EFO_0010382
EFO_0010381	phosphatidylcholine 36:3 measurement	http://www.ebi.ac.uk/efo/EFO_0010381
EFO_0010380	phosphatidylcholine 36:2 measurement	http://www.ebi.ac.uk/efo/EFO_0010380
EFO_0010379	phosphatidylcholine 36:1 measurement	http://www.ebi.ac.uk/efo/EFO_0010379
EFO_0010378	phosphatidylcholine 34:4 measurement	http://www.ebi.ac.uk/efo/EFO_0010378
EFO_0010377	phosphatidylcholine 34:3 measurement	http://www.ebi.ac.uk/efo/EFO_0010377
EFO_0010376	phosphatidylcholine 34:2 measurement	http://www.ebi.ac.uk/efo/EFO_0010376
EFO_0010375	phosphatidylcholine 34:1 measurement	http://www.ebi.ac.uk/efo/EFO_0010375
EFO_0010374	phosphatidylcholine 32:2 measurement	http://www.ebi.ac.uk/efo/EFO_0010374
EFO_0010373	phosphatidylcholine 32:1 measurement	http://www.ebi.ac.uk/efo/EFO_0010373
EFO_0010372	phosphatidylcholine 32:0 measurement	http://www.ebi.ac.uk/efo/EFO_0010372
EFO_0010371	lysophosphatidylethanolamine 22:6 measurement	http://www.ebi.ac.uk/efo/EFO_0010371
EFO_0010370	lysophosphatidylethanolamine 20:4 measurement	http://www.ebi.ac.uk/efo/EFO_0010370
EFO_0010369	lysophosphatidylethanolamine 18:2 measurement	http://www.ebi.ac.uk/efo/EFO_0010369
EFO_0010368	lysophosphatidylethanolamine 18:1 measurement	http://www.ebi.ac.uk/efo/EFO_0010368
EFO_0010367	lysophosphatidylethanolamine 18:0 measurement	http://www.ebi.ac.uk/efo/EFO_0010367
EFO_0010366	lysophosphatidylethanolamine 16:0 measurement	http://www.ebi.ac.uk/efo/EFO_0010366
EFO_0010365	lysophosphatidylcholine 22:6 measurement	http://www.ebi.ac.uk/efo/EFO_0010365
EFO_0010364	lysophosphatidylcholine 20:5 measurement	http://www.ebi.ac.uk/efo/EFO_0010364
EFO_0010363	lysophosphatidylcholine 20:4 measurement	http://www.ebi.ac.uk/efo/EFO_0010363
EFO_0010362	lysophosphatidylcholine 20:3 measurement	http://www.ebi.ac.uk/efo/EFO_0010362
EFO_0010361	lysophosphatidylcholine 18:2 measurement	http://www.ebi.ac.uk/efo/EFO_0010361
EFO_0010360	lysophosphatidylcholine 18:1 measurement	http://www.ebi.ac.uk/efo/EFO_0010360
EFO_0010359	lysophosphatidylcholine 18:0 measurement	http://www.ebi.ac.uk/efo/EFO_0010359
EFO_0010358	lysophosphatidylcholine 16:1 measurement	http://www.ebi.ac.uk/efo/EFO_0010358
EFO_0010357	lysophosphatidylcholine 16:0 measurement	http://www.ebi.ac.uk/efo/EFO_0010357
EFO_0010356	lysophosphatidylcholine 14:0 measurement	http://www.ebi.ac.uk/efo/EFO_0010356
EFO_0010355	diacylglycerol 36:2 measurement	http://www.ebi.ac.uk/efo/EFO_0010355
EFO_0010354	diacylglycerol 36:1 measurement	http://www.ebi.ac.uk/efo/EFO_0010354
EFO_0010353	diacylglycerol 34:2 measurement	http://www.ebi.ac.uk/efo/EFO_0010353
EFO_0010352	diacylglycerol 34:1 measurement	http://www.ebi.ac.uk/efo/EFO_0010352
EFO_0010351	cholesteryl ester measurement	http://www.ebi.ac.uk/efo/EFO_0010351
EFO_0010350	cholesteryl ester 22:6 measurement	http://www.ebi.ac.uk/efo/EFO_0010350
EFO_0010349	cholesteryl ester 20:5 measurement	http://www.ebi.ac.uk/efo/EFO_0010349
EFO_0010348	cholesteryl ester 20:4 measurement	http://www.ebi.ac.uk/efo/EFO_0010348
EFO_0010347	cholesteryl ester 20:3 measurement	http://www.ebi.ac.uk/efo/EFO_0010347
EFO_0010346	cholesteryl ester 18:3 measurement	http://www.ebi.ac.uk/efo/EFO_0010346
EFO_0010345	cholesteryl ester 18:2 measurement	http://www.ebi.ac.uk/efo/EFO_0010345
EFO_0009962	response to radioiodine	http://www.ebi.ac.uk/efo/EFO_0009962
EFO_0009963	bipolar I disorder	http://www.ebi.ac.uk/efo/EFO_0009963
EFO_0009964	bipolar II disorder	http://www.ebi.ac.uk/efo/EFO_0009964
EFO_0009965	Schizoaffective disorder-bipolar type	http://www.ebi.ac.uk/efo/EFO_0009965
MONDO_0002491	substance abuse	http://purl.obolibrary.org/obo/MONDO_0002491
EFO_0004145	myopathy	http://www.ebi.ac.uk/efo/EFO_0004145
EFO_0010099	chronic widespread pain	http://www.ebi.ac.uk/efo/EFO_0010099
EFO_0010100	multisite chronic pain	http://www.ebi.ac.uk/efo/EFO_0010100
EFO_0010084	anti-meningococcal C IgG measurement	http://www.ebi.ac.uk/efo/EFO_0010084
EFO_0010085	anti-tetanus toxoid IgG measurement	http://www.ebi.ac.uk/efo/EFO_0010085
EFO_0010086	anti-Haemophilus influenzae type b polyribosylribitol phosphate IgG measurement	http://www.ebi.ac.uk/efo/EFO_0010086
EFO_0010087	anti-meningococcal C serum bactericidal antibody measurement	http://www.ebi.ac.uk/efo/EFO_0010087
EFO_0010091	tea consumption measurement	http://www.ebi.ac.uk/efo/EFO_0010091
EFO_0010092	bitter alcoholic beverage consumption measurement	http://www.ebi.ac.uk/efo/EFO_0010092
EFO_0010093	bitter non-alcoholic beverage consumption measurement	http://www.ebi.ac.uk/efo/EFO_0010093
EFO_0010094	grapefruit juice consumption measurement	http://www.ebi.ac.uk/efo/EFO_0010094
EFO_0010095	non-grapefruit juice consumption measurement	http://www.ebi.ac.uk/efo/EFO_0010095
EFO_0010096	artificially sweetened beverage consumption measurement	http://www.ebi.ac.uk/efo/EFO_0010096
EFO_0010097	sugar sweetened beverage consumption measurement	http://www.ebi.ac.uk/efo/EFO_0010097
EFO_0010089	bitter beverage consumption measurement	http://www.ebi.ac.uk/efo/EFO_0010089
EFO_0010090	sweet beverage consumption measurement	http://www.ebi.ac.uk/efo/EFO_0010090
EFO_0010098	stress-related disorder	http://www.ebi.ac.uk/efo/EFO_0010098
EFO_0010101	decreased susceptibility to hepatitis C infection	http://www.ebi.ac.uk/efo/EFO_0010101
EFO_0010103	response to peginterferon alfa-2a	http://www.ebi.ac.uk/efo/EFO_0010103
EFO_0010104	health literacy measurement	http://www.ebi.ac.uk/efo/EFO_0010104
EFO_0010105	CD4-positive T-lymphocyte count	http://www.ebi.ac.uk/efo/EFO_0010105
EFO_0010106	CD3-positive T-lymphocyte count	http://www.ebi.ac.uk/efo/EFO_0010106
EFO_0010107	CD8-positive T-lymphocyte count	http://www.ebi.ac.uk/efo/EFO_0010107
EFO_0010108	CD19-positive B-lymphocyte count	http://www.ebi.ac.uk/efo/EFO_0010108
EFO_0010109	CD56-positive NK-lymphocyte cell count	http://www.ebi.ac.uk/efo/EFO_0010109
EFO_0010110	ketone body measurement	http://www.ebi.ac.uk/efo/EFO_0010110
EFO_0010111	acetoacetate measurement	http://www.ebi.ac.uk/efo/EFO_0010111
EFO_0010112	acetate measurement	http://www.ebi.ac.uk/efo/EFO_0010112
EFO_0010113	3-hydroxybutyric acid measurement	http://www.ebi.ac.uk/efo/EFO_0010113
EFO_0010114	citrate measurement	http://www.ebi.ac.uk/efo/EFO_0010114
EFO_0010115	glycerol measurement	http://www.ebi.ac.uk/efo/EFO_0010115
EFO_0010116	choline measurement	http://www.ebi.ac.uk/efo/EFO_0010116
EFO_0010117	pyruvate measurement	http://www.ebi.ac.uk/efo/EFO_0010117
EFO_0010118	sphingomyelin measurement	http://www.ebi.ac.uk/efo/EFO_0010118
EFO_0010119	omega-3 polyunsaturated fatty acid measurement	http://www.ebi.ac.uk/efo/EFO_0010119
EFO_0010120	fasting blood glucose change measurement	http://www.ebi.ac.uk/efo/EFO_0010120
EFO_0009522	disturbance of skin sensation	http://www.ebi.ac.uk/efo/EFO_0009522
HP_0001760	Abnormal foot morphology	http://purl.obolibrary.org/obo/HP_0001760
HP_0002141	gait imbalance	http://purl.obolibrary.org/obo/HP_0002141
HP_0003474	sensory impairment	http://purl.obolibrary.org/obo/HP_0003474
EFO_0010132	decreased fine motor function	http://www.ebi.ac.uk/efo/EFO_0010132
EFO_0010131	decreased walking ability	http://www.ebi.ac.uk/efo/EFO_0010131
EFO_0010130	health study participation	http://www.ebi.ac.uk/efo/EFO_0010130
EFO_0010125	viral load	http://www.ebi.ac.uk/efo/EFO_0010125
EFO_0010123	response to antiviral drug	http://www.ebi.ac.uk/efo/EFO_0010123
EFO_0010126	time to first cigarette measurement	http://www.ebi.ac.uk/efo/EFO_0010126
EFO_0010127	serum immunoglobulin measurement	http://www.ebi.ac.uk/efo/EFO_0010127
EFO_0010128	immunoglobulin isotype switching measurement	http://www.ebi.ac.uk/efo/EFO_0010128
EFO_0010129	breakfast skipping measurement	http://www.ebi.ac.uk/efo/EFO_0010129
EFO_0010124	response to atorvastatin	http://www.ebi.ac.uk/efo/EFO_0010124
EFO_0010133	diabetic maculopathy	http://www.ebi.ac.uk/efo/EFO_0010133
EFO_0010134	kidney transplant	http://www.ebi.ac.uk/efo/EFO_0010134
EFO_1000826	atrophic gastritis	http://www.ebi.ac.uk/efo/EFO_1000826
EFO_0010139	fish consumption measurement	http://www.ebi.ac.uk/efo/EFO_0010139
EFO_0010140	opioid overdose severity measurement	http://www.ebi.ac.uk/efo/EFO_0010140
EFO_0010141	sexual behavior	http://www.ebi.ac.uk/efo/EFO_0010141
EFO_0010142	same-sex sexual behavior	http://www.ebi.ac.uk/efo/EFO_0010142
GO_0050916	sensory perception of sweet taste	http://purl.obolibrary.org/obo/GO_0050916
EFO_0009186	platelet larger cell ratio	http://www.ebi.ac.uk/efo/EFO_0009186
EFO_0010234	viral subtype carrier status	http://www.ebi.ac.uk/efo/EFO_0010234
EFO_0010239	cortisol:DHEAS ratio measurement	http://www.ebi.ac.uk/efo/EFO_0010239
EFO_0010240	dehydroepiandrosterone measurement	http://www.ebi.ac.uk/efo/EFO_0010240
EFO_0010241	galectin-3-binding protein measurement	http://www.ebi.ac.uk/efo/EFO_0010241
EFO_0010242	beta globulin measurement	http://www.ebi.ac.uk/efo/EFO_0010242
EFO_0010243	inorganic ion measurement	http://www.ebi.ac.uk/efo/EFO_0010243
EFO_0010272	abdominal aortic calcification measurement	http://www.ebi.ac.uk/efo/EFO_0010272
EFO_0010273	thoracic aortic calcification measurement	http://www.ebi.ac.uk/efo/EFO_0010273
EFO_1001243	wheat allergic reaction	http://www.ebi.ac.uk/efo/EFO_1001243
EFO_0010288	brain density measurement	http://www.ebi.ac.uk/efo/EFO_0010288
EFO_0010306	Grey matter density measurement	http://www.ebi.ac.uk/efo/EFO_0010306
EFO_0010287	brain cortex volume measurement	http://www.ebi.ac.uk/efo/EFO_0010287
EFO_0010309	insular cortex volume measurement	http://www.ebi.ac.uk/efo/EFO_0010309
EFO_0010291	cerebellum cortex volume measurement	http://www.ebi.ac.uk/efo/EFO_0010291
EFO_0010337	ventral diencephalon volume measurement	http://www.ebi.ac.uk/efo/EFO_0010337
EFO_0010335	third ventricle volume measurement	http://www.ebi.ac.uk/efo/EFO_0010335
EFO_0010313	limbic lobe volume measurement	http://www.ebi.ac.uk/efo/EFO_0010313
EFO_0010303	fourth ventricle volume measurement	http://www.ebi.ac.uk/efo/EFO_0010303
EFO_0010299	corpus callosum volume measurement	http://www.ebi.ac.uk/efo/EFO_0010299
EFO_0010294	cingulate cortex volume measurement	http://www.ebi.ac.uk/efo/EFO_0010294
EFO_0010293	choroid plexus volume measurement	http://www.ebi.ac.uk/efo/EFO_0010293
EFO_0010292	cerebral cortex volume measurement	http://www.ebi.ac.uk/efo/EFO_0010292
EFO_0010333	temporal horn of lateral ventricle volume measurement	http://www.ebi.ac.uk/efo/EFO_0010333
EFO_0010329	superior frontal gyrus volume measurement	http://www.ebi.ac.uk/efo/EFO_0010329
EFO_0010328	rostral middle frontal gyrus volume measurement	http://www.ebi.ac.uk/efo/EFO_0010328
EFO_0010325	precentral gyrus volume measurement	http://www.ebi.ac.uk/efo/EFO_0010325
EFO_0010321	pars triangularis volume measurement	http://www.ebi.ac.uk/efo/EFO_0010321
EFO_0010320	pars orbitalis volume measurement	http://www.ebi.ac.uk/efo/EFO_0010320
EFO_0010319	pars opercularis volume measurement	http://www.ebi.ac.uk/efo/EFO_0010319
EFO_0010317	paracentral lobule volume measurement	http://www.ebi.ac.uk/efo/EFO_0010317
EFO_0010315	medial orbital frontal cortex volume measurement	http://www.ebi.ac.uk/efo/EFO_0010315
EFO_0010312	lateral orbital frontal cortex volume measurement	http://www.ebi.ac.uk/efo/EFO_0010312
EFO_0010304	frontal pole volume measurement	http://www.ebi.ac.uk/efo/EFO_0010304
EFO_0010290	caudal middle frontal gyrus volume measurement	http://www.ebi.ac.uk/efo/EFO_0010290
EFO_0010322	pericalcarine cortex volume measurement	http://www.ebi.ac.uk/efo/EFO_0010322
EFO_0010314	lingual gyrus volume measurement	http://www.ebi.ac.uk/efo/EFO_0010314
EFO_0010311	lateral occipital cortex volume measurement	http://www.ebi.ac.uk/efo/EFO_0010311
EFO_0010301	cuneus cortex volume measurement	http://www.ebi.ac.uk/efo/EFO_0010301
EFO_0010332	supramarginal gyrus volume measurement	http://www.ebi.ac.uk/efo/EFO_0010332
EFO_0010330	superior parietal cortex volume measurement	http://www.ebi.ac.uk/efo/EFO_0010330
EFO_0010326	precuneus cortex volume measurement	http://www.ebi.ac.uk/efo/EFO_0010326
EFO_0010323	postcentral gyrus volume measurement	http://www.ebi.ac.uk/efo/EFO_0010323
EFO_0010307	inferior parietal cortex volume measurement	http://www.ebi.ac.uk/efo/EFO_0010307
EFO_0010336	transverse temporal cortex volume measurement	http://www.ebi.ac.uk/efo/EFO_0010336
EFO_0010334	temporal pole volume measurement	http://www.ebi.ac.uk/efo/EFO_0010334
EFO_0010331	superior temporal gyrus volume measurement	http://www.ebi.ac.uk/efo/EFO_0010331
EFO_0010316	middle temporal gyrus volume measurement	http://www.ebi.ac.uk/efo/EFO_0010316
EFO_0010308	inferior temporal gyrus volume measurement	http://www.ebi.ac.uk/efo/EFO_0010308
EFO_0010305	fusiform gyrus volume measurement	http://www.ebi.ac.uk/efo/EFO_0010305
EFO_0010302	entorhinal cortex volume measurement	http://www.ebi.ac.uk/efo/EFO_0010302
EFO_0010286	banks of the superior temporal sulcus volume measurement	http://www.ebi.ac.uk/efo/EFO_0010286
EFO_0010327	rostral anterior cingulate cortex volume measurement	http://www.ebi.ac.uk/efo/EFO_0010327
EFO_0010324	posterior cingulate cortex volume measurement	http://www.ebi.ac.uk/efo/EFO_0010324
EFO_0010310	isthmus cingulate cortex volume measurement	http://www.ebi.ac.uk/efo/EFO_0010310
EFO_0010289	caudal anterior cingulate cortex volume measurement	http://www.ebi.ac.uk/efo/EFO_0010289
EFO_0010300	corpus collosum mid-posterior volume measurement	http://www.ebi.ac.uk/efo/EFO_0010300
EFO_0010298	corpus callosum posterior volume measurement	http://www.ebi.ac.uk/efo/EFO_0010298
EFO_0010296	corpus callosum central volume measurement	http://www.ebi.ac.uk/efo/EFO_0010296
EFO_0010297	corpus callosum mid-anterior volume measurement	http://www.ebi.ac.uk/efo/EFO_0010297
EFO_0010295	corpus callosum anterior volume measurement	http://www.ebi.ac.uk/efo/EFO_0010295
EFO_0010318	parahippocampal gyrus volume measurement	http://www.ebi.ac.uk/efo/EFO_0010318
EFO_0010549	xanthosine measurement	http://www.ebi.ac.uk/efo/EFO_0010549
EFO_0010548	xanthine measurement	http://www.ebi.ac.uk/efo/EFO_0010548
EFO_0010547	ursodeoxycholate measurement	http://www.ebi.ac.uk/efo/EFO_0010547
EFO_0010546	uridine measurement	http://www.ebi.ac.uk/efo/EFO_0010546
EFO_0010545	uridine diphosphate measurement	http://www.ebi.ac.uk/efo/EFO_0010545
EFO_0010544	uridine diphosphate glucose measurement	http://www.ebi.ac.uk/efo/EFO_0010544
EFO_0010543	uridine diphosphate galactose measurement	http://www.ebi.ac.uk/efo/EFO_0010543
EFO_0010542	ureidopropionic acid measurement	http://www.ebi.ac.uk/efo/EFO_0010542
EFO_0010541	trimethylamine-N-oxide measurement	http://www.ebi.ac.uk/efo/EFO_0010541
EFO_0010540	thiamine measurement	http://www.ebi.ac.uk/efo/EFO_0010540
EFO_0010539	taurodeoxycholate measurement	http://www.ebi.ac.uk/efo/EFO_0010539
EFO_0010538	taurocholate measurement	http://www.ebi.ac.uk/efo/EFO_0010538
EFO_0010537	taurochenodeoxycholate measurement	http://www.ebi.ac.uk/efo/EFO_0010537
EFO_0010536	taurine measurement	http://www.ebi.ac.uk/efo/EFO_0010536
EFO_0010535	sucrose measurement	http://www.ebi.ac.uk/efo/EFO_0010535
EFO_0010534	suberic acid measurement	http://www.ebi.ac.uk/efo/EFO_0010534
EFO_0010533	sorbitol measurement	http://www.ebi.ac.uk/efo/EFO_0010533
EFO_0010532	salicylurate measurement	http://www.ebi.ac.uk/efo/EFO_0010532
EFO_0010531	S-adenosylhomocysteine measurement	http://www.ebi.ac.uk/efo/EFO_0010531
EFO_0010530	ribulose-5-phosphate measurement	http://www.ebi.ac.uk/efo/EFO_0010530
EFO_0010529	ribose-5-phosphate measurement	http://www.ebi.ac.uk/efo/EFO_0010529
EFO_0010528	quinolinic acid measurement	http://www.ebi.ac.uk/efo/EFO_0010528
EFO_0010527	pyridoxate measurement	http://www.ebi.ac.uk/efo/EFO_0010527
EFO_0010526	purine measurement	http://www.ebi.ac.uk/efo/EFO_0010526
EFO_0010525	propionic acid measurement	http://www.ebi.ac.uk/efo/EFO_0010525
EFO_0010524	pimelic acid measurement	http://www.ebi.ac.uk/efo/EFO_0010524
EFO_0010523	phosphoglyceric acid measurement	http://www.ebi.ac.uk/efo/EFO_0010523
EFO_0010522	phosphoenolpyruvic acid measurement	http://www.ebi.ac.uk/efo/EFO_0010522
EFO_0010521	phosphocreatine measurement	http://www.ebi.ac.uk/efo/EFO_0010521
EFO_0010520	peptide measurement	http://www.ebi.ac.uk/efo/EFO_0010520
EFO_0010519	pantothenic acid mesurement	http://www.ebi.ac.uk/efo/EFO_0010519
EFO_1001282	candidemia	http://www.ebi.ac.uk/efo/EFO_1001282
EFO_0009658	adverse effect	http://www.ebi.ac.uk/efo/EFO_0009658
HP_0011037	Decreased urine output	http://purl.obolibrary.org/obo/HP_0011037
HP_0030839	knee pain	http://purl.obolibrary.org/obo/HP_0030839
EFO_0010143	chronic mountain sickness	http://www.ebi.ac.uk/efo/EFO_0010143
EFO_0010144	frontal lobe volume measurement	http://www.ebi.ac.uk/efo/EFO_0010144
EFO_0010145	occipital lobe volume measurement	http://www.ebi.ac.uk/efo/EFO_0010145
EFO_0010146	parietal lobe volume measurement	http://www.ebi.ac.uk/efo/EFO_0010146
EFO_0010147	temporal lobe volume measurement	http://www.ebi.ac.uk/efo/EFO_0010147
EFO_0010148	pepsinogen-I measurement	http://www.ebi.ac.uk/efo/EFO_0010148
EFO_0010149	pepsinogen I/II ratio	http://www.ebi.ac.uk/efo/EFO_0010149
EFO_0010150	anti-anoctamin 2 antibody measurement	http://www.ebi.ac.uk/efo/EFO_0010150
MONDO_0018906	follicular lymphoma	http://purl.obolibrary.org/obo/MONDO_0018906
HP_0000565	esotropia	http://purl.obolibrary.org/obo/HP_0000565
HP_0020046	accommodative esotropia	http://purl.obolibrary.org/obo/HP_0020046
HP_0031760	Non-accomodative esotropia	http://purl.obolibrary.org/obo/HP_0031760
MONDO_0001020	amblyopia (disease)	http://purl.obolibrary.org/obo/MONDO_0001020
MONDO_0004891	hyperopia	http://purl.obolibrary.org/obo/MONDO_0004891
EFO_0010151	soluble triggering receptor expressed on myeloid cells 2 measurement	http://www.ebi.ac.uk/efo/EFO_0010151
EFO_0010155	taste liking measurement	http://www.ebi.ac.uk/efo/EFO_0010155
EFO_0010156	sweet liking measurement	http://www.ebi.ac.uk/efo/EFO_0010156
EFO_0010157	sucrose liking measurement	http://www.ebi.ac.uk/efo/EFO_0010157
EFO_0010158	sugar consumption measurement	http://www.ebi.ac.uk/efo/EFO_0010158
EFO_1001375	myocardial ischemia	http://www.ebi.ac.uk/efo/EFO_1001375
EFO_0004566	body weight gain	http://www.ebi.ac.uk/efo/EFO_0004566
EFO_0006842	diabetes mellitus biomarker	http://www.ebi.ac.uk/efo/EFO_0006842
GO_0006950	response to stress	http://purl.obolibrary.org/obo/GO_0006950
EFO_1000244	Epithelioid Cell Uveal Melanoma	http://www.ebi.ac.uk/efo/EFO_1000244
EFO_0005105	lipid or lipoprotein measurement	http://www.ebi.ac.uk/efo/EFO_0005105
HP_0001647	bicuspid aortic valve	http://purl.obolibrary.org/obo/HP_0001647
CHEBI_16027	adenosine 5'-monophosphate	http://purl.obolibrary.org/obo/CHEBI_16027
HP_0000132	Menorrhagia	http://purl.obolibrary.org/obo/HP_0000132
HP_0000486	strabismus	http://purl.obolibrary.org/obo/HP_0000486
EFO_0007208	Churg-Strauss syndrome	http://www.ebi.ac.uk/efo/EFO_0007208
EFO_0010445	cocaine use disorder	http://www.ebi.ac.uk/efo/EFO_0010445
EFO_0010518	oxide measurement	http://www.ebi.ac.uk/efo/EFO_0010518
EFO_0010517	oxalate measurement	http://www.ebi.ac.uk/efo/EFO_0010517
EFO_0010516	orotic acid measurement	http://www.ebi.ac.uk/efo/EFO_0010516
EFO_0010515	organic cation measurement	http://www.ebi.ac.uk/efo/EFO_0010515
EFO_0010514	organic anion measurement	http://www.ebi.ac.uk/efo/EFO_0010514
EFO_0010513	nucleotide measurement	http://www.ebi.ac.uk/efo/EFO_0010513
EFO_0010512	nucleoside measurement	http://www.ebi.ac.uk/efo/EFO_0010512
EFO_0010511	niacinamide measurement	http://www.ebi.ac.uk/efo/EFO_0010511
EFO_0010510	NG-monomethyl-arginine measurement	http://www.ebi.ac.uk/efo/EFO_0010510
EFO_0010509	maleate measurement	http://www.ebi.ac.uk/efo/EFO_0010509
EFO_0010508	malate measurement	http://www.ebi.ac.uk/efo/EFO_0010508
EFO_0010507	lactose measurement	http://www.ebi.ac.uk/efo/EFO_0010507
EFO_0010506	kynurenic acid measurement	http://www.ebi.ac.uk/efo/EFO_0010506
EFO_0010505	isocitrate measurement	http://www.ebi.ac.uk/efo/EFO_0010505
EFO_0010504	inositol measurement	http://www.ebi.ac.uk/efo/EFO_0010504
EFO_0010503	inosine measurement	http://www.ebi.ac.uk/efo/EFO_0010503
EFO_0010502	indoxyl sulfate measurement	http://www.ebi.ac.uk/efo/EFO_0010502
EFO_0010501	indole-3-propionate measurement	http://www.ebi.ac.uk/efo/EFO_0010501
EFO_0010500	hypoxanthine mesurement	http://www.ebi.ac.uk/efo/EFO_0010500
EFO_0010499	hyodeoxycholate measurement	http://www.ebi.ac.uk/efo/EFO_0010499
EFO_0010498	hydroxyproline measurement	http://www.ebi.ac.uk/efo/EFO_0010498
EFO_0010497	hydroxide measurement	http://www.ebi.ac.uk/efo/EFO_0010497
EFO_0010496	hippuric acid measurement	http://www.ebi.ac.uk/efo/EFO_0010496
EFO_0010495	guanosine monophosphate measurement	http://www.ebi.ac.uk/efo/EFO_0010495
EFO_0010494	guanosine diphosphate measurement	http://www.ebi.ac.uk/efo/EFO_0010494
EFO_0010493	glycodeoxycholate measurement	http://www.ebi.ac.uk/efo/EFO_0010493
EFO_0010492	glycocholic acid measurement	http://www.ebi.ac.uk/efo/EFO_0010492
EFO_0010491	glycocholate measurement	http://www.ebi.ac.uk/efo/EFO_0010491
EFO_0010490	glycochenodeoxycholate measurement	http://www.ebi.ac.uk/efo/EFO_0010490
EFO_0010489	glycerophosphocholine measurement	http://www.ebi.ac.uk/efo/EFO_0010489
EFO_0010488	glycerol-3-phosphate measurement	http://www.ebi.ac.uk/efo/EFO_0010488
EFO_0010487	glutamate measurement	http://www.ebi.ac.uk/efo/EFO_0010487
EFO_0010486	glucuronate measurement	http://www.ebi.ac.uk/efo/EFO_0010486
EFO_0010485	glucose-6-phosphate measurement	http://www.ebi.ac.uk/efo/EFO_0010485
EFO_0010484	glucose-1-phosphate measurement	http://www.ebi.ac.uk/efo/EFO_0010484
EFO_0010483	gentisic acid measurement	http://www.ebi.ac.uk/efo/EFO_0010483
EFO_0010482	gamma-aminoisobutyric acid measurement	http://www.ebi.ac.uk/efo/EFO_0010482
EFO_0010481	galactose measurement	http://www.ebi.ac.uk/efo/EFO_0010481
EFO_0010480	fumarate measurement	http://www.ebi.ac.uk/efo/EFO_0010480
EFO_0010479	fructose-6-phosphate measurement	http://www.ebi.ac.uk/efo/EFO_0010479
EFO_0010478	fructose-1-phosphate measurement	http://www.ebi.ac.uk/efo/EFO_0010478
EFO_0010477	fructose measurement	http://www.ebi.ac.uk/efo/EFO_0010477
EFO_0010476	dimethylglycine measurement	http://www.ebi.ac.uk/efo/EFO_0010476
EFO_0010475	deoxycholate measurement	http://www.ebi.ac.uk/efo/EFO_0010475
EFO_0010474	cystathionine measurement	http://www.ebi.ac.uk/efo/EFO_0010474
EFO_0010473	cyclic adenosine monophosphate measurement	http://www.ebi.ac.uk/efo/EFO_0010473
EFO_0010472	creatine measurement	http://www.ebi.ac.uk/efo/EFO_0010472
EFO_0010471	chenodeoxycholate measurement	http://www.ebi.ac.uk/efo/EFO_0010471
EFO_0010470	carnosine measurement	http://www.ebi.ac.uk/efo/EFO_0010470
EFO_0010469	carnitine measurement	http://www.ebi.ac.uk/efo/EFO_0010469
EFO_0010468	carboxylic acid measurement	http://www.ebi.ac.uk/efo/EFO_0010468
EFO_0010467	carboxylic acid anion measurement	http://www.ebi.ac.uk/efo/EFO_0010467
EFO_0010466	carboxamide measurement	http://www.ebi.ac.uk/efo/EFO_0010466
EFO_0010465	beta-hydroxybutyric acid measurement	http://www.ebi.ac.uk/efo/EFO_0010465
EFO_0010464	beta-aminoisobutyric acid measurement	http://www.ebi.ac.uk/efo/EFO_0010464
EFO_0010463	asymmetric dimethylarginine measurement	http://www.ebi.ac.uk/efo/EFO_0010463
EFO_0010462	aspartate measurement	http://www.ebi.ac.uk/efo/EFO_0010462
EFO_0010461	argininosuccinate measurement	http://www.ebi.ac.uk/efo/EFO_0010461
EFO_0010460	anthranilic acid measurement	http://www.ebi.ac.uk/efo/EFO_0010460
EFO_0010459	aminoadipic acid measurement	http://www.ebi.ac.uk/efo/EFO_0010459
EFO_0010458	alpha-hydroxybutyric acid measurement	http://www.ebi.ac.uk/efo/EFO_0010458
EFO_0010457	Alpha ketoglutarate measurement	http://www.ebi.ac.uk/efo/EFO_0010457
EFO_0010456	allantoin measurement	http://www.ebi.ac.uk/efo/EFO_0010456
EFO_0010455	adipic acid mesurement	http://www.ebi.ac.uk/efo/EFO_0010455
EFO_0010454	adenosine monophosphate measurement	http://www.ebi.ac.uk/efo/EFO_0010454
EFO_0010453	adenosine measurement	http://www.ebi.ac.uk/efo/EFO_0010453
EFO_0010452	adenosine diphosphate measurement	http://www.ebi.ac.uk/efo/EFO_0010452
EFO_0010451	aconitate measurement	http://www.ebi.ac.uk/efo/EFO_0010451
EFO_0010450	3-phosphoglyceric acid	http://www.ebi.ac.uk/efo/EFO_0010450
EFO_0010449	3-methyladipic acid measurement	http://www.ebi.ac.uk/efo/EFO_0010449
EFO_0010448	3-hydroxyphenylacetic acid measurement	http://www.ebi.ac.uk/efo/EFO_0010448
EFO_0010447	3-hydroxyanthranilic acid measurement	http://www.ebi.ac.uk/efo/EFO_0010447
EFO_0010446	2-hydroxyglutaric acid measurement	http://www.ebi.ac.uk/efo/EFO_0010446
HP_0000738	hallucinations	http://purl.obolibrary.org/obo/HP_0000738
EFO_0010557	lactose tolerance test	http://www.ebi.ac.uk/efo/EFO_0010557
EFO_0000198	myelodysplastic syndrome	http://www.ebi.ac.uk/efo/EFO_0000198
HP_0000989	Pruritus	http://purl.obolibrary.org/obo/HP_0000989
EFO_0003929	relapsing-remitting multiple sclerosis	http://www.ebi.ac.uk/efo/EFO_0003929
MONDO_0003783	lymphopenia (disease)	http://purl.obolibrary.org/obo/MONDO_0003783
EFO_0010577	response to dimethyl fumarate	http://www.ebi.ac.uk/efo/EFO_0010577
EFO_0010572	growth rate measurement	http://www.ebi.ac.uk/efo/EFO_0010572
EFO_0010573	kallikrein-11 measurement	http://www.ebi.ac.uk/efo/EFO_0010573
EFO_0010574	epithelial cell adhesion molecule measurement	http://www.ebi.ac.uk/efo/EFO_0010574
EFO_0010575	vascular endothelial growth factor D measurement	http://www.ebi.ac.uk/efo/EFO_0010575
EFO_0010576	liver fibrosis measurement	http://www.ebi.ac.uk/efo/EFO_0010576
HP_0200023	priapism	http://purl.obolibrary.org/obo/HP_0200023
EFO_0010578	complex trait	http://www.ebi.ac.uk/efo/EFO_0010578
HP_0012532	chronic pain	http://purl.obolibrary.org/obo/HP_0012532
EFO_0010586	CD40 measurement	http://www.ebi.ac.uk/efo/EFO_0010586
EFO_0010587	interleukin-2 receptor subunit alpha measurement	http://www.ebi.ac.uk/efo/EFO_0010587
EFO_0010588	matrix metalloproteinase 1 measurement	http://www.ebi.ac.uk/efo/EFO_0010588
EFO_0010589	matrix metalloproteinase 10 measurement	http://www.ebi.ac.uk/efo/EFO_0010589
EFO_0010590	matrix metalloproteinase 12 measurement	http://www.ebi.ac.uk/efo/EFO_0010590
EFO_0010591	matrix metalloproteinase 7 measurement	http://www.ebi.ac.uk/efo/EFO_0010591
EFO_0010592	tumor necrosis factor ligand superfamily member 8 measurement	http://www.ebi.ac.uk/efo/EFO_0010592
EFO_0010593	cystatin B measurement	http://www.ebi.ac.uk/efo/EFO_0010593
EFO_0010594	Fms-related tyrosine kinase 3 ligand measurement	http://www.ebi.ac.uk/efo/EFO_0010594
EFO_0010595	heat shock protein beta-1 measurement	http://www.ebi.ac.uk/efo/EFO_0010595
EFO_0010596	monocyte chemotactic protein 1 measurement	http://www.ebi.ac.uk/efo/EFO_0010596
EFO_0010597	NF-kappa-B essential modulator measurement	http://www.ebi.ac.uk/efo/EFO_0010597
EFO_0010598	platelet endothelial cell adhesion molecule measurement	http://www.ebi.ac.uk/efo/EFO_0010598
EFO_0010599	ST2 protein measurement	http://www.ebi.ac.uk/efo/EFO_0010599
EFO_0010600	angiopoietin-1 receptor measurement	http://www.ebi.ac.uk/efo/EFO_0010600
EFO_0010601	hepatitis A virus cellular receptor 1 measurement	http://www.ebi.ac.uk/efo/EFO_0010601
EFO_0010604	urine volume measurement	http://www.ebi.ac.uk/efo/EFO_0010604
EFO_0010605	brain stem volume measurement	http://www.ebi.ac.uk/efo/EFO_0010605
EFO_0010606	sclerostin measurement	http://www.ebi.ac.uk/efo/EFO_0010606
HP_0002916	Abnormality of chromosome segregation	http://purl.obolibrary.org/obo/HP_0002916
EFO_0010629	prointerleukin16 measurement	http://www.ebi.ac.uk/efo/EFO_0010629
EFO_0010607	tumor necrosis factor, receptor superfamily, member 5 measurement	http://www.ebi.ac.uk/efo/EFO_0010607
EFO_0010608	stromelysin1 measurement	http://www.ebi.ac.uk/efo/EFO_0010608
EFO_0010609	mucin16 measurement	http://www.ebi.ac.uk/efo/EFO_0010609
EFO_0009609	myocarditis	http://www.ebi.ac.uk/efo/EFO_0009609
EFO_0009549	female reproductive system disease	http://www.ebi.ac.uk/efo/EFO_0009549
MONDO_0019472	extranodal nasal NK/T cell lymphoma	http://purl.obolibrary.org/obo/MONDO_0019472
HP_0001822	hallux valgus	http://purl.obolibrary.org/obo/HP_0001822
EFO_0010650	creativity measurement	http://www.ebi.ac.uk/efo/EFO_0010650
HP_0000639	nystagmus	http://purl.obolibrary.org/obo/HP_0000639
EFO_0010696	soluble gp130 measurement	http://www.ebi.ac.uk/efo/EFO_0010696
HP_0010992	stress urinary incontinence	http://purl.obolibrary.org/obo/HP_0010992
EFO_0005773	retinal detachment	http://www.ebi.ac.uk/efo/EFO_0005773
EFO_0010698	retinal break	http://www.ebi.ac.uk/efo/EFO_0010698
MONDO_0007182	Machado-Joseph disease	http://purl.obolibrary.org/obo/MONDO_0007182
EFO_0010699	diffuse plaque measurement	http://www.ebi.ac.uk/efo/EFO_0010699
EFO_0010702	opioid use disorder	http://www.ebi.ac.uk/efo/EFO_0010702
EFO_0010703	trauma exposure measurement	http://www.ebi.ac.uk/efo/EFO_0010703
Orphanet_139390	isolated craniosynostosis	http://www.orpha.net/ORDO/Orphanet_139390
EFO_0008511	metopic craniosynostosis	http://www.ebi.ac.uk/efo/EFO_0008511
EFO_0010718	response to amisulpride	http://www.ebi.ac.uk/efo/EFO_0010718
MONDO_0002046	alcohol abuse	http://purl.obolibrary.org/obo/MONDO_0002046
EFO_1001950	colon carcinoma	http://www.ebi.ac.uk/efo/EFO_1001950
EFO_1002032	primary hypertension	http://www.ebi.ac.uk/efo/EFO_1002032
HP_0002172	postural instability	http://purl.obolibrary.org/obo/HP_0002172
EFO_0010906	merkel cell virus seropositivity	http://www.ebi.ac.uk/efo/EFO_0010906
EFO_0010932	urokinase plasminogen activator surface receptor measurement	http://www.ebi.ac.uk/efo/EFO_0010932
EFO_0010931	tumor necrosis factor receptor 1 measurement	http://www.ebi.ac.uk/efo/EFO_0010931
EFO_0010930	TNF-related apoptosis-inducing ligand receptor 2 measurement	http://www.ebi.ac.uk/efo/EFO_0010930
EFO_0010929	TNF-related activation-induced cytokine measurement	http://www.ebi.ac.uk/efo/EFO_0010929
EFO_1001893	hand-foot syndrome	http://www.ebi.ac.uk/efo/EFO_1001893
MONDO_0000870	childhood acute lymphoblastic leukemia	http://purl.obolibrary.org/obo/MONDO_0000870
EFO_0010947	epidermal growth factor measurement	http://www.ebi.ac.uk/efo/EFO_0010947
EFO_0010948	lower face morphology measurement	http://www.ebi.ac.uk/efo/EFO_0010948
EFO_0010949	upper face morphology measurement	http://www.ebi.ac.uk/efo/EFO_0010949
EFO_0006325	response to serotonin-norephinephrine reuptake inhibitor	http://www.ebi.ac.uk/efo/EFO_0006325
MONDO_0002334	hematopoietic and lymphoid system neoplasm	http://purl.obolibrary.org/obo/MONDO_0002334
MONDO_0018469	pulmonary non-tuberculous mycobacterial infection	http://purl.obolibrary.org/obo/MONDO_0018469
EFO_0010970	severe malarial anemia	http://www.ebi.ac.uk/efo/EFO_0010970
MONDO_0009410	Addison disease	http://purl.obolibrary.org/obo/MONDO_0009410
EFO_0010822	stenosing tenosynovitis	http://www.ebi.ac.uk/efo/EFO_0010822
EFO_0011009	glycochenodeoxycholate 3-O-glucuronide measurement	http://www.ebi.ac.uk/efo/EFO_0011009
EFO_0011010	glycodeoxycholate 3-O-glucuronide measurement	http://www.ebi.ac.uk/efo/EFO_0011010
EFO_0011014	health-related quality of life measurement	http://www.ebi.ac.uk/efo/EFO_0011014
EFO_0011015	educational attainment	http://www.ebi.ac.uk/efo/EFO_0011015
NCIT_C82004	brain-derived neurotrophic factor measurement	http://purl.obolibrary.org/obo/NCIT_C82004
HP_0012444	Brain atrophy	http://purl.obolibrary.org/obo/HP_0012444
MONDO_0041052	postherpetic neuralgia	http://purl.obolibrary.org/obo/MONDO_0041052
EFO_0005741	infectious disease	http://www.ebi.ac.uk/efo/EFO_0005741
EFO_1001164	SAPHO syndrome	http://www.ebi.ac.uk/efo/EFO_1001164
EFO_0009431	intestinal disease	http://www.ebi.ac.uk/efo/EFO_0009431
EFO_0000493	family history	http://www.ebi.ac.uk/efo/EFO_0000493
EFO_0011037	anti-human herpes virus 6 antibody measurement	http://www.ebi.ac.uk/efo/EFO_0011037
EFO_0011038	anti-human herpes virus 7 antibody measurement	http://www.ebi.ac.uk/efo/EFO_0011038
EFO_1001095	peptic esophagitis	http://www.ebi.ac.uk/efo/EFO_1001095
EFO_0007160	autoimmune thrombocytopenic purpura	http://www.ebi.ac.uk/efo/EFO_0007160
EFO_0001124	response to liver transplant	http://www.ebi.ac.uk/efo/EFO_0001124
EFO_0011043	neck circumference	http://www.ebi.ac.uk/efo/EFO_0011043
EFO_0011039	myeloperoxidase (MPO)-DNA complex measurement	http://www.ebi.ac.uk/efo/EFO_0011039
MONDO_0002078	heart septal defect	http://purl.obolibrary.org/obo/MONDO_0002078
MONDO_0000153	transposition of the great arteries	http://purl.obolibrary.org/obo/MONDO_0000153
HP_0030680	abnormality of cardiovascular system morphology	http://purl.obolibrary.org/obo/HP_0030680
EFO_0600001	ghrelin measurement	http://www.ebi.ac.uk/efo/EFO_0600001
EFO_0010812	T-cell immunoglobulin and mucin domain 1 measurement	http://www.ebi.ac.uk/efo/EFO_0010812
HP_0001397	hepatic steatosis	http://purl.obolibrary.org/obo/HP_0001397
EFO_0002950	pregnancy	http://www.ebi.ac.uk/efo/EFO_0002950
EFO_1001947	childhood T acute lymphoblastic leukemia	http://www.ebi.ac.uk/efo/EFO_1001947
EFO_0005251	hypotension	http://www.ebi.ac.uk/efo/EFO_0005251
EFO_0010928	SIR2-like protein 2 measurement	http://www.ebi.ac.uk/efo/EFO_0010928
EFO_0010927	proto-oncogene tyrosine-protein kinase Src measurement	http://www.ebi.ac.uk/efo/EFO_0010927
EFO_0010926	proteinase-activated receptor 1 measurement	http://www.ebi.ac.uk/efo/EFO_0010926
EFO_0010925	protein S100-A12 measurement	http://www.ebi.ac.uk/efo/EFO_0010925
EFO_0010924	proheparin-binding EGF-like growth factor measurement	http://www.ebi.ac.uk/efo/EFO_0010924
EFO_0010923	pentraxin-related protein PTX3 measurement	http://www.ebi.ac.uk/efo/EFO_0010923
EFO_0010922	P-selectin glycoprotein ligand 1 measurement	http://www.ebi.ac.uk/efo/EFO_0010922
EFO_0010921	N-terminal prohormone brain natriuretic peptide measurement	http://www.ebi.ac.uk/efo/EFO_0010921
EFO_0010920	membrane-bound aminopeptidase P measurement	http://www.ebi.ac.uk/efo/EFO_0010920
EFO_0010919	melusin measurement	http://www.ebi.ac.uk/efo/EFO_0010919
EFO_0010918	lectin-like oxidized LDL receptor 1 measurement	http://www.ebi.ac.uk/efo/EFO_0010918
EFO_0010917	kidney injury molecule 1 measurement	http://www.ebi.ac.uk/efo/EFO_0010917
EFO_0010916	interleukin-27 measurement	http://www.ebi.ac.uk/efo/EFO_0010916
EFO_0010915	heat shock 27 kDa protein measurement	http://www.ebi.ac.uk/efo/EFO_0010915
EFO_0010914	fatty acid-binding protein, adipocyte measurement	http://www.ebi.ac.uk/efo/EFO_0010914
EFO_0010913	eosinophil cationic protein measurement	http://www.ebi.ac.uk/efo/EFO_0010913
EFO_0010912	endothelial cell-specific molecule 1 measurement	http://www.ebi.ac.uk/efo/EFO_0010912
EFO_0010911	C-X-C motif chemokine 16 measurement	http://www.ebi.ac.uk/efo/EFO_0010911
EFO_0010910	C-C motif chemokine 20 measurement	http://www.ebi.ac.uk/efo/EFO_0010910
EFO_0010909	adrenomedullin measurement	http://www.ebi.ac.uk/efo/EFO_0010909
EFO_0009819	comparative body size at age 10, self-reported	http://www.ebi.ac.uk/efo/EFO_0009819
EFO_0011007	estrogen measurement	http://www.ebi.ac.uk/efo/EFO_0011007
EFO_0011013	vaginal microbiome measurement	http://www.ebi.ac.uk/efo/EFO_0011013
EFO_0010682	liver transplant	http://www.ebi.ac.uk/efo/EFO_0010682
Orphanet_636	neurofibromatosis type 1	http://www.orpha.net/ORDO/Orphanet_636
EFO_0008514	neurofibromatosis	http://www.ebi.ac.uk/efo/EFO_0008514
HP_0000957	cafe-au-lait spot	http://purl.obolibrary.org/obo/HP_0000957
Orphanet_791	retinitis pigmentosa	http://www.orpha.net/ORDO/Orphanet_791
EFO_1000882	coronary stenosis	http://www.ebi.ac.uk/efo/EFO_1000882
MONDO_0004247	peptic ulcer disease	http://purl.obolibrary.org/obo/MONDO_0004247
EFO_0011031	Intestinal permeability measurement	http://www.ebi.ac.uk/efo/EFO_0011031
HP_0001662	Bradycardia	http://purl.obolibrary.org/obo/HP_0001662
EFO_0011041	response to BCG intravesical immunotherapy	http://www.ebi.ac.uk/efo/EFO_0011041
EFO_0011045	fetal weight	http://www.ebi.ac.uk/efo/EFO_0011045
EFO_0600000	sortilin measurement	http://www.ebi.ac.uk/efo/EFO_0600000
EFO_1001904	oral mucositis	http://www.ebi.ac.uk/efo/EFO_1001904
EFO_0010700	reticulocyte measurement	http://www.ebi.ac.uk/efo/EFO_0010700
EFO_0010819	clonal hematopoiesis	http://www.ebi.ac.uk/efo/EFO_0010819
EFO_0010818	sensory perception of dietary content	http://www.ebi.ac.uk/efo/EFO_0010818
EFO_0010816	dietary fat liking measurement	http://www.ebi.ac.uk/efo/EFO_0010816
EFO_0010817	self-injurious ideation	http://www.ebi.ac.uk/efo/EFO_0010817
EFO_0003774	hyperlipidemia	http://www.ebi.ac.uk/efo/EFO_0003774
Orphanet_768	Familial long QT syndrome	http://www.orpha.net/ORDO/Orphanet_768
EFO_0000365	colorectal adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0000365
EFO_0004289	lymphoid leukemia	http://www.ebi.ac.uk/efo/EFO_0004289
MONDO_0002367	kidney cancer	http://purl.obolibrary.org/obo/MONDO_0002367
EFO_0005952	non-Hodgkins lymphoma	http://www.ebi.ac.uk/efo/EFO_0005952
EFO_0009551	heart valve disease	http://www.ebi.ac.uk/efo/EFO_0009551
EFO_0010940	microglial activation measurement	http://www.ebi.ac.uk/efo/EFO_0010940
EFO_1000904	drug-Induced dyskinesia	http://www.ebi.ac.uk/efo/EFO_1000904
EFO_0007444	Plasmodium falciparum malaria	http://www.ebi.ac.uk/efo/EFO_0007444
EFO_0005803	hematologic disease	http://www.ebi.ac.uk/efo/EFO_0005803
MONDO_0003060	biliary tract cancer	http://purl.obolibrary.org/obo/MONDO_0003060
EFO_1000049	pulmonary tuberculosis	http://www.ebi.ac.uk/efo/EFO_1000049
EFO_1000783	diabetic neuropathy	http://www.ebi.ac.uk/efo/EFO_1000783
EFO_0011011	sitting height measurement	http://www.ebi.ac.uk/efo/EFO_0011011
EFO_0011012	blood bicarbonate measurement	http://www.ebi.ac.uk/efo/EFO_0011012
EFO_0007167	Bell's palsy	http://www.ebi.ac.uk/efo/EFO_0007167
EFO_0009001	Mastocytosis	http://www.ebi.ac.uk/efo/EFO_0009001
EFO_1000886	cutaneous mastocytosis	http://www.ebi.ac.uk/efo/EFO_1000886
MONDO_0016586	systemic mastocytosis	http://purl.obolibrary.org/obo/MONDO_0016586
PATO_0000047	sex	http://purl.obolibrary.org/obo/PATO_0000047
EFO_0011036	matrix metalloproteinase-degraded type I collagen measurement	http://www.ebi.ac.uk/efo/EFO_0011036
EFO_0007229	cryptococcosis	http://www.ebi.ac.uk/efo/EFO_0007229
EFO_1001448	ventricular outflow obstruction	http://www.ebi.ac.uk/efo/EFO_1001448
EFO_0005046	cutaneous Leishmaniasis	http://www.ebi.ac.uk/efo/EFO_0005046
EFO_0011044	BMI-adjusted neck circumference	http://www.ebi.ac.uk/efo/EFO_0011044
MONDO_0008903	lung cancer	http://purl.obolibrary.org/obo/MONDO_0008903
EFO_0000771	bacterial disease	http://www.ebi.ac.uk/efo/EFO_0000771
Orphanet_1945	Rolandic epilepsy	http://www.orpha.net/ORDO/Orphanet_1945
EFO_0010701	mean reticulocyte volume	http://www.ebi.ac.uk/efo/EFO_0010701
EFO_0010821	liver fat measurement	http://www.ebi.ac.uk/efo/EFO_0010821
EFO_0010820	Spontaneous coronary artery dissection	http://www.ebi.ac.uk/efo/EFO_0010820
EFO_0004949	clinical temporal measurement	http://www.ebi.ac.uk/efo/EFO_0004949
HP_0004299	hernia of the abdominal wall	http://purl.obolibrary.org/obo/HP_0004299
EFO_0010825	response to fluoropyrimidines	http://www.ebi.ac.uk/efo/EFO_0010825
EFO_1001178	shoulder impingement syndrome	http://www.ebi.ac.uk/efo/EFO_1001178
EFO_0010824	response to rhododendrol	http://www.ebi.ac.uk/efo/EFO_0010824
EFO_0009482	drug allergy	http://www.ebi.ac.uk/efo/EFO_0009482
EFO_0010834	tumor necrosis factor measurement	http://www.ebi.ac.uk/efo/EFO_0010834
EFO_0009168	response to prednisolone	http://www.ebi.ac.uk/efo/EFO_0009168
EFO_0010908	Epstein-Barr virus seropositivity	http://www.ebi.ac.uk/efo/EFO_0010908
EFO_0010907	polyomavirus 2 seropositivity	http://www.ebi.ac.uk/efo/EFO_0010907
EFO_0010905	BK polyomavirus seropositivity	http://www.ebi.ac.uk/efo/EFO_0010905
EFO_0010904	anti-BK polyomavirus antibody measurement	http://www.ebi.ac.uk/efo/EFO_0010904
EFO_0010903	anti-chlamydia trachomatis antibody measurement	http://www.ebi.ac.uk/efo/EFO_0010903
EFO_0011033	ST segment duration	http://www.ebi.ac.uk/efo/EFO_0011033
EFO_0009685	rectal disease	http://www.ebi.ac.uk/efo/EFO_0009685
EFO_0010900	anti-polyomavirus 2 antibody measurement	http://www.ebi.ac.uk/efo/EFO_0010900
EFO_0010899	anti-merkel cell virus antibody measurement	http://www.ebi.ac.uk/efo/EFO_0010899
HP_0003146	hypocholesterolemia	http://purl.obolibrary.org/obo/HP_0003146
Orphanet_101953	rare dyslipidemia	http://www.orpha.net/ORDO/Orphanet_101953
EFO_0010966	pneumonia severity measurement	http://www.ebi.ac.uk/efo/EFO_0010966
EFO_0010971	response to metamizole	http://www.ebi.ac.uk/efo/EFO_0010971
HP_0001510	short stature	http://purl.obolibrary.org/obo/HP_0001510
EFO_0010969	response to growth hormone	http://www.ebi.ac.uk/efo/EFO_0010969
EFO_0009486	diabetic eye disease	http://www.ebi.ac.uk/efo/EFO_0009486
EFO_0010978	chemotherapy-induced cytotoxicity measurement	http://www.ebi.ac.uk/efo/EFO_0010978
EFO_0011005	urea measurement	http://www.ebi.ac.uk/efo/EFO_0011005
EFO_0011004	trimethylamine oxide measurement	http://www.ebi.ac.uk/efo/EFO_0011004
EFO_0011003	trimethylamine measurement	http://www.ebi.ac.uk/efo/EFO_0011003
EFO_0011002	succinate measurement	http://www.ebi.ac.uk/efo/EFO_0011002
EFO_0011001	scyllo-inositol measurement	http://www.ebi.ac.uk/efo/EFO_0011001
EFO_0011000	proline betaine measurement	http://www.ebi.ac.uk/efo/EFO_0011000
EFO_0010999	p-hydroxyphenylacetate measurement	http://www.ebi.ac.uk/efo/EFO_0010999
EFO_0010998	p-cresol sulfate measurement	http://www.ebi.ac.uk/efo/EFO_0010998
EFO_0010997	n1-methyl-nicotinamide measurement	http://www.ebi.ac.uk/efo/EFO_0010997
EFO_0010996	n-methylpicolinic acid measurement	http://www.ebi.ac.uk/efo/EFO_0010996
EFO_0010995	n-methylnicotinic acid measurement	http://www.ebi.ac.uk/efo/EFO_0010995
EFO_0010994	n-methyl-2-pyridone-5-carboxamide measurement	http://www.ebi.ac.uk/efo/EFO_0010994
EFO_0010993	n-acetyl neuraminic acid measurement	http://www.ebi.ac.uk/efo/EFO_0010993
EFO_0010992	hippurate measurement	http://www.ebi.ac.uk/efo/EFO_0010992
EFO_0010991	formate measurement	http://www.ebi.ac.uk/efo/EFO_0010991
EFO_0010990	dimethylamine measurement	http://www.ebi.ac.uk/efo/EFO_0010990
EFO_0010989	acetone measurement	http://www.ebi.ac.uk/efo/EFO_0010989
EFO_0010988	5-oxoproline measurement	http://www.ebi.ac.uk/efo/EFO_0010988
EFO_0010987	4-deoxythreonic acid measurement	http://www.ebi.ac.uk/efo/EFO_0010987
EFO_0010986	4-deoxyerythronic acid measurement	http://www.ebi.ac.uk/efo/EFO_0010986
EFO_0010985	3-Indoxylsulfate measurement	http://www.ebi.ac.uk/efo/EFO_0010985
EFO_0010984	3-hydroxyisovalerate measurement	http://www.ebi.ac.uk/efo/EFO_0010984
EFO_0010983	3-hydroxyisobutyrate measurement	http://www.ebi.ac.uk/efo/EFO_0010983
EFO_0010982	3-hydroxybutyrate measurement	http://www.ebi.ac.uk/efo/EFO_0010982
EFO_0010980	3-aminoisobutyrate measurement	http://www.ebi.ac.uk/efo/EFO_0010980
EFO_0010979	2-hydroxyisobutyrate measurement	http://www.ebi.ac.uk/efo/EFO_0010979
EFO_0010977	macrovascular complications of diabetes	http://www.ebi.ac.uk/efo/EFO_0010977
EFO_1000883	coronary thrombosis	http://www.ebi.ac.uk/efo/EFO_1000883
HP_0008770	Obsessive-compulsive trait	http://purl.obolibrary.org/obo/HP_0008770
EFO_0011022	BRCA2 mutation carrier status	http://www.ebi.ac.uk/efo/EFO_0011022
EFO_0011021	BRCA1 mutation carrier status	http://www.ebi.ac.uk/efo/EFO_0011021
EFO_0011023	concussion	http://www.ebi.ac.uk/efo/EFO_0011023
EFO_1001354	Kleine-Levin Syndrome	http://www.ebi.ac.uk/efo/EFO_1001354
EFO_0008505	hepatitis virus-related hepatocellular carcinoma	http://www.ebi.ac.uk/efo/EFO_0008505
EFO_0001668	human papilloma virus infection	http://www.ebi.ac.uk/efo/EFO_0001668
EFO_0011034	T wave duration	http://www.ebi.ac.uk/efo/EFO_0011034
EFO_0011035	TP segment duration	http://www.ebi.ac.uk/efo/EFO_0011035
EFO_0009552	hemorrhoid	http://www.ebi.ac.uk/efo/EFO_0009552
